Disease on EC 3.5.2.17 - hydroxyisourate hydrolase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Abortion, Spontaneous
Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss.
Acquired Immunodeficiency Syndrome
MicroRNA regulation of Transthyretin in trophoblast differentiation and Intra-Uterine Growth Restriction.
Acquired Immunodeficiency Syndrome
Nutritional status in patients with HIV infection and AIDS.
Acquired Immunodeficiency Syndrome
The acute-phase protein response to human immunodeficiency virus infection in human subjects.
Acute Kidney Injury
Gene Microarray Integrated with High-Throughput Proteomics for the Discovery of Transthyretin in Rhabdomyolysis-Induced Acute Kidney Injury.
Adenocarcinoma
Identification and verification of transthyretin as a potential biomarker for pancreatic ductal adenocarcinoma.
Adenocarcinoma
Immunohistochemical Assessment of Transthyretin Association with Colorectal Adenocarcinoma.
Adenocarcinoma of Lung
CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain.
Adenoma
Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels.
Albuminuria
Albumin/creatinine (uACR) and protein/creatinine (uPCR) ratios in spot urine samples can be used to evaluate albuminuria and proteinuria in hereditary transthyretin amyloidosis patients.
Alzheimer Disease
A highly sensitive fluorescent probe that quantifies transthyretin in human plasma as an early diagnostic tool of Alzheimer's disease.
Alzheimer Disease
A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein Aggregation.
Alzheimer Disease
A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition.
Alzheimer Disease
Accurate, strong, and stable reporting of choroid plexus epithelial cells in transgenic mice using a human transthyretin BAC.
Alzheimer Disease
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Alzheimer Disease
Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients: relation with the senile plaques and cytoskeleton biochemistry.
Alzheimer Disease
Association of TTR polymorphisms with hippocampal atrophy in Alzheimer disease families.
Alzheimer Disease
Asymmetric expression patterns of brain transthyretin in normal mice and a transgenic mouse model of Alzheimer's disease.
Alzheimer Disease
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis.
Alzheimer Disease
Calorimetric Studies of Binary and Ternary Molecular Interactions between Transthyretin, A? Peptides, and Small-Molecule Chaperones toward an Alternative Strategy for Alzheimer's Disease Drug Discovery.
Alzheimer Disease
Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease.
Alzheimer Disease
Chromolaena odorata (Siam weed): A natural reservoir of bioactive compounds with potent anti-fibrillogenic, antioxidative, and cytocompatible properties.
Alzheimer Disease
Concurrent cardiac transthyretin and brain ? amyloid accumulation among the older adults: The Hisayama study.
Alzheimer Disease
Crystal and molecular structure of piceatannol; scavenging features of resveratrol and piceatannol on hydroxyl and peroxyl radicals and docking with transthyretin.
Alzheimer Disease
Differential post-translational modifications of transthyretin in Alzheimer's disease: A study of the cerebral spinal fluid.
Alzheimer Disease
Distinct transthyretin oxidation isoform profile in spinal fluid from patients with Alzheimer's disease and mild cognitive impairment.
Alzheimer Disease
Effect of Red Wine Polyphenols on the Expression of Transthyretin in Murine Choroid Plexus.
Alzheimer Disease
Effects on transthyretin in plasma and cerebrospinal fluid by DHA-rich n - 3 fatty acid supplementation in patients with Alzheimer's disease: the OmegAD study.
Alzheimer Disease
Elevated risks for amyotrophic lateral sclerosis and blood disorders in Ashkenazi schizophrenic pedigrees suggest new candidate genes in schizophrenia.
Alzheimer Disease
Evidence for synergistic action of transthyretin and IGF-I over the IGF-I receptor.
Alzheimer Disease
Exploring the Physiological Role of Transthyretin in Glucose Metabolism in the Liver.
Alzheimer Disease
Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins.
Alzheimer Disease
Gender-Dependent Transthyretin Modulation of Brain Amyloid-? Levels: Evidence from a Mouse Model of Alzheimer's Disease.
Alzheimer Disease
Human Serum Transthyretin Levels Correlate Inversely with Alzheimer's Disease.
Alzheimer Disease
Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.
Alzheimer Disease
Isolated atrial amyloidosis and the importance of molecular classification.
Alzheimer Disease
Mechanisms of transthyretin inhibition of ?-amyloid aggregation in vitro.
Alzheimer Disease
Mitochondria-targeted catalase reduces abnormal APP processing, amyloid ? production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
Alzheimer Disease
Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective?
Alzheimer Disease
Neuroprotection in early stages of Alzheimer's disease is promoted by transthyretin angiogenic properties.
Alzheimer Disease
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Alzheimer Disease
Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
Alzheimer Disease
Preparative Scale Production of Recombinant Human Transthyretin for Biophysical Studies of Protein-Ligand and Protein-Protein Interactions.
Alzheimer Disease
Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.
Alzheimer Disease
Rare Genetic Variants of the Transthyretin Gene Are Associated with Alzheimer's Disease in Han Chinese.
Alzheimer Disease
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.
Alzheimer Disease
Serum levels of proteins involved in amyloid-? clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairment.
Alzheimer Disease
Serum transthyretin and risk of cognitive decline and dementia: 22-year longitudinal study.
Alzheimer Disease
Stability of the transthyretin molecule as a key factor in the interaction with a-beta peptide--relevance in Alzheimer's disease.
Alzheimer Disease
Sustained choroid plexus function in human elderly and Alzheimer's disease patients.
Alzheimer Disease
The effects of age, apolipoprotein E phenotype and gender on the concentration of amyloid-beta (A beta) 40, A beta 4242, apolipoprotein E and transthyretin in human cerebrospinal fluid.
Alzheimer Disease
The Function of Transthyretin Complexes with Metallothionein in Alzheimer's Disease.
Alzheimer Disease
The protease activity of transthyretin reverses the effect of pH on the amyloid-? protein/heparan sulfate proteoglycan interaction: a biochromatographic study.
Alzheimer Disease
The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.
Alzheimer Disease
Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Alzheimer Disease
Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?
Alzheimer Disease
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
Alzheimer Disease
Transthyretin binding to A-Beta peptide - Impact on A-Beta fibrillogenesis and toxicity.
Alzheimer Disease
Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.
Alzheimer Disease
Transthyretin stability is critical in assisting beta amyloid clearance- Relevance of transthyretin stabilization in Alzheimer's disease.
Alzheimer Disease
Transthyretin stabilization by iododiflunisal promotes amyloid-? peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
Alzheimer Disease
Undiscovered Roles for Transthyretin: From a Transporter Protein to a New Therapeutic Target for Alzheimer's Disease.
Alzheimer Disease
[Identification of transthyretin posttranslational modifications 1n human blood using mass-spectrometric methods].
Alzheimer Disease
[Transthyretin levels in serum and cerebrospinal fluid sustain the nutrio-viral hypothesis of the Cuban epidemic neuropathy]
Amyloid Neuropathies
A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy.
Amyloid Neuropathies
A novel transthyretin mutation V32A in a Chinese man with late-onset amyloid polyneuropathy.
Amyloid Neuropathies
Amyloid Neuropathy with Transthyretin Mutations: Overview and Unique Ala97Ser in Taiwan.
Amyloid Neuropathies
Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
Amyloid Neuropathies
Amyloid polyneuropathy in two German-American families: a new transthyretin variant (Val 107).
Amyloid Neuropathies
Amyloid polyneuropathy with transthyretin Arg50 in a Japanese case from Osaka.
Amyloid Neuropathies
An amyotrophic lateral sclerosis-like syndrome revealing an amyloid polyneuropathy associated with a novel transthyretin mutation.
Amyloid Neuropathies
Applying an artificial neural network model for developing a severity score for patients with hereditary amyloid polyneuropathy.
Amyloid Neuropathies
C1q ablation exacerbates amyloid deposition: A study in a transgenic mouse model of ATTRV30M amyloid neuropathy.
Amyloid Neuropathies
Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Amyloid Neuropathies
Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser.
Amyloid Neuropathies
Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
Amyloid Neuropathies
Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid.
Amyloid Neuropathies
Cutaneous Manifestations of Familial Transthyretin Amyloid Polyneuropathy.
Amyloid Neuropathies
Diagnosis of small fiber neuropathy: A comparative study of five neurophysiological tests.
Amyloid Neuropathies
Diflunisal compassive use in transthyretin hereditary amyloid polyneuropathy: report of a first Spanish experience.
Amyloid Neuropathies
Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy.
Amyloid Neuropathies
Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
Amyloid Neuropathies
Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy.
Amyloid Neuropathies
Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases.
Amyloid Neuropathies
Epidemiological and clinical characteristics of symptomatic hereditary transthyretin amyloid polyneuropathy: a global case series.
Amyloid Neuropathies
Estimating the annual economic burden for the management of patients with transthyretin amyloid polyneuropathy in Spain.
Amyloid Neuropathies
Expression of a synthetic gene encoding human transthyretin in Escherichia coli.
Amyloid Neuropathies
Familial amyloid polyneuropathy: alanine-for-threonine substitution in the transthyretin (prealbumin) molecule.
Amyloid Neuropathies
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Amyloid Neuropathies
Follow-up in transthyretin familial amyloid polyneuropathy: Useful investigations.
Amyloid Neuropathies
Genetic study of transthyretin amyloid neuropathies: carrier risks among French and Portuguese families.
Amyloid Neuropathies
Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Amyloid Neuropathies
Global epidemiology of transthyretin hereditary amyloid polyneuropathy: a systematic review.
Amyloid Neuropathies
Hard to swallow: atypical transthyretin amyloid neuropathy mistaken for CIDP.
Amyloid Neuropathies
Hereditary amyloid neuropathy by transthyretin Val107 mutation in a patient of African origin.
Amyloid Neuropathies
Historical overview of analytical methods for the measurement of transthyretin.
Amyloid Neuropathies
Identification of a new transthyretin variant (Ile49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and nonisotopic RNase cleavage assay.
Amyloid Neuropathies
Immunoassay for transthyretin variants associated with amyloid neuropathy.
Amyloid Neuropathies
Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy.
Amyloid Neuropathies
Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy.
Amyloid Neuropathies
Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Amyloid Neuropathies
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.
Amyloid Neuropathies
Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition. A clinicopathologic study of twelve cases.
Amyloid Neuropathies
Metabolic turn over of amyloid fibrils and post-treatment regression of amyloid deposits in systemic amyloidosis with polyneuropathy.
Amyloid Neuropathies
Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy.
Amyloid Neuropathies
New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå Sweden, June 1999.
Amyloid Neuropathies
New transthyretin mutation V28M in a Portuguese kindred with amyloid polyneuropathy.
Amyloid Neuropathies
Parent-of-origin effect in transthyretin related amyloid polyneuropathy.
Amyloid Neuropathies
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy.
Amyloid Neuropathies
Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
Amyloid Neuropathies
PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.
Amyloid Neuropathies
Phenotypes of Late-Onset Transthyretin Amyloid Neuropathy: A Diagnostic Challenge.
Amyloid Neuropathies
Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: case report.
Amyloid Neuropathies
Population pharmacokinetic modelling and simulation of tafamidis in healthy subjects and patients with transthyretin amyloidosis.
Amyloid Neuropathies
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas.
Amyloid Neuropathies
Progression of transthyretin amyloid neuropathy after liver transplantation.
Amyloid Neuropathies
Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy.
Amyloid Neuropathies
Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.
Amyloid Neuropathies
Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25.
Amyloid Neuropathies
Refine penetrance estimates in the main pathogenic variants of transthyretin hereditary (familial) amyloid polyneuropathy (TTR-FAP) using a new non-parametric approach (NPSE).
Amyloid Neuropathies
Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials.
Amyloid Neuropathies
Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates.
Amyloid Neuropathies
Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.
Amyloid Neuropathies
Tafamidis for a Transplant Patient with Transthyretin Amyloid Polyneuropathy.
Amyloid Neuropathies
The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
Amyloid Neuropathies
Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?
Amyloid Neuropathies
Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
Amyloid Neuropathies
Transthyretin amyloidosis presenting with multifocal demyelinating mononeuropathies.
Amyloid Neuropathies
Transthyretin gene mutations in British and French patients with amyloid neuropathy.
Amyloid Neuropathies
Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
Amyloid Neuropathies
Transthyretin Val 107 in a Japanese patient with familial amyloid polyneuropathy.
Amyloid Neuropathies
Treatment of hereditary and acquired forms of transthyretin amyloidosis in the era of personalized medicine: the role of randomized controlled trials.
Amyloid Neuropathies
Unravelling the colourful tapestry of hereditary transthyretin amyloid polyneuropathy in Poland.
Amyloid Neuropathies
[Two elderly cases of transthyretin amyloid polyneuropathy without a family history].
Amyloid Neuropathies, Familial
"Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
1H-NMR structural studies of a cystine-linked peptide containing residues 71-93 of transthyretin and effects of a Ser84 substitution implicated in familial amyloidotic polyneuropathy.
Amyloid Neuropathies, Familial
A case of familial amyloid polyneuropathy (FAP ATTR Ile107Val) with proximal muscle weakness in the lower extremities.
Amyloid Neuropathies, Familial
A case of familial amyloid polyneuropathy due to Phe33Val TTR with vitreous involvement as the initial manifestation.
Amyloid Neuropathies, Familial
A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings.
Amyloid Neuropathies, Familial
A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.
Amyloid Neuropathies, Familial
A European family with histidine 58 transthyretin mutation in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
A homozygote case of familial amyloid polyneuropathy amyloidgenic transthyretin Val30Met in a non-endemic area.
Amyloid Neuropathies, Familial
A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
Amyloid Neuropathies, Familial
A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
A Missense Variant p.Ala117Ser in the Transthyretin Gene of a Han Chinese Family with Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
A new mutant transthyretin (Arg 10) associated with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
A new prion disease: relationship with central and peripheral amyloidoses.
Amyloid Neuropathies, Familial
A new transthyretin variant (Ser 24) associated with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.
Amyloid Neuropathies, Familial
A peripheral pathway to restless legs syndrome? Clues from familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy.
Amyloid Neuropathies, Familial
A selective transthyretin-adsorption column for the treatment of patients with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
A woman with a rare p.Glu74Gly transthyretin mutation presenting exclusively with a rapidly progressive neuropathy: a case report.
Amyloid Neuropathies, Familial
ABO-incompatible auxiliary partial orthotopic liver transplant for late-onset familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Ala97Ser mutation is common among ethnic Chinese Malaysians with transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Alanine-to-threonine substitutions and amyloid diseases: Butyrylcholinesterase as a case study.
Amyloid Neuropathies, Familial
Ambulatory Medicines Cost With Transthyretin Familial Amyloid Polyneuropathy In Portugal.
Amyloid Neuropathies, Familial
Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin.
Amyloid Neuropathies, Familial
Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
An aggressive form of familial amyloid polyneuropathy caused by a Glu54Gly mutation in the transthyretin gene.
Amyloid Neuropathies, Familial
An Isolated Case of Late-onset Amyloidogenic Transthyretin Type Familial Amyloid Polyneuropathy Associated with a Mutant Transthyretin Substituting Methionine for Valine at Position 30 Showing Latent Progressive Cardiac Involvement Confirmed by Serial Annual Electrocardiograms.
Amyloid Neuropathies, Familial
Annual electrocardiograms consistent with silent progression of cardiac involvement in sporadic familial amyloid polyneuropathy: a case report.
Amyloid Neuropathies, Familial
Arrhythmia--a pitfall in tests of cardiac autonomic function after liver transplantation for familial amyloidotic polyneuropathy: a long-term follow-up of Swedish patients.
Amyloid Neuropathies, Familial
Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Asymptomatic homozygous gene carrier in a family with type I familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Author response: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).
Amyloid Neuropathies, Familial
Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise".
Amyloid Neuropathies, Familial
Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS).
Amyloid Neuropathies, Familial
Biophysical characterization and modulation of Transthyretin Ala97Ser.
Amyloid Neuropathies, Familial
Birth of two healthy females after preimplantation genetic diagnosis for familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
C1QA and C1QC modify age-at-onset in familial amyloid polyneuropathy patients.
Amyloid Neuropathies, Familial
Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin.
Amyloid Neuropathies, Familial
Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant.
Amyloid Neuropathies, Familial
Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability.
Amyloid Neuropathies, Familial
Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation.
Amyloid Neuropathies, Familial
Characterisation and management of vitreous and nerve amyloid in familial amyloid polyneuropathy due to variant transthyretin, Phe33Val.
Amyloid Neuropathies, Familial
Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance.
Amyloid Neuropathies, Familial
Characterization of a transthyretin-related amyloid fibril protein from cerebral amyloid angiopathy in type I familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Characterization of Pain in Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
Amyloid Neuropathies, Familial
Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers.
Amyloid Neuropathies, Familial
Clinical and biochemical outcome of hepatorenal transplantation for hereditary systemic amyloidosis associated with apolipoprotein AI Gly26Arg.
Amyloid Neuropathies, Familial
Clinical and genetic findings in eight Israeli patients with transthyretin-associated familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Amyloid Neuropathies, Familial
Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Clinical features of familial amyloid polyneuropathy carrying transthyretin mutations in four Chinese kindreds.
Amyloid Neuropathies, Familial
Clinical measures in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Clinical presentations and skin denervation in amyloid neuropathy due to transthyretin Ala97Ser.
Amyloid Neuropathies, Familial
Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Coexistence of transthyretin familial amyloid polyneuropathy and hereditary neuropathy with liability to pressure palsy.
Amyloid Neuropathies, Familial
Comparison Between 99mTc-Diphosphonate Imaging and MRI With Late Gadolinium Enhancement in Evaluating Cardiac Involvement in Patients With Transthyretin Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
Comparison of lethal and nonlethal transthyretin variants and their relationship to amyloid disease.
Amyloid Neuropathies, Familial
Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis.
Amyloid Neuropathies, Familial
Corneal sub-basal whorl-like nerve plexus: a landmark for early and follow-up evaluation in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
Amyloid Neuropathies, Familial
Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Current and Future Treatment Approaches in Transthyretin Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.
Amyloid Neuropathies, Familial
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Amyloid Neuropathies, Familial
Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.
Amyloid Neuropathies, Familial
Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
Amyloid Neuropathies, Familial
Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Amyloid Neuropathies, Familial
Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.
Amyloid Neuropathies, Familial
Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP).
Amyloid Neuropathies, Familial
Diffuse metabolic changes in the brain of patients with familial amyloid polyneuropathy. A proton MRSI study.
Amyloid Neuropathies, Familial
Diflunisal stabilizes familial amyloid polyneuropathy-associated transthyretin variant tetramers in serum against dissociation required for amyloidogenesis.
Amyloid Neuropathies, Familial
Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
Amyloid Neuropathies, Familial
Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Domino liver transplantation: a practical option in the face of the organ shortage.
Amyloid Neuropathies, Familial
Early detection of sympathetic myocardial denervation in patients with familial amyloid polyneuropathy type I.
Amyloid Neuropathies, Familial
Early diagnosis in patients with transthyretin familial amyloid polyneuropathy: A comparative study.
Amyloid Neuropathies, Familial
Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Editors' note: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Varl30Met: A phase III, open-label study.
Amyloid Neuropathies, Familial
Efficiency of silencing RNA for removal of transthyretin V30M in a TTR leptomeningeal animal model.
Amyloid Neuropathies, Familial
Electromyographic findings in transthyretin (TTR)-related familial amyloid polyneuropathy (FAP).
Amyloid Neuropathies, Familial
Electrophysiological features of familial amyloid polyneuropathy in endemic area.
Amyloid Neuropathies, Familial
Electrophysiological features of late-onset transthyretin Met30 familial amyloid polyneuropathy unrelated to endemic foci.
Amyloid Neuropathies, Familial
Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
Amyloid Neuropathies, Familial
Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Endoscopic Findings of Small-Bowel Lesions in Familial Amyloid Polyneuropathy: A Case Report.
Amyloid Neuropathies, Familial
Epidemiology of Transthyretin Familial Amyloid Polyneuropathy in Portugal: A Nationwide Study.
Amyloid Neuropathies, Familial
Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study.
Amyloid Neuropathies, Familial
Estimating the global prevalence of transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.
Amyloid Neuropathies, Familial
Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells.
Amyloid Neuropathies, Familial
Extended phenotype in the transthyretin Tyr77 familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Extremely Early Onset Transthyretin Familial Amyloid Polyneuropathy with a Leu55Pro Mutation: A Pediatric Case Report and Literature Review.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy associated with transthyretin Gly42 mutation: a quantitative light and electron microscopic study of the peripheral nervous system.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy in a Spanish family with a transthyretin deletion (deltaVal 122) presenting with carpal tunnel syndrome.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy in Taiwan: identification of transthyretin variant (Leu55-->Pro).
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy involving a homozygous Val30Met mutation in the amyloidogenic transthyretin gene presenting with superficial siderosis: a case report.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy related to transthyretin Gly42 in a Japanese family.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy related to transthyretin mutation Val30 to Leu in a Japanese family.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy with chronic paroxysmal dry cough in Mainland China: A Chinese family with a proven heterozygous missense mutation c.349G>T in the transthyretin gene.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy with genetic anticipation associated to a gly47glu transthyretin variant in an Italian kindred.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy: a clinico-pathologic study.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy: alanine-for-threonine substitution in the transthyretin (prealbumin) molecule.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.
Amyloid Neuropathies, Familial
Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?
Amyloid Neuropathies, Familial
Familial amyloidotic polyneuropathy: current and emerging treatment options for transthyretin-mediated amyloidosis.
Amyloid Neuropathies, Familial
Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy.
Amyloid Neuropathies, Familial
First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Follow-up in transthyretin familial amyloid polyneuropathy: Useful investigations.
Amyloid Neuropathies, Familial
Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone's Particle Size on Sustained Release.
Amyloid Neuropathies, Familial
FRET studies of various conformational states adopted by transthyretin.
Amyloid Neuropathies, Familial
Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
Amyloid Neuropathies, Familial
Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.
Amyloid Neuropathies, Familial
Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Amyloid Neuropathies, Familial
Haplotypes and DNA sequence variation within and surrounding the transthyretin gene: genotype-phenotype correlations in familial amyloid polyneuropathy (V30M) in Portugal and Sweden.
Amyloid Neuropathies, Familial
Health-Related Quality of Life In Patients With Transthyretin Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosis.
Amyloid Neuropathies, Familial
Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population.
Amyloid Neuropathies, Familial
High hydrostatic pressure dissociates early aggregates of TTR105-115, but not the mature amyloid fibrils.
Amyloid Neuropathies, Familial
Hsf-1 affects podocyte markers NPHS1, NPHS2 and WT1 in a transgenic mouse model of TTRVal30Met-related amyloidosis.
Amyloid Neuropathies, Familial
Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
Amyloid Neuropathies, Familial
Ineffectiveness of dialysis in transthyretin (TTR) clearance in familial amyloid polyneuropathy type I, in spite of lower stability of the TTR Met30 variant.
Amyloid Neuropathies, Familial
Inflammatory profiling of patients with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin.
Amyloid Neuropathies, Familial
Inhibiting transthyretin amyloid fibril formation via protein stabilization.
Amyloid Neuropathies, Familial
Inhibition of human transthyretin aggregation by non-steroidal anti-inflammatory compounds: a structural and thermodynamic analysis.
Amyloid Neuropathies, Familial
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
Amyloid Neuropathies, Familial
Involvement of Macrophages in the Pathogenesis of Familial Amyloid Polyneuropathy and Efficacy of Human iPS Cell-Derived Macrophages in Its Treatment.
Amyloid Neuropathies, Familial
Large normal alleles of ATXN2 decrease age at onset in transthyretin familial amyloid polyneuropathy Val30Met patients.
Amyloid Neuropathies, Familial
Late-onset and fast progressive neuropathy and cardiomyopathy in Val32Ala transthyretin gene mutation.
Amyloid Neuropathies, Familial
Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history.
Amyloid Neuropathies, Familial
Late-onset familial amyloid polyneuropathy: an autopsy study of two Japanese brothers.
Amyloid Neuropathies, Familial
Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Amyloid Neuropathies, Familial
Liver transplantation and anemia in familial amyloidosis ATTR V30M.
Amyloid Neuropathies, Familial
Liver transplantation as treatment for neurological disorders.
Amyloid Neuropathies, Familial
Liver transplantation in transthyretin familial amyloid polyneuropathy: first report from Argentina.
Amyloid Neuropathies, Familial
Liver transplantation in transthyretin-related familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type).
Amyloid Neuropathies, Familial
Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M).
Amyloid Neuropathies, Familial
Long-term survival after liver transplantation in patients with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study.
Amyloid Neuropathies, Familial
Lower kinetic limit to protein thermal stability: a proposal regarding protein stability in vivo and its relation with misfolding diseases.
Amyloid Neuropathies, Familial
Macular and optic disc edema and retinal vascular leakage in familial amyloid polyneuropathy with a transthyretin Val30Met mutation: a case report.
Amyloid Neuropathies, Familial
Management of asymptomatic gene carriers of transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Modifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights into Its Binding Properties and High Plasma Specificity.
Amyloid Neuropathies, Familial
Motor excitability measurements in early stage familial amyloid polyneuropathy: The influence of tafamidis treatment.
Amyloid Neuropathies, Familial
MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation.
Amyloid Neuropathies, Familial
Multimodal retinal imaging of familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Amyloid Neuropathies, Familial
Myopathic phenotype of familial amyloid polyneuropathy with a rare transthyretin variant: ATTR Ala45Asp.
Amyloid Neuropathies, Familial
Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas.
Amyloid Neuropathies, Familial
Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy.
Amyloid Neuropathies, Familial
Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
Amyloid Neuropathies, Familial
Neurophysiological markers of small fibre neuropathy in TTR-FAP mutation carriers.
Amyloid Neuropathies, Familial
Neurophysiological techniques to detect early small-fiber dysfunction in transthyretin amyloid polyneuropathy.
Amyloid Neuropathies, Familial
New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå Sweden, June 1999.
Amyloid Neuropathies, Familial
Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Amyloid Neuropathies, Familial
Occupational and other risk factors for clinically overt familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
On the origin of the transthyretin Val30Met familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Ophthalmic manifestations in a Chinese family with familial amyloid polyneuropathy due to a TTR Gly83Arg mutation.
Amyloid Neuropathies, Familial
Optimizing the management of transthyretin familial amyloid polyneuropathy in Europe: early diagnosis and effective care.
Amyloid Neuropathies, Familial
Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan.
Amyloid Neuropathies, Familial
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Pathology and functional diagnosis of small-fiber painful neuropathy.
Amyloid Neuropathies, Familial
Patient-reported outcomes on familial amyloid polyneuropathy (FAP).
Amyloid Neuropathies, Familial
Penetrance estimation of TTR familial amyloid polyneuropathy (type I) in Brazilian families.
Amyloid Neuropathies, Familial
Pharmacological treatment for familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Phenotypic expression of familial amyloid polyneuropathy in Brazil.
Amyloid Neuropathies, Familial
Phenotypic heterogeneity in a family with FAP due to a TTR Leu58Arg mutation: a clinicopathologic study.
Amyloid Neuropathies, Familial
Polymer-doxycycline conjugates as fibril disrupters: an approach towards the treatment of a rare amyloidotic disease.
Amyloid Neuropathies, Familial
Poor Yield of Routine Transthyretin Screening in Patients with Idiopathic Neuropathy.
Amyloid Neuropathies, Familial
Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
Amyloid Neuropathies, Familial
Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Amyloid Neuropathies, Familial
Post hoc analysis of nutritional status in patients with transthyretin familial amyloid polyneuropathy: impact of tafamidis.
Amyloid Neuropathies, Familial
Postmortem findings in a familial amyloid polyneuropathy patient with homozygosity of the mutant Val30Met transthyretin gene.
Amyloid Neuropathies, Familial
Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
Amyloid Neuropathies, Familial
Prevalence of Transthyretin Familial Amyloid Polyneuropathy In Portugal.
Amyloid Neuropathies, Familial
Progression of myocardial sympathetic denervation assessed by (123)I-MIBG imaging in familial amyloid polyneuropathy and the effect of liver transplantation.
Amyloid Neuropathies, Familial
Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
Amyloid Neuropathies, Familial
Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis.
Amyloid Neuropathies, Familial
Progressive wild-type transthyretin deposition after liver transplantation preferentially occurs onto myocardium in FAP patients.
Amyloid Neuropathies, Familial
Psychopathological Dimensions in Portuguese Subjects with Transthyretin Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
Amyloid Neuropathies, Familial
Rational design of potent human transthyretin amyloid disease inhibitors.
Amyloid Neuropathies, Familial
Reader response: Natural history and survival in stage 1 Val30Met transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.
Amyloid Neuropathies, Familial
Recurrent syncope as persistently isolated feature of transthyretin amyloidotic polyneuropathy.
Amyloid Neuropathies, Familial
Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer.
Amyloid Neuropathies, Familial
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.
Amyloid Neuropathies, Familial
Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil.
Amyloid Neuropathies, Familial
Retrospective Mapping of SAR Data for TTR Protein in Chemico-Biological Space Using Ligand Efficiency Indices as a Guide to Drug Discovery Strategies.
Amyloid Neuropathies, Familial
Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Amyloid Neuropathies, Familial
S-sulfonation of transthyretin is an important trigger step in the formation of transthyretin-related amyloid fibril.
Amyloid Neuropathies, Familial
Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Amyloid Neuropathies, Familial
Sensory nerve degeneration in a mouse model mimicking early manifestations of familial amyloid polyneuropathy due to transthyretin Ala97Ser.
Amyloid Neuropathies, Familial
Sequential (domino) transplantation of the liver in a transthyretin-50 familial amyloid polyneuropathy. Special reference to cardiological diagnosis and complications.
Amyloid Neuropathies, Familial
Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation.
Amyloid Neuropathies, Familial
Serum transthyretin monomer in patients with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Severe amyloid deposition in mammary glands of familial amyloid polyneuropathy patients.
Amyloid Neuropathies, Familial
Severe heart disease in an unusual case of familial amyloid polyneuropathy type I.
Amyloid Neuropathies, Familial
Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review.
Amyloid Neuropathies, Familial
Sixty years of transthyretin familial amyloid polyneuropathy (TTR-FAP) in Europe: where are we now? A European network approach to defining the epidemiology and management patterns for TTR-FAP.
Amyloid Neuropathies, Familial
Skin Nerve Pathology: Biomarkers of Premanifest and Manifest Amyloid Neuropathy.
Amyloid Neuropathies, Familial
Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Spinal cord stimulation markedly ameliorated refractory neuropathic pain in transthyretin Val30Met familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Structural stabilization of transthyretin by a new compound, 6-benzoyl-2-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione.
Amyloid Neuropathies, Familial
Sudomotor innervation in transthyretin amyloid neuropathy: Pathology and functional correlates.
Amyloid Neuropathies, Familial
Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro.
Amyloid Neuropathies, Familial
Sural nerve injury in familial amyloid polyneuropathy: MR neurography vs clinicopathologic tools.
Amyloid Neuropathies, Familial
Susceptibility and modifier genes in Portuguese transthyretin V30M amyloid polyneuropathy: complexity in a single-gene disease.
Amyloid Neuropathies, Familial
Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Amyloid Neuropathies, Familial
Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR).
Amyloid Neuropathies, Familial
Tafamidis delays disease progression in patients with early stage transthyretin familial amyloid polyneuropathy: additional supportive analyses from the pivotal trial.
Amyloid Neuropathies, Familial
Tafamidis delays neurological progression comparably across Val30Met and non-Val30Met genotypes in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Tafamidis for transthyretin familial amyloid polyneuropathy: A randomized, controlled trial.
Amyloid Neuropathies, Familial
Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial.
Amyloid Neuropathies, Familial
Tafamidis, a Noninvasive Therapy for Delaying Transthyretin Familial Amyloid Polyneuropathy: Systematic Review and Meta-Analysis.
Amyloid Neuropathies, Familial
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Amyloid Neuropathies, Familial
Tafamidis: a review of its use in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation.
Amyloid Neuropathies, Familial
The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.
Amyloid Neuropathies, Familial
The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
The diagnostic utility of neurophysiologic tests for early diagnostic of transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
The effect of tafamidis on the QTC interval in healthy subjects.
Amyloid Neuropathies, Familial
The Endoplasmic Reticulum-associated Degradation of Transthyretin Variants Is Negatively Regulated by BiP in Mammalian Cells.
Amyloid Neuropathies, Familial
The first Transthyretin Familial Amyloid Polyneuropathy gait quantification study - preliminary results.
Amyloid Neuropathies, Familial
The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.
Amyloid Neuropathies, Familial
The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.
Amyloid Neuropathies, Familial
The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.
Amyloid Neuropathies, Familial
The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies.
Amyloid Neuropathies, Familial
The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
The Temporal Profiles of Changes in Nerve Excitability Indices in Familial Amyloid Polyneuropathy.
Amyloid Neuropathies, Familial
The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Therapeutic Oligonucleotides Targeting Liver Disease: TTR Amyloidosis.
Amyloid Neuropathies, Familial
Three Turkish families with different transthyretin mutations.
Amyloid Neuropathies, Familial
Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimicker.
Amyloid Neuropathies, Familial
Toward the discovery of functional transthyretin amyloid inhibitors: application of virtual screening methods.
Amyloid Neuropathies, Familial
Transthyretin Ala97Ser in Chinese-Taiwanese patients with familial amyloid polyneuropathy: genetic studies and phenotype expression.
Amyloid Neuropathies, Familial
Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
Amyloid Neuropathies, Familial
Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors.
Amyloid Neuropathies, Familial
Transthyretin familial amyloid polyneuropathy (TTR-FAP) in Mallorca: A comparison between late- and early-onset disease.
Amyloid Neuropathies, Familial
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.
Amyloid Neuropathies, Familial
Transthyretin familial amyloid polyneuropathy due to lle107Val mutation mimicking atypical chronic inflammatory demyelinating polyneuropathy: case report.
Amyloid Neuropathies, Familial
Transthyretin Familial Amyloid Polyneuropathy Impact on Health-Related Quality of Life.
Amyloid Neuropathies, Familial
Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Transthyretin gene mutations in British and French patients with amyloid neuropathy.
Amyloid Neuropathies, Familial
Transthyretin Ile84Thr is associated with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Transthyretin interacts with actin regulators in a Drosophila model of familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity.
Amyloid Neuropathies, Familial
Transthyretin is up-regulated by sex hormones in mice liver.
Amyloid Neuropathies, Familial
Transthyretin mutation (serine 84) associated with familial amyloid polyneuropathy in a Hungarian family.
Amyloid Neuropathies, Familial
Transthyretin mutation (TTRGly47Ala) associated with familial amyloid polyneuropathy in a French family.
Amyloid Neuropathies, Familial
Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity.
Amyloid Neuropathies, Familial
Transthyretin Tyr77 familial amyloid polyneuropathy: a clinicopathological study of a large kindred.
Amyloid Neuropathies, Familial
Transthyretin Val 107 in a Japanese patient with familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Transthyretin Val30Met familial amyloid polyneuropathy: a considerably different clinical picture and natural course in endemic and non-endemic areas.
Amyloid Neuropathies, Familial
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area.
Amyloid Neuropathies, Familial
Treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a case report.
Amyloid Neuropathies, Familial
Trigger finger as an initial manifestation of familial amyloid polyneuropathy in a patient with Ile107Val TTR.
Amyloid Neuropathies, Familial
TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
Amyloid Neuropathies, Familial
TTR kinetic stabilizers and TTR gene silencing: a new era in therapy for familial amyloidotic polyneuropathies.
Amyloid Neuropathies, Familial
TTR-FAP Progression Evaluation Based on Gait Analysis Using a Single RGB-D Camera.
Amyloid Neuropathies, Familial
TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.
Amyloid Neuropathies, Familial
Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal.
Amyloid Neuropathies, Familial
Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant.
Amyloid Neuropathies, Familial
Type I familial amyloid polyneuropathy. A pathological study of the peripheral nervous system.
Amyloid Neuropathies, Familial
Ultrasound evaluation in transthyretin-related amyloid neuropathy.
Amyloid Neuropathies, Familial
Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.
Amyloid Neuropathies, Familial
Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Usefulness of combined nerve and muscle biopsy in the diagnosis of amyloid neuropathy--a study of 6 new cases.
Amyloid Neuropathies, Familial
Usefulness of MALDI/TOF mass spectrometry of immunoprecipitated serum variant transthyretin in the diagnosis of familial amyloid polyneuropathy.
Amyloid Neuropathies, Familial
Validation of a Single RGB-D Camera for Gait Assessment of Polyneuropathy Patients.
Amyloid Neuropathies, Familial
Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M).
Amyloid Neuropathies, Familial
Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.
Amyloid Neuropathies, Familial
Vitreous Amyloidosis: Ocular, Systemic, and Genetic Insights.
Amyloid Neuropathies, Familial
Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis.
Amyloid Neuropathies, Familial
Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met.
Amyloid Neuropathies, Familial
[Aged onset of amyloidosis caused by transthyretin gene mutations]
Amyloid Neuropathies, Familial
[Case report of transthyretin Val30Met familial amyloid polyneuropathy presenting hydrocephalus].
Amyloid Neuropathies, Familial
[Clinical and genetic heterogeneity in familial amyloidotic polyneuropathy associated with variant transthyretin]
Amyloid Neuropathies, Familial
[Demonstration of genetic mutation in most of the amyloid neuropathies with sporadic occurrence]
Amyloid Neuropathies, Familial
[Diagnosis of familial amyloid polyneuropathy type I in Argentina]
Amyloid Neuropathies, Familial
[Familial amyloid neuropathy associated with the Cys114 mutation of the transthyretin gene in a Russian family]
Amyloid Neuropathies, Familial
[Familial amyloid polyneuropathy: liver transplantation as first-line therapy].
Amyloid Neuropathies, Familial
[Genetic analysis and a new therapy for a hereditary disease: familial amyloid polyneuropathy]
Amyloid Neuropathies, Familial
[Identification of transthyretin posttranslational modifications 1n human blood using mass-spectrometric methods].
Amyloid Neuropathies, Familial
[Liver transplantation in familial amyloid polyneuropathy. Case report and review of the literature]
Amyloid Neuropathies, Familial
[Perioperative management for liver transplant in a patient with familial amyloid polyneuropathy with heart involvement.]
Amyloid Neuropathies, Familial
[Presentations of transthyretin associated familial amyloid polyneuropathy in Argentina].
Amyloid Neuropathies, Familial
[The ocular involvement in the transthyretin-related familial amyloid polyneuropathy].
Amyloid Neuropathies, Familial
[Transthyretin familial amyloid polyneuropathy - three Hungarian cases with rare mutations (His88Arg and Phe33Leu)].
Amyloid Neuropathies, Familial
[Two elderly cases of transthyretin amyloid polyneuropathy without a family history].
Amyloid Neuropathies, Familial
[Variant transthyretin genes associated with familial amyloid polyneuropathy]
Amyloidosis
(99m)Tc-DPD uptake reflects amyloid fibril composition in hereditary transthyretin amyloidosis.
Amyloidosis
18F-Florbetapir Binds Specifically to Myocardial Light Chain and Transthyretin Amyloid Deposits: Autoradiography Study.
Amyloidosis
1H-NMR structural studies of a cystine-linked peptide containing residues 71-93 of transthyretin and effects of a Ser84 substitution implicated in familial amyloidotic polyneuropathy.
Amyloidosis
2021 Advocacy Statements for the Role of 99mTc-Pyrophosphate Scintigraphy in the Diagnosis of Transthyretin Cardiac Amyloidosis: A Report of the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China.
Amyloidosis
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR).
Amyloidosis
99mTc DPD is the preferential bone tracer for diagnosis of cardiac transthyretin amyloidosis.
Amyloidosis
99mTc-Pyrophosphate Retention in Atelectatic Pulmonary Tissues of a Patient With Transthyretin Cardiac Amyloidosis.
Amyloidosis
99mTechnetium pyrophosphate scintigraphy with cadmium zinc telluride cameras is a highly sensitive and specific imaging modality to diagnose transthyretin cardiac amyloidosis.
Amyloidosis
?-Synuclein aggregation in the saliva of familial transthyretin amyloidosis: a potential biomarker.
Amyloidosis
A case of a senile systemic amyloidosis patient presenting with angina pectoris and dilated cardiomyopathy.
Amyloidosis
A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation.
Amyloidosis
A case of cardiac amyloidosis in an elderly Japanese patient with amyloidogenic transthyretin Val122Ile variant.
Amyloidosis
A case of late onset cardiac amyloidosis with a new transthyretin variant (lysine 92).
Amyloidosis
A Case of Late-onset Hereditary ATTR Amyloidosis with a Novel p.P63S (P43S) Transthyretin Variant.
Amyloidosis
A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G?>?T, p.Ala140Ser).
Amyloidosis
A case of unilateral shoulder joint hydrarthrosis with wild-type amyloidogenic transthyretin amyloidosis.
Amyloidosis
A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.
Amyloidosis
A case of wild-type transthyretin amyloidosis associated with organizing pneumonia.
Amyloidosis
A case of wild-type transthyretin cardiac amyloidosis with rheumatoid arthritis.
Amyloidosis
A case report of an uncommon presentation of 99mtechnetium pyrophosphate scintigraphy in transthyretin cardiac amyloidosis: A potential diagnostic pitfall, pseudo-positive or pseudo-negative?
Amyloidosis
A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M.
Amyloidosis
A case study of likely wild-type cardiac transthyretin amyloidosis causing rapid deterioration.
Amyloidosis
A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
Amyloidosis
A challenging road to diagnosing transthyretin cardiac amyloidosis and using technetium-99m pyrophosphate bone scintigraphy in nuclear cardiology - A case report.
Amyloidosis
A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction.
Amyloidosis
A complex equilibrium among partially unfolded conformations in monomeric transthyretin.
Amyloidosis
A compound T60A and V122I heterozygosity in the transthyretin gene causing early onset severe cardiac amyloidosis.
Amyloidosis
A comprehensive safety profile of tafamidis in patients with transthyretin amyloid polyneuropathy.
Amyloidosis
A current pharmacologic agent versus the promise of next generation therapeutics to ameliorate protein misfolding and/or aggregation diseases.
Amyloidosis
A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features.
Amyloidosis
A Descriptive Analysis of ATTR Amyloidosis in Spain from the Transthyretin Amyloidosis Outcomes Survey.
Amyloidosis
A Focused Review on the Pathophysiology, Diagnosis, and Management of Cardiac Amyloidosis.
Amyloidosis
A genealogical and clinical study of the phenotypical variation within the Swedish transthyretin His88Arg (p. His108Arg) amyloidosis family.
Amyloidosis
A Heart too Stiff to Beat: A Case of Familial Transthyretin Amyloidosis Cardiomyopathy.
Amyloidosis
A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology.
Amyloidosis
A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.
Amyloidosis
A library of ATTR amyloidosis patient-specific induced pluripotent stem cells for disease modelling and in vitro testing of novel therapeutics.
Amyloidosis
A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
Amyloidosis
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
Amyloidosis
A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only.
Amyloidosis
A multi-modal diagnostic model improves detection of cardiac amyloidosis among patients with diagnostic confirmation by cardiac biopsy.
Amyloidosis
A Mutation in NPAS3 That Segregates with Schizophrenia in a Small Family Leads to Protein Aggregation.
Amyloidosis
A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient.
Amyloidosis
A new amyloidogenic transthyretin variant, [D38A], detected by electrospray ionization/mass spectrometry.
Amyloidosis
A New Arg54Gly Transthyretin Gene Mutation Associated with Vitreous Amyloidosis in Chinese.
Amyloidosis
A new crystal form of human transthyretin obtained with a curcumin derived ligand.
Amyloidosis
A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP).
Amyloidosis
A new human hereditary amyloidosis: the result of a stop-codon mutation in the apolipoprotein AII gene.
Amyloidosis
A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis.
Amyloidosis
A new simple and rapid screening method for variant transthyretin-related amyloidosis.
Amyloidosis
A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis.
Amyloidosis
A new transthyretin mutation associated with amyloidotic vitreous opacities. Asparagine for isoleucine at position 84.
Amyloidosis
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia.
Amyloidosis
A novel bis-furan scaffold for transthyretin stabilization and amyloid inhibition.
Amyloidosis
A novel risk score to predict survival in advanced heart failure due to cardiac amyloidosis.
Amyloidosis
A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo.
Amyloidosis
A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndrome.
Amyloidosis
A novel transthyretin variant p.H110D (H90D) as a cause of familial amyloid polyneuropathy in a large Irish kindred.
Amyloidosis
A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of kappa light chains.
Amyloidosis
A novel variant of transthyretin (Glu42Asp) associated with sporadic late-onset cardiac amyloidosis.
Amyloidosis
A novel variant of transthyretin, 59Thr-->Lys, associated with autosomal dominant cardiac amyloidosis in an Italian family.
Amyloidosis
A pair of peptides inhibits seeding of the hormone transporter transthyretin into amyloid fibrils.
Amyloidosis
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis.
Amyloidosis
A rare variant of transthyretin-related amyloidosis associated with exclusive cardiomyopathy in a Hong Kong Chinese patient.
Amyloidosis
A representative case of hereditary transthyretin amyloidosis complicated by intramyocardial hemorrhage.
Amyloidosis
A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis.
Amyloidosis
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis.
Amyloidosis
A serine protease secreted from Bacillus subtilis cleaves human plasma transthyretin to generate an amyloidogenic fragment.
Amyloidosis
A simple and reliable method of detecting variant transthyretins by multidimensional liquid chromatography coupled to electrospray ionization mass spectrometry.
Amyloidosis
A simple core dataset and disease severity score for hereditary transthyretin (ATTRv) amyloidosis.
Amyloidosis
A simple screening test for variant transthyretins associated with familial transthyretin amyloidosis using isoelectric focusing.
Amyloidosis
A specific test for transthyretin 122 (Val----Ile), based on PCR-primer-introduced restriction analysis (PCR-PIRA): confirmation of the gene frequency in blacks.
Amyloidosis
A sporadic case of late-onset familial amyloid polyneuropathy with a monoclonal gammopathy.
Amyloidosis
A Statement on the Appropriate Administration of Tafamidis in Patients With Transthyretin Cardiac Amyloidosis.
Amyloidosis
A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK.
Amyloidosis
A transthyretin mutation (Tyr78Phe) associated with peripheral neuropathy, carpal tunnel syndrome and skin amyloidosis.
Amyloidosis
Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis.
Amyloidosis
Abdominal fat pad excisional biopsy for the diagnosis and typing of systemic amyloidosis.
Amyloidosis
Abnormal Coronary Flow Velocity Reserve and Decreased Myocardial Contractile Reserve Are Main Factors in Relation to Physical Exercise Capacity in Cardiac Amyloidosis.
Amyloidosis
Abnormal small bowel motility in patients with hereditary transthyretin amyloidosis.
Amyloidosis
Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis.
Amyloidosis
Accurate, strong, and stable reporting of choroid plexus epithelial cells in transgenic mice using a human transthyretin BAC.
Amyloidosis
Acidic pH-induced conformational changes in amyloidogenic mutant transthyretin.
Amyloidosis
Acquired transthyretin amyloidosis after domino liver transplant: Phenotypic correlation, implication of liver retransplantation.
Amyloidosis
Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis.
Amyloidosis
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.
Amyloidosis
Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
Amyloidosis
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects.
Amyloidosis
Advantages and Emerging Problems of Novel Treatments for Transthyretin Cardiac Amyloidosis.
Amyloidosis
Affinity capillary electrophoresis is a powerful tool to identify transthyretin binding drugs for potential therapeutic use in amyloidosis.
Amyloidosis
AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
Amyloidosis
Age-dependent cognitive dysfunction in untreated hereditary transthyretin amyloidosis.
Amyloidosis
Age-related oxidative modifications of transthyretin modulate its amyloidogenicity.
Amyloidosis
Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease.
Amyloidosis
Ageing and amyloid fibrillogenesis: lessons from apolipoprotein AI, transthyretin and islet amyloid polypeptide.
Amyloidosis
Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
Amyloidosis
Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis.
Amyloidosis
Albumin/creatinine (uACR) and protein/creatinine (uPCR) ratios in spot urine samples can be used to evaluate albuminuria and proteinuria in hereditary transthyretin amyloidosis patients.
Amyloidosis
Allele specific expression of the transthyretin gene in swedish patients with hereditary transthyretin amyloidosis (ATTR V30M) is similar between the two alleles.
Amyloidosis
Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.
Amyloidosis
Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.
Amyloidosis
Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
Amyloidosis
Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis.
Amyloidosis
Amyloid Fibril Composition as a Predictor of Development of Cardiomyopathy After Liver Transplantation for Hereditary Transthyretin Amyloidosis.
Amyloidosis
Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
Amyloidosis
Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families.
Amyloidosis
Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin.
Amyloidosis
Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type.
Amyloidosis
Amyloid PET imaging in cardiac amyloidosis: a pilot study using 18F-flutemetamol positron emission tomography.
Amyloidosis
Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
Amyloidosis
Amyloid seeding of transthyretin by ex vivo cardiac fibrils and its inhibition.
Amyloidosis
Amyloidogenic and associated proteins in systemic amyloidosis proteome of adipose tissue.
Amyloidosis
Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage.
Amyloidosis
Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types.
Amyloidosis
Amyloidosis of the gastrointestinal tract: a 13-year single center referral experience.
Amyloidosis
Amyloidosis with Cardiac Involvement: Identification, Characterization, and Management.
Amyloidosis
Amyloidosis: diagnosis and new therapies for a misunderstood and misdiagnosed disease.
Amyloidosis
Amyloidotic breast nodule in hereditary transthyretin amyloidosis (hATTR): a case report.
Amyloidosis
An autopsy case of leptomeningeal amyloidosis associated with transthyretin Gly47Arg mutation.
Amyloidosis
An Exploratory Study of Cognitive Involvement in Hereditary Transthyretin Amyloidosis.
Amyloidosis
An optimized imaging protocol for [99mTc]Tc-DPD scintigraphy and SPECT/CT quantification in cardiac transthyretin (ATTR) amyloidosis.
Amyloidosis
An unusual case of hereditary transthyretin-related amyloidosis and ulcerative colitis in a young Indian girl.
Amyloidosis
Analysis of serum transthyretin by on-line immunoaffinity solid-phase extraction capillary electrophoresis mass spectrometry using magnetic beads.
Amyloidosis
Analysis of the TTR gene in the investigation of amyloidosis: A 25-year single UK center experience.
Amyloidosis
Analysis of transthyretin in human serum by capillary zone electrophoresis electrospray ionization time-of-flight mass spectrometry. Application to familial amyloidotic polyneuropathy type I.
Amyloidosis
Angiographic Signatures of the Predominant Form of Familial Transthyretin Amyloidosis (Val30Met Mutation).
Amyloidosis
Animal models of human amyloidoses: are transgenic mice worth the time and trouble?
Amyloidosis
Anion shielding of electrostatic repulsions in transthyretin modulates stability and amyloidosis: insight into the chaotrope unfolding dichotomy.
Amyloidosis
Anterior Chamber Flare as an Objective and Quantitative Noninvasive Method for Oculopathy in Transthyretin V30M Amyloidosis Patients.
Amyloidosis
Anticipation on age at onset in kindreds with hereditary ATTRV30M amyloidosis from the Majorcan cluster.
Amyloidosis
Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding.
Amyloidosis
Aortic stenosis, transcatheter aortic valve replacement and transthyretin cardiac amyloidosis: are we progressively unraveling the tangle?
Amyloidosis
Aortic Valve Calcium in Patients With Transthyretin Cardiac Amyloidosis: A Propensity-Matched Analysis.
Amyloidosis
Apical sparing pattern of left ventricular myocardial (99m)Tc-HMDP uptake in patients with transthyretin cardiac amyloidosis.
Amyloidosis
Apical Sparing Pattern of Longitudinal Strain and Positive Bone Scintigraphy in Metastatic Myocardial Calcification.
Amyloidosis
APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA.
Amyloidosis
Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis.
Amyloidosis
Applying an artificial neural network model for developing a severity score for patients with hereditary amyloid polyneuropathy.
Amyloidosis
Arrhythmia--a pitfall in tests of cardiac autonomic function after liver transplantation for familial amyloidotic polyneuropathy: a long-term follow-up of Swedish patients.
Amyloidosis
Asp58Ala is the Predominant Mutation of the TTR Gene in Korean Patients with Hereditary Transthyretin-Related Amyloidosis.
Amyloidosis
Assessment of patients with hereditary transthyretin amyloidosis - understanding the impact of management and disease progression.
Amyloidosis
Association between a point mutation at the -743-bp region of the transthyretin (TTR) gene and familial vitreous amyloidosis.
Amyloidosis
Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis.
Amyloidosis
Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.
Amyloidosis
Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
Amyloidosis
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.
Amyloidosis
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
Amyloidosis
Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
Amyloidosis
Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Amyloidosis
Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis.
Amyloidosis
Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients.
Amyloidosis
Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality.
Amyloidosis
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
Amyloidosis
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: The Growing Need to Look Forward.
Amyloidosis
Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
Amyloidosis
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.
Amyloidosis
Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis).
Amyloidosis
Autopsy evaluation of the implantation site of a His bundle pacing lead demonstrating selective capture.
Amyloidosis
Autosomal-dominant transthyretin (TTR)-related amyloidosis is not a frequent CMT2 neuropathy "in disguise".
Amyloidosis
Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner.
Amyloidosis
Baseline disease characteristics in Brazilian patients enrolled in Transthyretin Amyloidosis Outcome Survey (THAOS).
Amyloidosis
Baseline ECG Features and Arrhythmic Profile in Transthyretin Versus Light Chain Cardiac Amyloidosis.
Amyloidosis
Becoming familiar with hereditary transthyretin amyloidosis, a treatable neuropathy.
Amyloidosis
Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
Amyloidosis
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis.
Amyloidosis
Best Practices in Specialized Amyloidosis Centers in the United States: A Survey of Cardiologists, Nurses, Patients, and Patient Advocates.
Amyloidosis
Beyond Val30Met transthyretin (TTR): variants associated with age-at-onset in hereditary ATTRv amyloidosis.
Amyloidosis
Binding of Monovalent and Bivalent Ligands by Transthyretin Causes Different Short- and Long-Distance Conformational Changes.
Amyloidosis
Binding site asymmetry in human transthyretin: insights from a joint neutron and X-ray crystallographic analysis using perdeuterated protein.
Amyloidosis
Biochemical and Electrophysiological Modification of Amyloid Transthyretin on Cardiomyocytes.
Amyloidosis
Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis.
Amyloidosis
Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis.
Amyloidosis
Biophysical analysis of normal transthyretin: implications for fibril formation in senile systemic amyloidosis.
Amyloidosis
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient.
Amyloidosis
Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS).
Amyloidosis
Bone Scintigraphy Imaging for Transthyretin Cardiac Amyloidosis: Still Much to Learn.
Amyloidosis
Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
Amyloidosis
Can Nuclear Imaging Techniques Predict Patient Outcome and Guide Medical Management in Hereditary Transthyretin Cardiac Amyloidosis?
Amyloidosis
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
Amyloidosis
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.
Amyloidosis
Cardiac AA amyloidosis in a patient with obstructive hypertrophic cardiomyopathy.
Amyloidosis
Cardiac amyloidosis associated with a novel transthyretin aspartic acid-18 glutamic acid de novo mutation.
Amyloidosis
Cardiac Amyloidosis Associated With Amyloidogenic Transthyretin V122I Variant in an Elderly Japanese Woman.
Amyloidosis
Cardiac amyloidosis associated with the transthyretin Ile122 mutation in a Caucasian family.
Amyloidosis
Cardiac amyloidosis detection by early bisphosphonate (99mTc-HMDP) scintigraphy.
Amyloidosis
Cardiac Amyloidosis for the Primary Care Provider: A Practical Review to Promote Earlier Recognition of Disease.
Amyloidosis
Cardiac amyloidosis imaging with amyloid positron emission tomography: A systematic review and meta-analysis.
Amyloidosis
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
Amyloidosis
Cardiac Amyloidosis Phenotype Associated With a Glu89Lys Transthyretin Mutation.
Amyloidosis
Cardiac amyloidosis, a monoclonal gammopathy and a potentially misleading mutation.
Amyloidosis
Cardiac amyloidosis-A review of current literature for the practicing physician.
Amyloidosis
Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
Amyloidosis
Cardiac amyloidosis: diagnostic challenges and recent advancement in the treatment of transthyretin amyloidosis (ATTR).
Amyloidosis
Cardiac Amyloidosis: Multimodal Imaging of Disease Activity and Response to Treatment.
Amyloidosis
Cardiac Amyloidosis: Presentations, Diagnostic Work-up and Collaborative Approach for Comprehensive Clinical Management.
Amyloidosis
Cardiac amyloidosis: report of a patient heterozygous for the transthyretin isoleucine 122 variant.
Amyloidosis
Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation.
Amyloidosis
Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
Amyloidosis
Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality.
Amyloidosis
Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation.
Amyloidosis
Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis.
Amyloidosis
Cardiac involvement after liver transplantation in patients with Val30Met transthyretin amyloidosis from Majorca focus.
Amyloidosis
Cardiac involvement in a large cohort of patients with Val30Met transthyretin amyloidosis from Majorca focus.
Amyloidosis
Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis.
Amyloidosis
Cardiac Involvement Secondary to a Familial Form of Transthyretin Amyloidosis Resulting From the Glu54Gln Mutation.
Amyloidosis
Cardiac involvement, morbidity and mortality in hereditary transthyretin amyloidosis because of p.Glu89Gln mutation.
Amyloidosis
Cardiac manifestations and prognostic implications of hereditary transthyretin amyloidosis associated with transthyretin Ala97Ser.
Amyloidosis
Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.
Amyloidosis
Cardiac sympathetic denervation in familial amyloid polyneuropathy assessed by iodine-123 metaiodobenzylguanidine scintigraphy and heart rate variability.
Amyloidosis
Cardiac transthyretin amyloidosis 99mTc-DPD SPECT correlates with strain echocardiography and biomarkers.
Amyloidosis
Cardiac Transthyretin Amyloidosis: A Nuclear Medicine Leading Role. Situation in a Spanish Center and "State of the Art" in Nuclear Medicine.
Amyloidosis
Cardiomyopathy in a Japanese family with the Glu61Lys transthyretin variant: a new phenotype.
Amyloidosis
Cardiovascular autonomic functions in late-onset hereditary transthyretin amyloidosis with Val30Met mutation.
Amyloidosis
Carpal tunnel syndrome and associated symptoms as first manifestation of hATTR amyloidosis.
Amyloidosis
Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?
Amyloidosis
Carpal Tunnel Syndrome Due to Iatrogenic Amyloidosis After Domino Liver Transplantation From Hereditary Transthyretin Amyloidosis: A Case Report.
Amyloidosis
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.
Amyloidosis
Carpal Tunnel Syndrome in Transthyretin Cardiac Amyloidosis: Implications and Protocol for Diagnosis and Treatment.
Amyloidosis
Carpal tunnel syndrome is associated with high fibrinogen and fibrinogen deposits.
Amyloidosis
Case report of a young patient with transthyretin amyloidosis associated with Gly67Ala mutation.
Amyloidosis
Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis.
Amyloidosis
Cause of death analysis and temporal trends in survival after liver transplantation for transthyretin familial amyloid polyneuropathy.
Amyloidosis
Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis.
Amyloidosis
Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation.
Amyloidosis
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
Amyloidosis
Cellular clearance of circulating transthyretin decreases cell-nonautonomous proteotoxicity in Caenorhabditis elegans.
Amyloidosis
Cellular secretion and cytotoxicity of transthyretin mutant proteins underlie late-onset amyloidosis and neurodegeneration.
Amyloidosis
Cerebral embolism secondary to cardiac amyloidosis: A case report and literature review.
Amyloidosis
Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.
Amyloidosis
Cervicomedullary compression as the main manifestation of wild-type transthyretin amyloidosis.
Amyloidosis
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature.
Amyloidosis
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy.
Amyloidosis
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany.
Amyloidosis
Changes in tissue proteome associated with ATTR amyloidosis: insights into pathogenesis.
Amyloidosis
Characterisation of serum transthyretin by electrospray ionisation-ion mobility mass spectrometry: Application to familial amyloidotic polyneuropathy type I (FAP-I).
Amyloidosis
Characteristics of acquired transthyretin amyloidosis: A case series and review of the literature.
Amyloidosis
Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance.
Amyloidosis
Characteristics of Patients with Late- vs. Early-Onset Val30Met Transthyretin Amyloidosis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Amyloidosis
Characteristics of South Korean Patients with Hereditary Transthyretin Amyloidosis.
Amyloidosis
Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M).
Amyloidosis
Characterization of population genetic structure of hereditary transthyretin amyloidosis in Bulgaria.
Amyloidosis
Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implications for wild-type, V30M, and L55P amyloid fibril formation.
Amyloidosis
Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry.
Amyloidosis
Characterization of transthyretin variants in familial transthyretin amyloidosis by mass spectrometric peptide mapping and DNA sequence analysis.
Amyloidosis
Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.
Amyloidosis
Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers.
Amyloidosis
Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review.
Amyloidosis
Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Amyloidosis
Chromolaena odorata (Siam weed): A natural reservoir of bioactive compounds with potent anti-fibrillogenic, antioxidative, and cytocompatible properties.
Amyloidosis
Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis.
Amyloidosis
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis.
Amyloidosis
Clearance of extracellular misfolded proteins in systemic amyloidosis: Experience with transthyretin.
Amyloidosis
Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis.
Amyloidosis
Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses.
Amyloidosis
Clinical and genetic profiles of hereditary transthyretin amyloidosis in Taiwan.
Amyloidosis
Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Amyloidosis
Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
Amyloidosis
Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapies.
Amyloidosis
Clinical characteristics and prognosis of cardiac amyloidosis defined by mass spectrometry-based proteomics in an Australian cohort.
Amyloidosis
Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population.
Amyloidosis
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disproving myths.
Amyloidosis
Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review.
Amyloidosis
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy.
Amyloidosis
Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
Amyloidosis
Clinical Experience With the Use of Doxycycline and Ursodeoxycholic Acid for the Treatment of Transthyretin Cardiac Amyloidosis.
Amyloidosis
Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy.
Amyloidosis
Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis.
Amyloidosis
Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Amyloidosis
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
Amyloidosis
Clinical symptomatic de novo systemic transthyretin amyloidosis 9 years after domino liver transplantation.
Amyloidosis
Clinical, ECG and echocardiographic clues to the diagnosis of TTR-related cardiomyopathy.
Amyloidosis
Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study.
Amyloidosis
Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation.
Amyloidosis
Clinicopathological correlations of sural nerve biopsies in TTR Val30Met familial amyloid polyneuropathy.
Amyloidosis
Clinicopathological features of clinically undiagnosed sporadic transthyretin cardiac amyloidosis: a forensic autopsy-based series.
Amyloidosis
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.
Amyloidosis
CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Amyloidosis
Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis.
Amyloidosis
Coexistence of aortic valve stenosis and cardiac amyloidosis: echocardiographic and clinical significance.
Amyloidosis
Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
Amyloidosis
Coexistence of transthyretin- and A?-type cerebral amyloid angiopathy in a patient with hereditary transthyretin V30M amyloidosis.
Amyloidosis
Coexistent asymptomatic myeloma and hereditary cardiac amyloidosis: an unusual case of heart failure.
Amyloidosis
Combination of Commonly Examined Parameters Is a Useful Predictor of Positive 99 mTc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis.
Amyloidosis
Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
Amyloidosis
Comments on pupillometry: An objective test to assess endocular hereditary transthyretin amyloidosis.
Amyloidosis
Common clinicopathological features in late-onset hereditary transthyretin amyloidosis (Ala97Gly, Val94Gly and Val30Met).
Amyloidosis
Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin.
Amyloidosis
Comparative study of the stabilities of synthetic in vitro and natural ex vivo transthyretin amyloid fibrils.
Amyloidosis
Comparison of 18F-sodium fluoride positron emission tomography imaging and 99mTc-pyrophosphate in cardiac amyloidosis.
Amyloidosis
Comparison of capillary electrophoresis and capillary liquid chromatography coupled to mass spectrometry for the analysis of transthyretin in human serum.
Amyloidosis
Comparison of cardiac amyloidosis due to wild-type and V122I transthyretin in older adults referred to an academic medical center.
Amyloidosis
Comparison of different types of cardiac amyloidosis by cardiac magnetic resonance imaging.
Amyloidosis
Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.
Amyloidosis
Comparison of quantitative sensory testing and heart rate variability in Swedish Val30Met ATTR.
Amyloidosis
Comparison of the standard and speckle tracking echocardiographic features of wild-type and mutated transthyretin cardiac amyloidoses.
Amyloidosis
Comparison of the United Kingdom and United States approaches to approval of new neuromuscular therapies.
Amyloidosis
Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosis.
Amyloidosis
Conjunctival lymphangiectasia: a novel ocular manifestation of hereditary transthyretin amyloidosis.
Amyloidosis
Considerably Unfolded Transthyretin Monomers Preceed and Exchange with Dynamically Structured Amyloid Protofibrils.
Amyloidosis
Considering amyloidosis in patients with clinically unresponsive vitreous inflammation (Oculoleptomeningeal amyloidosis in 3 individuals with transthyretin variant Tyr69His. Vol. 44[3]).
Amyloidosis
Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews.
Amyloidosis
Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid.
Amyloidosis
Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis.
Amyloidosis
Conventional Molecular Dynamics and Metadynamics Simulation Studies of the Binding and Unbinding Mechanism of TTR Stabilizers AG10 and Tafamidis.
Amyloidosis
Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis.
Amyloidosis
Correction to: Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Amyloidosis
Corrigendum to: A new therapy for Transthyretin amyloidosis, no longer an orphan condition.
Amyloidosis
Corrigendum: Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.
Amyloidosis
CORRIGENDUM: Utility of 99 mTc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice.
Amyloidosis
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy.
Amyloidosis
Cost-effectiveness of technetium pyrophosphate scintigraphy versus heart biopsy for the diagnosis of transthyretin amyloidosis.
Amyloidosis
Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.
Amyloidosis
Current Challenges of Cardiac Amyloidosis Awareness among Romanian Cardiologists.
Amyloidosis
Current Review of Leptomeningeal Amyloidosis Associated With Transthyretin Mutations.
Amyloidosis
Cutaneous lymphatic amyloid deposits in "Hungarian-type" familial transthyretin amyloidosis: a case report.
Amyloidosis
Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis.
Amyloidosis
Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice?
Amyloidosis
Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions.
Amyloidosis
Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.
Amyloidosis
D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?
Amyloidosis
Dangerous relationships: aortic stenosis and transthyretin cardiac amyloidosis.
Amyloidosis
Days alive and outside of hospital from diagnosis of transthyretin vs. light chain cardiac amyloidosis.
Amyloidosis
Delayed diagnosis of transthyretin amyloidosis with a novel mutation (c.210T>A) in the transthyretin gene.
Amyloidosis
Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy.
Amyloidosis
Demyelinating Neuropathy in a Patient Treated With Revusiran for Transthyretin (Thr60Ala) Amyloidosis.
Amyloidosis
Derivatization strategies for CE-LIF analysis of biomarkers: Toward a clinical diagnostic of familial transthyretin amyloidosis.
Amyloidosis
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features.
Amyloidosis
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy.
Amyloidosis
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Amyloidosis
Design of mechanism-based inhibitors of transthyretin amyloidosis: studies with biphenyl ethers and new structural templates.
Amyloidosis
Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
Amyloidosis
Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization fourier-transform ion-cyclotron-resonance mass spectrometry.
Amyloidosis
Detection of high-molecular-weight amyloid serum protein complexes using biological on-line tracer sedimentation.
Amyloidosis
Detection of serum amyloid A-derived proteins in formalin-fixed paraffin-embedded tissues: reliability of the method and expansion of its spectrum.
Amyloidosis
Determinants and Prognostic Significance of Serial Right Heart Function Changes in Patients With Cardiac Amyloidosis.
Amyloidosis
Development and validation of a liquid chromatography-tandem mass spectrometry method for the assay of tafamidis in rat plasma: Application to a pharmacokinetic study in rats.
Amyloidosis
Development and validation of a TTR-specific copy number screening tool, and application to potentially relevant patient cohorts.
Amyloidosis
Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients.
Amyloidosis
Development of late amyloid cardiomyopathy following liver transplantation for hereditary Val30Met transthyretin amyloidosis.
Amyloidosis
Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS?+?7.
Amyloidosis
Development of transgenic Caenorhabditis elegans expressing human transthyretin as a model for drug screening.
Amyloidosis
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.
Amyloidosis
Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines.
Amyloidosis
Diagnosis and treatment of cardiac amyloidosis: an interdisciplinary consensus statement.
Amyloidosis
Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).
Amyloidosis
Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis.
Amyloidosis
Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
Amyloidosis
Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care.
Amyloidosis
Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
Amyloidosis
Diagnosis of Amyloidosis: A Survey of Current Awareness and Clinical Challenges Among Cardiologists in Switzerland.
Amyloidosis
Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin gene.
Amyloidosis
Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers.
Amyloidosis
Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
Amyloidosis
Diagnosis of transthyretin cardiac amyloidosis with cadmium zinc telluride cameras: Is it feasible?
Amyloidosis
Diagnostic and prognostic value of Technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis.
Amyloidosis
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy.
Amyloidosis
Diagnostic delay in wild type transthyretin cardiac amyloidosis - A clinical challenge.
Amyloidosis
Diagnostic Performance of Abnormal Nulling on Cardiac Magnetic Resonance Imaging Look Locker Inversion Time Sequence in Differentiating Cardiac Amyloidosis Types.
Amyloidosis
Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
Amyloidosis
Diagnostic performance of transthyretin measurement in fat tissue of patients with ATTR amyloidosis.
Amyloidosis
Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.
Amyloidosis
Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.
Amyloidosis
Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition.
Amyloidosis
Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
Amyloidosis
Different NT-proBNP circulating levels for different types of cardiac amyloidosis.
Amyloidosis
Differential expression of Cathepsin E in transthyretin amyloidosis: from neuropathology to the immune system.
Amyloidosis
Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
Amyloidosis
Diffuse Alveolar Septal Amyloidosis with Wild-Type Transthyretin with Spontaneous Lung Hematoma.
Amyloidosis
Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience.
Amyloidosis
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis.
Amyloidosis
Direct Tissue Evaluation via Immunofluorescence: in the Diagnosis of Hereditary Transthyretin Cardiac Amyloidosis.
Amyloidosis
Discordant Findings on 18F-NaF and 99mTc-HDP Bone Scans in a Patient With ATTR Cardiac Amyloidosis.
Amyloidosis
Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy.
Amyloidosis
DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis.
Amyloidosis
DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis: a comment.
Amyloidosis
Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective.
Amyloidosis
Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage.
Amyloidosis
Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation.
Amyloidosis
Disease-Modifying Therapy for Transthyretin Amyloidosis: Where to Start? Where to Stop?
Amyloidosis
Disparities, Uncertainties, and Societal Cost: Precision Medicine and Transthyretin Amyloidosis.
Amyloidosis
Disruption of blood-nerve barriers in hereditary transthyretin (ATTR) amyloidosis.
Amyloidosis
Dissecting the structure, thermodynamic stability, and aggregation properties of the A25T transthyretin (A25T-TTR) variant involved in leptomeningeal amyloidosis: identifying protein partners that co-aggregate during A25T-TTR fibrillogenesis in cerebrospinal fluid.
Amyloidosis
Dissociation of amyloid fibrils of alpha-synuclein and transthyretin by pressure reveals their reversible nature and the formation of water-excluded cavities.
Amyloidosis
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis.
Amyloidosis
Domino liver transplantation: full-length transthyretin in donor and recipient patients with ATTR Val30Met amyloidosis.
Amyloidosis
Doxycycline plus tauroursodeoxycholic acid for transthyretin amyloidosis: a phase II study.
Amyloidosis
Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story.
Amyloidosis
Drug discovery targeted at transthyretin cardiac amyloidosis: rational design, synthesis, and biological activity of new transthyretin amyloid inhibitors.
Amyloidosis
Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy.
Amyloidosis
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.
Amyloidosis
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR.
Amyloidosis
Early destructive spondyloarthropathy from combined beta2-microglobulin and transthyretin Met30 amyloidosis in a dialysed patient.
Amyloidosis
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis.
Amyloidosis
Early diagnosis of ATTR amyloidosis through targeted follow-up of identified carriers of TTR gene mutations.
Amyloidosis
Early Impairment of Right Ventricular Morphology and Function in Transthyretin-Related Cardiac Amyloidosis.
Amyloidosis
Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.
Amyloidosis
Early Progression of Aortic Stenosis Associated With Iatrogenic Variant Transthyretin Amyloidosis After Domino Liver Transplantation.
Amyloidosis
Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
Amyloidosis
Early-Onset of Transthyretin Amyloidosis in a Young Afro-Caribbean Woman With Thr60Ala Mutation.
Amyloidosis
Echocardiographic and Biohumoral Characteristics in Patients With AL and TTR Amyloidosis at Diagnosis.
Amyloidosis
Echocardiographic and pathologic findings of wild-type transthyretin senile systemic amyloidosis developed in early 50s.
Amyloidosis
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
Amyloidosis
Editorial response to Aimo et al Quality-of-life assessment in amyloid transthyretin amyloidosis.
Amyloidosis
Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
Amyloidosis
Effect of cyclodextrins on transthyretin amyloid formation in transthyretin-related amyloidosis.
Amyloidosis
Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
Amyloidosis
Effects of Chronic Stress on Prefrontal Cortex Transcriptome in Mice Displaying Different Genetic Backgrounds.
Amyloidosis
Effects of liver transplantation and tafamidis in hereditary transthyretin amyloidosis caused by transthyretin Leu55Pro mutation: a case report.
Amyloidosis
Effects of sporadic transthyretin amyloidosis frequently on the gallbladder and the correlation between amyloid deposition in the gallbladder and heart: A forensic autopsy-based histopathological evaluation.
Amyloidosis
Effects of Tafamidis on Transthyretin Stabilization and Clinical Outcomes in Patients with Non-Val30Met Transthyretin Amyloidosis.
Amyloidosis
Efficacy and safety of patisiran for familial amyloidotic polyneuropathy: a phase II multi-dose study.
Amyloidosis
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
Amyloidosis
Efficient 1-Hour Technetium-99 m Pyrophosphate Imaging Protocol for the Diagnosis of Transthyretin Cardiac Amyloidosis.
Amyloidosis
Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
Amyloidosis
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France.
Amyloidosis
Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis.
Amyloidosis
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis.
Amyloidosis
Emerging therapies in transthyretin amyloidosis - a new wave of hope after years of stagnancy?
Amyloidosis
End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases.
Amyloidosis
Endomyocardial Biopsy Characterization of Heart Failure With Preserved Ejection Fraction and Prevalence of Cardiac Amyloidosis.
Amyloidosis
Endoplasmic reticulum quality control regulates the fate of transthyretin variants in the cell.
Amyloidosis
Enhanced amyloidogenicity of sulfonated transthyretin in vitro, a hypothetical etiology of senile amyloidosis.
Amyloidosis
Enhanced transthyretin tetramer stability following expression of an amyloid disease transsuppressor variant in mammalian cells.
Amyloidosis
Enthalpic Forces Correlate with the Selectivity of Transthyretin-Stabilizing Ligands in Human Plasma.
Amyloidosis
Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.
Amyloidosis
Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis.
Amyloidosis
Epigenomic Profiles of African-American Transthyretin Val122Ile Carriers Reveals Putatively Dysregulated Amyloid Mechanisms.
Amyloidosis
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area.
Amyloidosis
Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining.
Amyloidosis
Establishment of an induced pluripotent stem cell line from a patient with hereditary transthyretin amyloidosis carrying transthyretin (TTR) mutation p.Phe53Val.
Amyloidosis
Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation.
Amyloidosis
Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis.
Amyloidosis
Estimating the Gender Distribution of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis.
Amyloidosis
Estimating the prevalence of allelic variants in the transthyretin gene by analysing large-scale sequencing data.
Amyloidosis
Estimation of prevalence of transthyretin (ATTR) cardiac amyloidosis in an Australian subpopulation using bone scans with echocardiography and clinical correlation.
Amyloidosis
Etiology of Amyloidosis Determines Myocardial 99mTc-DPD Uptake in Amyloidotic Cardiomyopathy.
Amyloidosis
Evaluating the binding selectivity of transthyretin amyloid fibril inhibitors in blood plasma.
Amyloidosis
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years.
Amyloidosis
Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation.
Amyloidosis
Evidence that glial cells attenuate G47R transthyretin accumulation in the central nervous system.
Amyloidosis
Evolution of amyloid fibrils in hereditary transthyretin amyloidosis: an ultrastructural study.
Amyloidosis
Examining the sensitivity of 18F-NaF PET for the imaging of cardiac amyloidosis.
Amyloidosis
Excisional goniotomy with Kahook Dual Blade in a patient with glaucoma secondary to Transthyretin Amyloidosis.
Amyloidosis
Exome analysis of connective tissue dysplasia: Death and rebirth of clinical genetics?
Amyloidosis
Experience of patisiran with transthyretin stabilizers in patients with hereditary transthyretin-mediated amyloidosis.
Amyloidosis
Experimental Inhibition of Fibrillogenesis and Neurotoxicity by amyloid-beta (A?) and Other Disease-Related Peptides/Proteins by Plant Extracts and Herbal Compounds.
Amyloidosis
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
Amyloidosis
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Amyloidosis
Exploration of the Misfolding Mechanism of Transthyretin Monomer: Insights from Hybrid-Resolution Simulations and Markov State Model Analysis.
Amyloidosis
EXPRESS: Riociguat for the treatment of transthyretin cardiac amyloidosis - Data from a named patient use program in Austria.
Amyloidosis
Expression of a synthetic gene encoding human transthyretin in Escherichia coli.
Amyloidosis
Expression of Amyloidogenic Transthyretin Drives Hepatic Proteostasis Remodeling in an Induced Pluripotent Stem Cell Model of Systemic Amyloid Disease.
Amyloidosis
Expression, purification, and in vitro cysteine-10 modification of native sequence recombinant human transthyretin.
Amyloidosis
Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.
Amyloidosis
Extracardiac Accumulation of Technetium-99m-Pyrophosphate in Transthyretin Cardiac Amyloidosis.
Amyloidosis
Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value.
Amyloidosis
Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate: preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study.
Amyloidosis
Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis.
Amyloidosis
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
Amyloidosis
False positive technetium-99m pyrophosphate scintigraphy in a patient with cardiac amyloidosis light chain: Case report.
Amyloidosis
False-positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy.
Amyloidosis
Familial amyloid cardiomyopathy masquerading as chronic Guillain-Barre syndrome: things are not always what they seem.
Amyloidosis
Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits.
Amyloidosis
Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
Amyloidosis
Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation.
Amyloidosis
Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variant.
Amyloidosis
Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent.
Amyloidosis
Familial amyloidotic polyneuropathy: protein aggregation in the peripheral nervous system.
Amyloidosis
Familial ATTR amyloidosis: microalbuminuria as a predictor of symptomatic disease and clinical nephropathy.
Amyloidosis
Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis.
Amyloidosis
Familial meningocerebrovascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly)
Amyloidosis
Familial Oculo-Leptomeningeal Transthyretin Amyloidosis Caused by Leu55Arg Mutation.
Amyloidosis
Familial Transthyretin Amyloidosis with Variant Asp38Ala Presenting with Orthostatic Hypotension and Chronic Diarrhea.
Amyloidosis
Family studies of the genetic abnormality in transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy.
Amyloidosis
Fatal cerebral haemorrhage after liver transplantation in a patient with transthyretin variant (gly53glu) amyloidosis.
Amyloidosis
Feasibility of assessing progression of transthyretin amyloid polyneuropathy using nerve conduction studies: Findings from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Amyloidosis
Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.
Amyloidosis
Fecal calprotectin concentrations in patients with hereditary transthyretin amyloidosis and gastrointestinal symptoms.
Amyloidosis
Fecal calprotectin levels are elevated in transthyretin amyloidosis patients with gastrointestinal manifestations.
Amyloidosis
Fibroblasts endocytose and degrade transthyretin aggregates in transthyretin-related amyloidosis.
Amyloidosis
First report of a rare mutation in a Polish patient with painful late-onset transthyretin amyloidosis.
Amyloidosis
First-in-Human Study of AG10, a Novel, Oral, Specific, Selective, and Potent Transthyretin Stabilizer for the Treatment of Transthyretin Amyloidosis: A Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study in Healthy Adult Volunteers.
Amyloidosis
Flavonoid interactions with human transthyretin: Combined structural and thermodynamic analysis.
Amyloidosis
Fluorotryptophan incorporation modulates the structure and stability of transthyretin in a site-specific manner.
Amyloidosis
Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg.
Amyloidosis
Frequency and genetic background of the position 122 (Val----Ile) variant transthyretin gene in the black population.
Amyloidosis
Frequency of ClinVar Pathogenic Variants in Chronic Kidney Disease Patients Surveyed for Return of Research Results at a Cleveland Public Hospital.
Amyloidosis
From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis.
Amyloidosis
From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
Amyloidosis
Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure.
Amyloidosis
Functional variation of the transthyretin gene among human populations and its correlation with amyloidosis phenotypes.
Amyloidosis
Gastric emptying in hereditary transthyretin amyloidosis: the impact of autonomic neuropathy.
Amyloidosis
Gastric peroral endoscopic myotomy for transthyretin amyloidosis gastroparesis.
Amyloidosis
Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis associated with Glu89Gln Mutation.
Amyloidosis
Gastrointestinal Manifestations in Hereditary Transthyretin Amyloidosis: a Single-Centre Experience.
Amyloidosis
Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.
Amyloidosis
Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
Amyloidosis
Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions.
Amyloidosis
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies.
Amyloidosis
Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Amyloidosis
Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
Amyloidosis
Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).
Amyloidosis
Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
Amyloidosis
Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis.
Amyloidosis
Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey).
Amyloidosis
Genotype, echocardiography, and survival in familial transthyretin amyloidosis.
Amyloidosis
Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study.
Amyloidosis
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.
Amyloidosis
Gross hematuria: An unusual presenting symptom of systemic wild-type transthyretinamyloidosis.
Amyloidosis
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain.
Amyloidosis
Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.
Amyloidosis
Heart complications in familial transthyretin amyloidosis: impact of age and gender.
Amyloidosis
Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
Amyloidosis
Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser.
Amyloidosis
Heart Failure Complicated by Alveolar Hemorrhage due to Vascular Collapse and Amyloid Deposits in Wild-Type Transthyretin Amyloidosis.
Amyloidosis
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study.
Amyloidosis
Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis.
Amyloidosis
Heart transplantation for homozygous familial transthyretin (TTR) V122I cardiac amyloidosis.
Amyloidosis
Heart transplantation in a 68-year-old patient with senile systemic amyloidosis.
Amyloidosis
Heavy and light chain (AHL)-type cardiac amyloidosis: first histopathologic-proven case illustrating involvement of the heart.
Amyloidosis
Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosis.
Amyloidosis
Hepatocyte-Targeted Delivery of siRNA Polyplex with PEG-Modified Lactosylated Dendrimer/Cyclodextrin Conjugates for Transthyretin-Related Amyloidosis Therapy.
Amyloidosis
Hereditary ATTR Amyloidosis in Austria: Prevalence and Epidemiological Hot Spots.
Amyloidosis
Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).
Amyloidosis
Hereditary ATTR amyloidosis: a single-institution experience with 266 patients.
Amyloidosis
Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
Amyloidosis
Hereditary cardiac amyloidosis associated with the transthyretin Ile122 mutation in a white man.
Amyloidosis
Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
Amyloidosis
Hereditary transthyretin amyloidosis in mainland China: a unicentric retrospective study.
Amyloidosis
Hereditary Transthyretin Amyloidosis- Clinical and Genetic Characteristics of a Multiracial South-East Asian Cohort in Singapore.
Amyloidosis
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
Amyloidosis
Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial.
Amyloidosis
Hereditary Transthyretin Amyloidosis: Clinical Presentation and Management Updates.
Amyloidosis
Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.
Amyloidosis
Hereditary Transthyretin Cardiac Amyloidosis in Refractory Spinal Canal Stenosis: Genetic and Pathologic Analysis.
Amyloidosis
High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis.
Amyloidosis
High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly.
Amyloidosis
Highly selective leptomeningeal amyloidosis with transthyretin variant Ala25Thr.
Amyloidosis
Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?
Amyloidosis
Homozygosity for the V122I mutation in transthyretin is associated with earlier onset of cardiac amyloidosis in the African American population in the seventh decade of life.
Amyloidosis
How to suspect transthyretin cardiac amyloidosis during daily clinical practice.
Amyloidosis
How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study.
Amyloidosis
Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?
Amyloidosis
Human-murine transthyretin heterotetramers are kinetically stable and non-amyloidogenic. A lesson in the generation of transgenic models of diseases involving oligomeric proteins.
Amyloidosis
Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease.
Amyloidosis
Hydrogen-bond network and pH sensitivity in transthyretin: Neutron crystal structure of human transthyretin.
Amyloidosis
Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis.
Amyloidosis
Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese.
Amyloidosis
Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Amyloidosis
Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
Amyloidosis
Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Amyloidosis
Identification of Transthyretin Tetramer Kinetic Stabilizers That Are Capable of Inhibiting the Retinol-Dependent Retinol Binding Protein 4-Transthyretin Interaction: Potential Novel Therapeutics for Macular Degeneration, Transthyretin Amyloidosis, and Their Common Age-Related Comorbidities.
Amyloidosis
Identification of Wild-Type Transthyretin Cardiac Amyloidosis by Quantifying Myocardial Extracellular Volume Using Cardiac Computed Tomography in Atrial Arrhythmias.
Amyloidosis
Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging.
Amyloidosis
Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?
Amyloidosis
Immunoaffinity chromatographic and immunoprecipitation methods combined with mass spectrometry for characterization of circulating transthyretin.
Amyloidosis
Immunogenicity Assessment of Inotersen, a 2'-O-(2-Methoxyethyl) Antisense Oligonucleotide in Animals and Humans: Effect on Pharmacokinetics, Pharmacodynamics, and Safety.
Amyloidosis
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.
Amyloidosis
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.
Amyloidosis
Impact of age and amyloidosis on thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.
Amyloidosis
Impact of aging on the progression of neuropathy after liver transplantation in transthyretin Val30Met amyloidosis.
Amyloidosis
Impact of clinical and echocardiographic characteristics on occurrence of cardiac events in cardiac amyloidosis as proven by endomyocardial biopsy.
Amyloidosis
Impact of Deuteration on the Assembly Kinetics of Transthyretin Monitored by Native Mass Spectrometry and Implications for Amyloidoses.
Amyloidosis
Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
Amyloidosis
Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy.
Amyloidosis
Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications.
Amyloidosis
Impact of liver transplantation on the natural history of oculopathy in Portuguese patients with transthyretin (V30M) amyloidosis.
Amyloidosis
Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy.
Amyloidosis
Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.
Amyloidosis
Impairment of autophagy by TTR V30M aggregates: in vivo reversal by TUDCA and curcumin.
Amyloidosis
Importance of Genetic Testing in the Diagnosis of Transthyretin Cardiac Amyloidosis.
Amyloidosis
Improved electrochemical detection of a transthyretin synthetic peptide in the nanomolar range with a two-electrode system integrated in a glass/PDMS microchip.
Amyloidosis
Improved outcomes after heart transplantation for cardiac amyloidosis in the modern era.
Amyloidosis
In silico analysis of TTR gene (coding and non-coding regions, and interactive network) and its implications in transthyretin-related amyloidosis.
Amyloidosis
In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
Amyloidosis
In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis.
Amyloidosis
In vivo molecular imaging of peripheral amyloidosis using heparin-binding peptides.
Amyloidosis
Inborn errors of apolipoprotein A-I metabolism: implications for disease, research and development.
Amyloidosis
Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele.
Amyloidosis
Inconsistency between hepatic expression and serum concentration of transthyretin in mice humanized at the transthyretin locus.
Amyloidosis
Increased Risk of Multiple Outpatient Surgeries in African-American Carriers of Transthyretin Val122Ile Mutation Is Modulated by Non-Coding Variants.
Amyloidosis
Increased thickness of lumbar spine ligamentum flavum in wild-type transthyretin amyloidosis.
Amyloidosis
Increasing the accuracy of proteomic typing by decellularisation of amyloid tissue biopsies.
Amyloidosis
Indications and diagnostic yield of endomyocardial biopsies for unexplained cardiomyopathy, a single center experience.
Amyloidosis
Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.
Amyloidosis
Induced pluripotent stem cell modeling of multisystemic, hereditary transthyretin amyloidosis.
Amyloidosis
Ineffectiveness of dialysis in transthyretin (TTR) clearance in familial amyloid polyneuropathy type I, in spite of lower stability of the TTR Met30 variant.
Amyloidosis
Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.
Amyloidosis
Inhibition of human transthyretin aggregation by non-steroidal anti-inflammatory compounds: a structural and thermodynamic analysis.
Amyloidosis
Inhibition of the Amyloidogenesis of Transthyretin by Natural Products and Synthetic Compounds.
Amyloidosis
Inhibition of transthyretin-met30 expression using Inosine(15.1)-Hammerhead ribozymes in cell culture.
Amyloidosis
Inhibitory activities of anthraquinone and xanthone derivatives against transthyretin amyloidogenesis.
Amyloidosis
Inhibitory activities of propolis and its promising component, caffeic acid phenethyl ester, against amyloidogenesis of human transthyretin.
Amyloidosis
Inotersen (transthyretin-specific antisense oligonucleotide) for treatment of transthyretin amyloidosis.
Amyloidosis
Inotersen preserves or improves quality of life in hereditary transthyretin amyloidosis.
Amyloidosis
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis.
Amyloidosis
Inotropic myocardial reserve deficiency is the predominant feature of exercise haemodynamics in cardiac amyloidosis.
Amyloidosis
Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy.
Amyloidosis
Inter-observer reproducibility and intra-observer repeatability in 99mTc-pyrophosphate scan interpretation for diagnosis of transthyretin cardiac amyloidosis.
Amyloidosis
Interactions amongst plasma retinol-binding protein, transthyretin and their ligands: implications in vitamin A homeostasis and transthyretin amyloidosis.
Amyloidosis
Interleukin-1 signaling pathway as a therapeutic target in transthyretin amyloidosis.
Amyloidosis
Intermediate-term outcomes of heart transplantation for cardiac amyloidosis in the current era.
Amyloidosis
Interpreting technetium-99m pyrophosphate cardiac scans to diagnose transthyretin cardiac amyloidosis: Need for due diligence.
Amyloidosis
Intracranial and systemic manifestations of familial leptomeningeal amyloidosis, as seen on CT and MRI.
Amyloidosis
Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis.
Amyloidosis
Intrinsic versus mutation dependent instability/flexibility: a comparative analysis of the structure and dynamics of wild-type transthyretin and its pathogenic variants.
Amyloidosis
Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.
Amyloidosis
Investigation of AGE, their receptor and NF-kappaB activation and apoptosis in patients with ATTR and Gelsolin amyloidosis.
Amyloidosis
Isolated atrial amyloidosis suspected by electrophysiological voltage mapping and diagnosed by 99m Tc-DPD scintigraphy.
Amyloidosis
Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
Amyloidosis
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings.
Amyloidosis
Kind and distribution of cutaneous sensation loss in hereditary transthyretin amyloidosis with polyneuropathy.
Amyloidosis
Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
Amyloidosis
Kinetic stabilization of an oligomeric protein under physiological conditions demonstrated by a lack of subunit exchange: implications for transthyretin amyloidosis.
Amyloidosis
L55P transthyretin accelerates subunit exchange and leads to rapid formation of hybrid tetramers.
Amyloidosis
Late-onset hereditary ATTR V30M amyloidosis with polyneuropathy: Characterization of Brazilian subjects from the THAOS registry.
Amyloidosis
Late-onset peripheral neuropathy in patients with wild type transthyretin amyloidosis (wtATTR).
Amyloidosis
Latent Class Analysis to Classify Patients with Transthyretin Amyloidosis by Signs and Symptoms.
Amyloidosis
Leading RNA Interference Therapeutics Part 1: Silencing Hereditary Transthyretin Amyloidosis, with a Focus on Patisiran.
Amyloidosis
LEFT ATRIAL FUNCTION AND VOLUME BY MAGNETIC RESONANCE IN PATIENTS WITH HEREDITARY AMYLOIDOSIS.
Amyloidosis
Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy?- Comparative Strain Imaging Study.
Amyloidosis
Left Bundle Branch Pacing in Transthyretin Cardiac Amyloidosis and Alternating Bundle Branch Block.
Amyloidosis
Left Ventricular Structure and Function in TTR-Related versus AL Cardiac Amyloidosis.
Amyloidosis
Length-dependent truncal A?-fiber dysfunction in hereditary transthyretin amyloidosis: An intra-epidermal electrical stimulation study.
Amyloidosis
Leukocyte Chemotactic Factor 2 (LECT2)-Associated Renal Amyloidosis: A Case Series.
Amyloidosis
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data.
Amyloidosis
Light chain and transthyretin cardiac amyloidosis: Clinical characteristics, natural history and prognostic factors.
Amyloidosis
Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
Amyloidosis
Liver biopsy discloses a new apolipoprotein A-I hereditary amyloidosis in several unrelated Italian families.
Amyloidosis
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative?
Amyloidosis
Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients.
Amyloidosis
Liver transplantation in transthyretin amyloidoses. When the neurological benefit outweighs the risk.
Amyloidosis
Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease.
Amyloidosis
Long-term follow-up of survival of liver transplant recipients with familial amyloid polyneuropathy (Portuguese type).
Amyloidosis
Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy.
Amyloidosis
Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
Amyloidosis
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Amyloidosis
Loss of gastric interstitial cells of Cajal in patients with hereditary transthyretin amyloidosis.
Amyloidosis
Low plasma apolipoprotein AII levels in human and mouse amyloidosis with mutant transthyretin (Met-30) gene.
Amyloidosis
Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
Amyloidosis
Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Amyloidosis
Lumbosacral stenosis in Labrador retriever military working dogs - an exomic exploratory study.
Amyloidosis
Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
Amyloidosis
Management of complications of cardiac amyloidosis: 10 questions and answers.
Amyloidosis
Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years.
Amyloidosis
Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac Amyloidosis.
Amyloidosis
Marked Systemic Amyloid Angiopathy in Patients With Val 107 Transthyretin Mutation.
Amyloidosis
Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype.
Amyloidosis
Mass Spectrometric-Based Proteomic Analysis of Amyloid Neuropathy Type in Nerve Tissue.
Amyloidosis
Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene.
Amyloidosis
Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Amyloidosis
Measurement of myocardial amyloid deposition in systemic amyloidosis: insights from cardiovascular magnetic resonance imaging.
Amyloidosis
Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin Amyloidosis.
Amyloidosis
Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations.
Amyloidosis
Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs.
Amyloidosis
Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)
Amyloidosis
Metabolic turn over of amyloid fibrils and post-treatment regression of amyloid deposits in systemic amyloidosis with polyneuropathy.
Amyloidosis
Metabolomics analysis for diagnosis and biomarker discovery of transthyretin amyloidosis.
Amyloidosis
Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands.
Amyloidosis
Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-associated amyloidosis.
Amyloidosis
Mispacking of the Phe87 side chain reduces the kinetic stability of human transthyretin.
Amyloidosis
Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients.
Amyloidosis
mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin-mediated amyloidosis.
Amyloidosis
Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
Amyloidosis
Modifications of the 7-Hydroxyl Group of the Transthyretin Ligand Luteolin Provide Mechanistic Insights into Its Binding Properties and High Plasma Specificity.
Amyloidosis
Modulating inhibitors of transthyretin fibrillogenesis via sulfation: Polychlorinated biphenyl sulfates as models.
Amyloidosis
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area.
Amyloidosis
Monitoring of asymptomatic family members at risk of hereditary transthyretin amyloidosis for early intervention with disease-modifying therapies.
Amyloidosis
Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy.
Amyloidosis
Monoclonal Gammopathy of Uncertain Significance and Transthyretin Cardiac Amyloidosis.
Amyloidosis
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
Amyloidosis
Most recent common ancestor of TTR Val30Met mutation in Italian population and its potential role in genotype-phenotype correlation.
Amyloidosis
Mucocutaneous manifestations in systemic amyloidosis A retrospective analytical study in a tertiary care center.
Amyloidosis
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Amyloidosis
Multimodality Imaging of Cardiac Transthyretin Amyloidosis 16 years after a Domino Liver Transplantation.
Amyloidosis
Multisystemic Disease Modeling of Liver-Derived Protein Folding Disorders Using Induced Pluripotent Stem Cells (iPSCs).
Amyloidosis
Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery.
Amyloidosis
Mutation p.G83R in the transthyretin gene is associated with hereditary vitreous amyloidosis in Han Chinese families.
Amyloidosis
Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis.
Amyloidosis
Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy.
Amyloidosis
Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.
Amyloidosis
Myocardial Oxygen Consumption and Efficiency in Patients With Cardiac Amyloidosis.
Amyloidosis
National patterns in imaging utilization for diagnosis of cardiac amyloidosis: A focus on Tc99m-pyrophosphate scintigraphy.
Amyloidosis
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.
Amyloidosis
Native state stabilization by NSAIDs inhibits transthyretin amyloidogenesis from the most common familial disease variants.
Amyloidosis
Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design.
Amyloidosis
Natural history and impact of treatment with tafamidis on major cardiovascular outcome-free survival time in a cohort of patients with transthyretin amyloidosis.
Amyloidosis
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.
Amyloidosis
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Amyloidosis
Nerve ultrasonography features in hereditary transthyretin amyloidosis with V30M mutation and polyneuropathy.
Amyloidosis
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
Amyloidosis
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers.
Amyloidosis
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
Amyloidosis
Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective?
Amyloidosis
Neuropathy symptom and change: Inotersen treatment of hereditary transthyretin amyloidosis.
Amyloidosis
Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
Amyloidosis
Neutron diffraction experiment with the Y116S variant of transthyretin using iBIX at J-PARC: application of a new integration method.
Amyloidosis
New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden.
Amyloidosis
New effective treatment options reinforce disease awareness: the case of transthyretin cardiac amyloidosis.
Amyloidosis
New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience.
Amyloidosis
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis.
Amyloidosis
New sequence variants in patients affected by amyloidosis show transthyretin instability by isoelectric focusing.
Amyloidosis
New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis.
Amyloidosis
New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå Sweden, June 1999.
Amyloidosis
No association between apolipoprotein E epsilon4 allele and the age of onset in type I familial amyloid polyneuropathy.
Amyloidosis
No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis.
Amyloidosis
Nodular cutaneous amyloidosis and carpal tunnel syndrome due to the amyloidogenic transthyretin His 114 variant.
Amyloidosis
Nodular senile pulmonary amyloidosis: a unique case confirmed by immunohistochemistry, mass spectrometry, and genetic study.
Amyloidosis
Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis.
Amyloidosis
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.
Amyloidosis
Non-invasive detection and differentiation of cardiac amyloidosis using 99mTc-pyrophosphate scintigraphy and 11C-Pittsburgh compound B PET imaging.
Amyloidosis
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.
Amyloidosis
Non-senile wild-type transthyretin systemic amyloidosis presenting as bilateral carpal tunnel syndrome.
Amyloidosis
Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
Amyloidosis
Noninvasive Detection of Cardiac Amyloid With 11C-Pittsburgh Compound B PET/CT and 99mTc-PYP Scintigraphy.
Amyloidosis
Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study.
Amyloidosis
Noninvasive diagnosis of hereditary transthyretin-related cardiac amyloidosis: A case report.
Amyloidosis
Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Amyloidosis
Noninvasive Mapping of the Electrophysiological Substrate in Cardiac Amyloidosis and Its Relationship to Structural Abnormalities.
Amyloidosis
Normal scores of deep breathing tests: beware of dysrhythmia in transthyretin amyloidosis.
Amyloidosis
Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro.
Amyloidosis
Not All Heart Uptakes on 99mTc-DPD Scintigraphy Are Amyloidosis: Chloroquine-Induced Cardiomyopathy.
Amyloidosis
Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis.
Amyloidosis
Novel conformation-specific monoclonal antibodies against amyloidogenic forms of transthyretin.
Amyloidosis
Novel insights into rare cardiomyopathies: arrhythmogenic cardiomyopathy, non-compaction, and transthyretin amyloidosis.
Amyloidosis
Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis.
Amyloidosis
Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis.
Amyloidosis
Novel variant transthyretin gene (Ser50 to Ile) in familial cardiac amyloidosis.
Amyloidosis
Novel Zn2+-binding sites in human transthyretin: implications for amyloidogenesis and retinol-binding protein recognition.
Amyloidosis
Nuclear Imaging for Cardiac Amyloidosis: Bone Scan, SPECT/CT, and Amyloid-Targeting PET.
Amyloidosis
Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
Amyloidosis
Occurrence factors and clinical picture of iatrogenic transthyretin amyloidosis after domino liver transplantation.
Amyloidosis
Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement.
Amyloidosis
Ocular angiographic features in Japanese patients with Val30Met hereditary transthyretin amyloidosis.
Amyloidosis
Ocular Involvement in Hereditary Transthyretin Amyloidosis: A Case Series Describing Novel Potential Biomarkers.
Amyloidosis
OCULAR MANIFESTATIONS OF ASP38ALA AND THR59LYS FAMILIAL TRANSTHYRETIN AMYLOIDOSIS.
Amyloidosis
Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64.
Amyloidosis
Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
Amyloidosis
Oculoleptomeningeal amyloidosis in 3 individuals with the transthyretin variant Tyr69His.
Amyloidosis
Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.
Amyloidosis
Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Amyloidosis
Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.
Amyloidosis
Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B.
Amyloidosis
Oligonucleotide Drugs for Transthyretin Amyloidosis.
Amyloidosis
On-a-chip tryptic digestion of transthyretin: a step toward an integrated microfluidic system for the follow-up of familial transthyretin amyloidosis.
Amyloidosis
On-line immunoaffinity solid-phase extraction capillary electrophoresis mass spectrometry using Fab´antibody fragments for the analysis of serum transthyretin.
Amyloidosis
One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.
Amyloidosis
Optimization of Serum Immunoglobulin Free Light Chain Analysis for Subclassification of Cardiac Amyloidosis.
Amyloidosis
Optimizing 99mTc-DPD scintigraphy: Adding value to the diagnosis and treatment of cardiac transthyretin amyloidosis.
Amyloidosis
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.
Amyloidosis
Orthotopic liver transplantation for familial amyloidotic polyneuropathy: a pathological study.
Amyloidosis
Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.
Amyloidosis
Outcome of exercise electrocardiography in familial amyloidotic polyneuropathy patients, Portuguese type, under evaluation for liver transplantation.
Amyloidosis
Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis.
Amyloidosis
Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients.
Amyloidosis
Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.
Amyloidosis
Outcomes in Patients With Cardiac Amyloidosis Undergoing Heart Transplantation.
Amyloidosis
Outcomes of Patients With Familial Transthyretin Amyloidosis After Liver Transplantation.
Amyloidosis
Overview of treatments used in transthyretin-related hereditary amyloidosis: a systematic review.
Amyloidosis
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy.
Amyloidosis
Pathogenesis of and therapeutic strategies to ameliorate the transthyretin amyloidoses.
Amyloidosis
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
Amyloidosis
Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
Amyloidosis
Patient-reported burden of hereditary transthyretin amyloidosis on functioning and well-being.
Amyloidosis
Patisiran for advanced heart failure with hereditary transthyretin cardiac amyloidosis.
Amyloidosis
Patisiran Pharmacokinetics, Pharmacodynamics, and Exposure-Response Analyses in the Phase 3 APOLLO Trial in Patients With Hereditary Transthyretin-Mediated (hATTR) Amyloidosis.
Amyloidosis
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis.
Amyloidosis
Pattern of myocardial 99mTc-HMDP uptake and impact on myocardial function in patients with transthyretin cardiac amyloidosis.
Amyloidosis
Pearls & Oy-sters: Number, Weaker, and Dizzier Due to Transthyretin Amyloidosis After 2 Liver Transplants.
Amyloidosis
Peripheral Blood Cell Gene Expression Diagnostic for Identifying Symptomatic Transthyretin Amyloidosis Patients: Male and Female Specific Signatures.
Amyloidosis
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).
Amyloidosis
Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
Amyloidosis
Pharmacological Stimulation of Phagocytosis Enhances Amyloid Plaque Clearance; Evidence from a Transgenic Mouse Model of ATTR Neuropathy.
Amyloidosis
Pharmacotherapy review: Emerging treatment modalities in transthyretin cardiac amyloidosis.
Amyloidosis
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Amyloidosis
Phenome-wide association study of TTR and RBP4 genes in 361,194 individuals reveals novel insights in the genetics of hereditary and wildtype transthyretin amyloidoses.
Amyloidosis
Phenotypes of Late-Onset Transthyretin Amyloid Neuropathy: A Diagnostic Challenge.
Amyloidosis
Phenotypic characterization of late onset cardiac amyloidosis caused by the transthyretin mutation TTRA45S, p.(Ala65Ser).
Amyloidosis
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS.
Amyloidosis
Phenotypic expressions of hereditary Transthyretin Ala97Ser related Amyloidosis (ATTR) in Taiwanese.
Amyloidosis
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
Amyloidosis
Physiological IgM class catalytic antibodies selective for transthyretin amyloid.
Amyloidosis
Pieter Cullis' quest for a lipid-based, fusogenic delivery system for nucleic acid therapeutics: success with siRNA so what about mRNA?
Amyloidosis
Plasma growth differentiation factor 15: a novel tool to detect early changes of hereditary transthyretin amyloidosis.
Amyloidosis
Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis.
Amyloidosis
Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.
Amyloidosis
Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy.
Amyloidosis
Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide.
Amyloidosis
Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis.
Amyloidosis
Population pharmacokinetic modelling and simulation of tafamidis in healthy subjects and patients with transthyretin amyloidosis.
Amyloidosis
Population Pharmacokinetic-Pharmacodynamic Model of Serum Transthyretin Following Patisiran Administration.
Amyloidosis
Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin Amyloidosis.
Amyloidosis
Positive Effectiveness of Tafamidis in Delaying Disease Progression in Transthyretin Familial Amyloid Polyneuropathy up to 2 Years: An Analysis from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Amyloidosis
Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR).
Amyloidosis
Potential Cardiac Amyloid PET/CT Imaging Targets for Differentiating Immunoglobulin Light Chain From Transthyretin Amyloidosis.
Amyloidosis
Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
Amyloidosis
Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis.
Amyloidosis
Prediction of long-term survival after liver transplantation for familial transthyretin amyloidosis.
Amyloidosis
Prediction of Medium-Term Mortality in Japanese Patients With Wild-Type Transthyretin Amyloidosis.
Amyloidosis
Predictors of survival stratification in patients with wild-type cardiac amyloidosis.
Amyloidosis
Prenatal diagnosis of hereditary amyloidosis in a Portuguese family living in France.
Amyloidosis
Presence of val30Met and val122ile mutations in a patient with hereditary amyloidosis.
Amyloidosis
Pressure-Volume Relationships in Patients With Transthyretin (ATTR) Cardiac Amyloidosis Secondary to V122I Mutations and Wild-Type Transthyretin: Transthyretin Cardiac Amyloid Study (TRACS).
Amyloidosis
Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review.
Amyloidosis
Prevalence and Prognostic Significance of Frailty Among Patients With Transthyretin Amyloidosis Cardiomyopathy.
Amyloidosis
Prevalence and prognostic value of autonomic neuropathy assessed by Sudoscan® in transthyretin wild-type cardiac amyloidosis.
Amyloidosis
Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
Amyloidosis
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas.
Amyloidosis
Prevalence of Positive 99 mTc-DPD Scintigraphy as an Indicator of the Prevalence of Wild-type Transthyretin Amyloidosis in the Elderly.
Amyloidosis
Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14?333 African-Americans.
Amyloidosis
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study.
Amyloidosis
Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
Amyloidosis
Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population.
Amyloidosis
Prevalence of wild type transtyrethin cardiac amyloidosis in a heart failure clinic.
Amyloidosis
Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
Amyloidosis
Prevention of transthyretin amyloid disease by changing protein misfolding energetics.
Amyloidosis
Primary prevention implantable cardioverter-defibrillators in transthyretin cardiac amyloidosis.
Amyloidosis
Probing conformational changes of monomeric transthyretin with second derivative fluorescence.
Amyloidosis
Probing solvent accessibility of transthyretin amyloid by solution NMR spectroscopy.
Amyloidosis
Production and functional analysis of normal and variant recombinant human transthyretin proteins.
Amyloidosis
Prognostic impact of light-chain and transthyretin-related categories in cardiac amyloidosis: a systematic review and meta-analysis.
Amyloidosis
Prognostic implication of relative regional strain ratio in cardiac amyloidosis.
Amyloidosis
Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis.
Amyloidosis
Prognostic significance of incidental suspected transthyretin amyloidosis on routine bone scintigraphy.
Amyloidosis
Prognostic Significance of Occult Transthyretin Cardiac Amyloidosis in Patients With Severe Aortic Stenosis Undergoing Surgical Aortic Valve Replacement: An Unrecognized Disease Modifier.
Amyloidosis
Prognostic Utility of Echocardiographic Atrial and Ventricular Strain Imaging in Patients With Cardiac Amyloidosis.
Amyloidosis
Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Amyloidosis
Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis.
Amyloidosis
Progress and challenges in the treatment of cardiac amyloidosis: a review of the literature.
Amyloidosis
Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation.
Amyloidosis
Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.
Amyloidosis
Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
Amyloidosis
Progression of transthyretin (TTR) amyloidosis in donors and recipients after domino liver transplantation-a prospective single-center cohort study.
Amyloidosis
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis.
Amyloidosis
Progressive deterioration of frailty is associated with poor outcomes in patients with transthyretin cardiac amyloidosis.
Amyloidosis
Proportion between wild-type and mutant protein in truncated compared to full-length ATTR: an analysis on transplanted transthyretin T60A amyloidosis patients.
Amyloidosis
Proposing a minimal set of metrics and methods to predict probabilities of amyloidosis disease and onset age in individuals.
Amyloidosis
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS).
Amyloidosis
Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis.
Amyloidosis
Proteomic characterization of amyloid deposits in transthyretin amyloidosis associated with various mutations.
Amyloidosis
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy.
Amyloidosis
Pupillometry: An objective test to assess endocular hereditary transthyretin amyloidosis.
Amyloidosis
Purification of transthyretin and transthyretin fragments from amyloid-rich human tissues.
Amyloidosis
Quantification of cardiac amyloid with [18F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis.
Amyloidosis
Quantification of myocardial 99mTc-labeled bisphosphonate uptake with cadmium zinc telluride camera in patients with transthyretin-related cardiac amyloidosis.
Amyloidosis
Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: the relationship between stability and amyloidosis.
Amyloidosis
Quantification of transthyretin kinetic stability in human plasma using subunit exchange.
Amyloidosis
Quantitation of 99mTc-DPD uptake in patients with transthyretin-related cardiac amyloidosis.
Amyloidosis
Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.
Amyloidosis
Quantitative SPECT/CT parameters of myocardial 99mTechnetium-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) uptake in suspected cardiac transthyretin amyloidosis.
Amyloidosis
Radionuclide Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis: Different Sensitivity in Early-Onset V30M Mutation?
Amyloidosis
Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers.
Amyloidosis
Rapid decline in ejection fraction and persistent elevation of troponin associated with cardiac amyloidosis.
Amyloidosis
Rapid method to characterize mutations in transthyretin in cerebrospinal fluid from familial amyloidotic polyneuropathy patients by use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Amyloidosis
Rapidly Progressive Transthyretin-Mediated Amyloidosis in a Domino Liver Transplant Recipient of a Ser23Asn Donor.
Amyloidosis
Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
Amyloidosis
Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
Amyloidosis
Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
Amyloidosis
Recent Advances and Current Dilemmas in the Diagnosis and Management of Transthyretin Cardiac Amyloidosis.
Amyloidosis
Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
Amyloidosis
Recent progress in the understanding and treatment of transthyretin amyloidosis.
Amyloidosis
Recipient Aging Accelerates Acquired Transthyretin Amyloidosis After Domino Liver Transplantation.
Amyloidosis
Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis.
Amyloidosis
Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus.
Amyloidosis
Recommendations for presymptomatic genetic testing and management of individuals at risk for hereditary transthyretin amyloidosis.
Amyloidosis
Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations.
Amyloidosis
Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu).
Amyloidosis
Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain.
Amyloidosis
Reduced intraepidermal nerve fibre density in patients with hereditary transthyretin amyloidosis.
Amyloidosis
Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.
Amyloidosis
Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
Amyloidosis
Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
Amyloidosis
Reduction of free radical activity in amyloid deposits following liver transplantation for familial amyloidotic polyneuropathy.
Amyloidosis
Refractory Heart Failure of Unknown Etiology May Be Cardiac Amyloid If Preceded by Hereditary Neurological Symptoms.
Amyloidosis
Regional Variation in Technetium Pyrophosphate Uptake in Transthyretin Cardiac Amyloidosis and Impact on Mortality.
Amyloidosis
Relation of clinical, echocardiographic and electrocardiographic features of cardiac amyloidosis to the presence of the transthyretin V122I allele in older African-American men.
Amyloidosis
Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
Amyloidosis
Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue.
Amyloidosis
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis.
Amyloidosis
Renal Involvement in Hereditary Transthyretin Amyloidosis: An Italian Single-Centre Experience.
Amyloidosis
Reply: Liver transplantation in transthyretin amyloidosis: Issues and challenges.
Amyloidosis
Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity.
Amyloidosis
Repurposing Benzbromarone for Familial Amyloid Polyneuropathy: A New Transthyretin Tetramer Stabilizer.
Amyloidosis
Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study.
Amyloidosis
Response: Atrial impairment in transthyretin cardiac amyloidosis: an early marker of cardiac involvement and a prognostic factor.
Amyloidosis
Restriction fragment length polymorphism analysis of mutated transthyretin in vitreous amyloidosis.
Amyloidosis
Restrictive cardiomyopathy in inherited ATTR amyloidosis (TTR-Ser23Asn) in a patient of German-Italian extraction.
Amyloidosis
Results of liver transplantation for familial amyloid polyneuropathy type I in Brazil.
Amyloidosis
Retinol binding protein 4 (RBP4) concentration identifies V122I transthyretin cardiac amyloidosis.
Amyloidosis
Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis.
Amyloidosis
Review of Transthyretin Silencers, Stabilizers, and Fibril Removal Agents in the Treatment of Transthyretin Cardiac Amyloid.
Amyloidosis
Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies.
Amyloidosis
Revisiting transthyretin related cardiac amyloidosis: Case report and review of literature.
Amyloidosis
Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone.
Amyloidosis
Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation.
Amyloidosis
Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis.
Amyloidosis
Role of Right Ventricular Strain Measured by Two-Dimensional Echocardiography in the Diagnosis of Cardiac Amyloidosis.
Amyloidosis
Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene.
Amyloidosis
Role of the glutamic acid 54 residue in transthyretin stability and thyroxine binding.
Amyloidosis
S-sulfonation of transthyretin is an important trigger step in the formation of transthyretin-related amyloid fibril.
Amyloidosis
Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy.
Amyloidosis
Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis.
Amyloidosis
Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: a study on Swedish transplanted and non-transplanted patients.
Amyloidosis
Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review.
Amyloidosis
Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness.
Amyloidosis
Screening for genetic mutations in patients with neuropathy without definite etiology is useful.
Amyloidosis
Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins.
Amyloidosis
Selection of hereditary transthyretin amyloid patients for liver transplantation: the Swedish experience.
Amyloidosis
Selective silencing of a mutant transthyretin allele by small interfering RNAs.
Amyloidosis
Self-reported gastrointestinal symptoms are more common in liver transplanted transthyretin amyloidosis patients than in healthy controls and in patients transplanted for end-stage liver disease.
Amyloidosis
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Amyloidosis
Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122).
Amyloidosis
Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study.
Amyloidosis
Senile Systemic Amyloidosis Presenting as Hematuria: A Rare Presentation and Review of Literature.
Amyloidosis
Senile transthyretin cardiac amyloidosis in patients with plasma cell dyscrasias: importance of cardiac biopsy for making the correct diagnosis.
Amyloidosis
Serial scanning with technetium pyrophosphate ((99m)Tc-PYP) in advanced ATTR cardiac amyloidosis.
Amyloidosis
Serum levels of NT-proBNP as surrogate for cardiac amyloid burden: new evidence from gadolinium-enhanced cardiac magnetic resonance imaging in patients with amyloidosis.
Amyloidosis
Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm).
Amyloidosis
Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.
Amyloidosis
Severe Aortic Stenosis and ATTRwt Amyloidosis - Beware in the Aging: A Case Report and Review of the Literature.
Amyloidosis
Severe hand pain as an extracardiac manifestation of transthyretin amyloidosis.
Amyloidosis
Severe heart disease in an unusual case of familial amyloid polyneuropathy type I.
Amyloidosis
Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure-Volume Analysis.
Amyloidosis
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
Amyloidosis
Single AAV-mediated CRISPR-Nme2Cas9 efficiently reduces mutant hTTR expression in a transgenic mouse model of transthyretin amyloidosis.
Amyloidosis
Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients.
Amyloidosis
Single-Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N-acetylgalactosamine-Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects.
Amyloidosis
Small fiber neuropathy in Sjögren syndrome: Comparison with other small fiber neuropathies.
Amyloidosis
Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis.
Amyloidosis
Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses.
Amyloidosis
Societal costs and burden of hereditary transthyretin amyloidosis polyneuropathy.
Amyloidosis
Specific Disruption of Transthyretin(105-115) Fibrilization Using "Stabilizing" Inhibitors of Transthyretin Amyloidogenesis.
Amyloidosis
Specific pathogen free conditions prevent transthyretin amyloidosis in mouse models.
Amyloidosis
Specific postoperative complications of vitrectomy in hereditary transthyretin amyloidosis.
Amyloidosis
Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations.
Amyloidosis
Speckle tracking echo to assess transthyretin amyloidosis type: is it useful (or necessary)?
Amyloidosis
Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series.
Amyloidosis
Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis.
Amyloidosis
Splenic regression of amyloid on multi-modality imaging in response to treatment with patisiran and diflunisal in hereditary transthyretin amyloidosis.
Amyloidosis
Spontaneous intramyocardial haemorrhage in a patient with wild-type transthyretin cardiac amyloidosis.
Amyloidosis
Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis.
Amyloidosis
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.
Amyloidosis
Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?
Amyloidosis
Standardization of (99m)Technetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.
Amyloidosis
Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy.
Amyloidosis
Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Amyloidosis
Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
Amyloidosis
Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis.
Amyloidosis
Structure of Monomeric Transthyretin Carrying the Clinically Important T119M Mutation.
Amyloidosis
Structure-activity relationships of flurbiprofen analogues as stabilizers of the amyloidogenic protein transthyretin.
Amyloidosis
Structure-based design of kinetic stabilizers that ameliorate the transthyretin amyloidoses.
Amyloidosis
Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.
Amyloidosis
Subclinical retinal angiopathy associated with hereditary transthyretin amyloidosis - assessed with optical coherence tomography angiography.
Amyloidosis
Substoichiometric inhibition of transthyretin misfolding by immune-targeting sparsely populated misfolding intermediates: a potential diagnostic and therapeutic for TTR amyloidoses.
Amyloidosis
Subthreshold Aortic Valve Calcium Scores in Severe Aortic Stenosis and Transthyretin Cardiac Amyloidosis.
Amyloidosis
Successful Heart and Liver Transplantation in a Swiss Patient With Glu89Lys Transthyretin Amyloidosis.
Amyloidosis
Supercentenarians and transthyretin amyloidosis: the next frontier of human life extension.
Amyloidosis
Support for the multigenic hypothesis of amyloidosis: the binding stoichiometry of retinol-binding protein, vitamin A, and thyroid hormone influences transthyretin amyloidogenicity in vitro.
Amyloidosis
Supporting the Assessment of Hereditary Transthyretin Amyloidosis Patients Based On 3-D Gait Analysis and Machine Learning.
Amyloidosis
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.
Amyloidosis
Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment.
Amyloidosis
Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.
Amyloidosis
Symptomatic Val122del mutated hereditary transthyretin amyloidosis: Need for early diagnosis and prioritization for heart and liver transplantation.
Amyloidosis
Syncope as a Phenotypic Expression of Hereditary Transthyretin Amyloidosis Val142Ile (Val122Ile).
Amyloidosis
Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Amyloidosis
Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
Amyloidosis
Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR).
Amyloidosis
Synthesis of an analog of the thyroid hormone-binding protein transthyretin via regioselective chemical ligation.
Amyloidosis
Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I.
Amyloidosis
Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.
Amyloidosis
Systemic angiopathy and axonopathy in hereditary transthyretin amyloidosis with Ala97Gly (p. Ala117Gly) mutation: a post-mortem analysis.
Amyloidosis
Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
Amyloidosis
Tafamidis for autonomic neuropathy in hereditary transthyretin (ATTR) amyloidosis: a review.
Amyloidosis
Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report.
Amyloidosis
Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.
Amyloidosis
Tafamidis, a Noninvasive Therapy for Delaying Transthyretin Familial Amyloid Polyneuropathy: Systematic Review and Meta-Analysis.
Amyloidosis
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Amyloidosis
Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Amyloidosis
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides.
Amyloidosis
Targeting a rare amyloidotic disease through rationally designed polymer conjugates.
Amyloidosis
Targeting Different Transthyretin Binding Sites with Unusual Natural Compounds.
Amyloidosis
Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis.
Amyloidosis
Targeting transthyretin amyloidosis in the eye with next-generation stabilizers: AT40 displays potent TTR stabilization in the human vitreous.
Amyloidosis
Tc-99m pyrophosphate imaging for transthyretin cardiac amyloidosis: Importance of estimation of cancer risk with the modality.
Amyloidosis
Teaching NeuroImages: Morphology of lumbosacral dorsal root ganglia and plexus in hereditary transthyretin amyloidosis.
Amyloidosis
Teaching NeuroImages: Neuromyopathy in a patient with hereditary transthyretin Thr60Ala amyloidosis.
Amyloidosis
Technetium 99m pyrophosphate radioisotope for diagnosis and prognosis of transthyretin cardiac amyloidosis: A call for collaboration.
Amyloidosis
Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
Amyloidosis
Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: Associations with echocardiographic disease severity and outcomes.
Amyloidosis
Tegsedi (Inotersen): An Antisense Oligonucleotide Approved for the Treatment of Adult Patients with Hereditary Transthyretin Amyloidosis.
Amyloidosis
Temporal Change in Longitudinal Strain After Domino Liver Transplantation With Liver Grafts Explanted From Patients With Hereditary Amyloidogenic Transthyretin Amyloidosis.
Amyloidosis
Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry.
Amyloidosis
Tenosynovial and Cardiac Transthyretin Amyloidosis in Japanese Patients Undergoing Carpal Tunnel Release.
Amyloidosis
Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation.
Amyloidosis
Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer.
Amyloidosis
Tetraparesis and sensorimotor axonal polyneuropathy due to co-occurrence of Pompe disease and hereditary ATTR amyloidosis.
Amyloidosis
THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
Amyloidosis
THAOS: gastrointestinal manifestations of transthyretin amyloidosis - common complications of a rare disease.
Amyloidosis
The Accumulation of Heparan Sulfate S-Domains in Kidney Transthyretin Deposits Accelerates Fibril Formation and Promotes Cytotoxicity.
Amyloidosis
The Bioequivalence of Tafamidis 61-mg Free Acid Capsules and Tafamidis Meglumine 4 × 20-mg Capsules in Healthy Volunteers.
Amyloidosis
The Clinical and Economic Burden of Newly Diagnosed Hereditary Transthyretin (ATTRv) Amyloidosis: A Retrospective Analysis of Claims Data.
Amyloidosis
The crystal structure of transthyretin in complex with diethylstilbestrol: a promising template for the design of amyloid inhibitors.
Amyloidosis
The current status of quantitative SPECT/CT in the assessment of transthyretin cardiac amyloidosis.
Amyloidosis
The current status of the Transthyretin Amyloidosis Outcomes Survey (THAOS) in Japan.
Amyloidosis
The demographic, genetic, and clinical characteristics of Brazilian subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey.
Amyloidosis
The demographic, genetic, and clinical characteristics of Latin American subjects enrolled in the Transthyretin Amyloidosis Outcomes Survey.
Amyloidosis
The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types.
Amyloidosis
The Effectiveness and Value of Patisiran and Inotersen for Hereditary Transthyretin Amyloidosis.
Amyloidosis
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.
Amyloidosis
The Evolving Role of Cardiovascular Magnetic Resonance Imaging in the Evaluation of Systemic Amyloidosis.
Amyloidosis
The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.
Amyloidosis
The first Caucasian patient with p.Val122Ile mutated-transthyretin cardiac amyloidosis treated with isolated heart transplantation.
Amyloidosis
The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic response.
Amyloidosis
The frequency of central nervous system complications in the Cypriot cohort of ATTRV30M neuropathy transplanted patients.
Amyloidosis
The genetic heterogeneity of hereditary transthyretin amyloidosis in a sample of the Brazilian population.
Amyloidosis
The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.
Amyloidosis
The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy.
Amyloidosis
The importance of a gatekeeper residue on the aggregation of transthyretin: implications for transthyretin-related amyloidoses.
Amyloidosis
The liver in systemic amyloidosis: insights from 123I serum amyloid P component scintigraphy in 484 patients.
Amyloidosis
The morphology of amyloid fibrils and their impact on tissue damage in hereditary transthyretin amyloidosis: An ultrastructural study.
Amyloidosis
The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis.
Amyloidosis
The pathologic spectrum of oculoleptomeningeal amyloidosis with Val30Gly transthyretin gene mutation in a postmortem case.
Amyloidosis
The pathological and biochemical identification of possible seed-lesions of transmitted transthyretin amyloidosis after domino liver transplantation.
Amyloidosis
The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis.
Amyloidosis
The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies.
Amyloidosis
The premortem recognition of systemic senile amyloidosis with cardiac involvement.
Amyloidosis
The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa.
Amyloidosis
The Prevalence of Advanced Interatrial Block and Its Relationship to Left Atrial Function in Patients with Transthyretin Cardiac Amyloidosis.
Amyloidosis
The prevalence of TTR cardiac amyloidosis among patients undergoing bone scintigraphy.
Amyloidosis
The prostate as a good candidate organ for proving amyloid deposition in non-endemic late onset hereditary transthyretin amyloidosis: Report of two cases.
Amyloidosis
The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis.
Amyloidosis
The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.
Amyloidosis
The role of fibrinogen glycation in ATTR: evidence for chaperone activity loss in disease.
Amyloidosis
The Role of Multi-modality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update.
Amyloidosis
The sensitivity of DPD scintigraphy to detect transthyretin cardiac amyloidosis in V30M mutation depends on the phenotypic expression of the disease.
Amyloidosis
The Structural Understanding of Transthyretin Misfolding and the Inspired Drug Approaches for the Treatment of Heart Failure Associated With Transthyretin Amyloidosis.
Amyloidosis
The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition.
Amyloidosis
The transmissible amyloidoses: genetical control of spontaneous generation of infectious amyloid proteins by nucleation of configurational change in host precursors: kuru-CJD-GSS-scrapie-BSE.
Amyloidosis
The Transthyretin Amyloidoses: From Delineating the Molecular Mechanism of Aggregation Linked to Pathology to a Regulatory-Agency-Approved Drug.
Amyloidosis
The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology.
Amyloidosis
The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis.
Amyloidosis
The use of subcutaneous fat tissue for amyloid typing by enzyme-linked immunosorbent assay.
Amyloidosis
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.
Amyloidosis
The Val142Ile transthyretin cardiac amyloidosis: more than an Afro-American pathogenic variant.
Amyloidosis
The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience.
Amyloidosis
The Value of Nerve Biopsy in Transthyretin Amyloidosis with Competing Comorbidities.
Amyloidosis
The value of screening biopsies in light-chain (AL) and transthyretin (ATTR) amyloidosis.
Amyloidosis
Therapeutic Potential of Polyamidoamine Dendrimer for Amyloidogenic Transthyretin Amyloidosis.
Amyloidosis
Thermodynamic Stability and Aggregation Kinetics of EF Helix and EF Loop Variants of Transthyretin.
Amyloidosis
Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.
Amyloidosis
Time Course of Common Clinical Manifestations in Patients with Transthyretin Cardiac Amyloidosis: Delay From Symptom Onset to Diagnosis.
Amyloidosis
Time Domain Optical Coherence Tomography in Familial Vitreous Amyloidosis Associated Transthyretin Met30 Mutation.
Amyloidosis
Tissue damage in the amyloidoses: Transthyretin monomers and nonnative oligomers are the major cytotoxic species in tissue culture.
Amyloidosis
Tolcapone, a potent aggregation inhibitor for the treatment of familial leptomeningeal amyloidosis.
Amyloidosis
Top-Down Analysis of Small Plasma Proteins Using an LTQ-Orbitrap. Potential for Mass Spectrometry-Based Clinical Assays for Transthyretin and Hemoglobin.
Amyloidosis
Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
Amyloidosis
Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation.
Amyloidosis
Transradial left ventricular endomyocardial biopsy feasibility, safety and clinical usefulness: Initial experience of a tertiary university center.
Amyloidosis
Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule.
Amyloidosis
Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
Amyloidosis
Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
Amyloidosis
Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.
Amyloidosis
Transthyretin Amyloid Fibril Disrupting Activities of Extracts and Fractions from Juglans mandshurica Maxim. var. cordiformis (Makino) Kitam.
Amyloidosis
Transthyretin amyloid fibrils alter primary fibroblast structure, function, and inflammatory gene expression.
Amyloidosis
Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?
Amyloidosis
Transthyretin amyloidoses of familial amyloidotic polyneuropathy as a paradigm for the genetic control of De Novo generation of Creutzfeldt-Jakob disease infectious amyloid by a spontaneous change in configuration of the host precursor protein.
Amyloidosis
Transthyretin amyloidoses of familial amyloidotic polyneuropathy as a paradigm for the genetic control of spontaneous generation of infectious amyloids by patterned configurational change in host precursors in Creutzfeldt-Jacob disease.
Amyloidosis
Transthyretin Amyloidosis (ATTR) - The Role of Multimodality in the Definitive Diagnosis.
Amyloidosis
Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy.
Amyloidosis
Transthyretin amyloidosis and herpes zoster infection: a mimic of temporal arteritis.
Amyloidosis
Transthyretin amyloidosis and two other aging-related amyloidoses in an aged vervet monkey.
Amyloidosis
Transthyretin amyloidosis associated with a novel variant (Trp41Leu) presenting with vitreous opacities.
Amyloidosis
Transthyretin amyloidosis in a patient of Iranian-Jewish extraction: a second Israeli-Jewish case.
Amyloidosis
Transthyretin amyloidosis in a septuagenarian masquerading as hypertrophic cardiomyopathy: the importance of multimodality imaging.
Amyloidosis
Transthyretin amyloidosis in Western Europe: a snapshot from the THAOS registry and a call for further perspectives.
Amyloidosis
Transthyretin Amyloidosis Mimicking Obstructive Hypertrophic Cardiomyopathy: A Great Imitator.
Amyloidosis
Transthyretin amyloidosis presenting with multifocal demyelinating mononeuropathies.
Amyloidosis
Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment.
Amyloidosis
Transthyretin amyloidosis with cardiomyopathy after domino liver transplantation: Results of a cross-sectional study.
Amyloidosis
Transthyretin amyloidosis with pulmonary involvement in a patient with monoclonal gammapathy.
Amyloidosis
Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease.
Amyloidosis
Transthyretin amyloidosis: Testing strategies and model for center of excellence support.
Amyloidosis
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies.
Amyloidosis
Transthyretin Anti-Amyloidogenic and Fibril Disrupting Activities of Bacopa monnieri (L.) Wettst (Brahmi) Extract.
Amyloidosis
Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications.
Amyloidosis
Transthyretin Cardiac Amyloidosis and Novel Therapies to Treat This Not-so-rare Cause of Cardiomyopathy.
Amyloidosis
Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
Amyloidosis
Transthyretin cardiac amyloidosis diagnosed by analyzing a prostatic tissue sample: a case report.
Amyloidosis
Transthyretin Cardiac Amyloidosis Due to Homozygous Val122Ile Mutation in a Caucasian Man.
Amyloidosis
Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
Amyloidosis
Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Amyloidosis
Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.
Amyloidosis
Transthyretin Cardiac Amyloidosis in the Elderly-Tip of a Heart Failure Iceberg?
Amyloidosis
Transthyretin Cardiac Amyloidosis Scintigraphy Using Planar D-SPECT on Dedicated Cardiac CZT Camera.
Amyloidosis
Transthyretin Cardiac Amyloidosis: A Noninvasive Multimodality Approach to Diagnosis Using Transthoracic Echocardiography, 99m-Tc-Labeled Phosphate Bone Scanning, and Cardiac Magnetic Resonance Imaging.
Amyloidosis
Transthyretin cardiac amyloidosis: a review of the nuclear imaging findings with emphasis on the radiotracers mechanisms.
Amyloidosis
Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
Amyloidosis
Transthyretin Cardiac Amyloidosis: From Rare Monogenic Disease to Common Pathway in Heart Failure?
Amyloidosis
Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
Amyloidosis
Transthyretin chemical chaperoning by flavonoids: Structure-activity insights towards the design of potent amyloidosis inhibitors.
Amyloidosis
Transthyretin deposition in the eye in the era of effective therapy for hereditary ATTRV30M amyloidosis.
Amyloidosis
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.
Amyloidosis
Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.
Amyloidosis
Transthyretin ILE20, a new variant associated with late-onset cardiac amyloidosis.
Amyloidosis
Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis.
Amyloidosis
Transthyretin Pro 36 associated with familial amyloidotic polyneuropathy in an Ashkenazic Jewish kindred.
Amyloidosis
Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement.
Amyloidosis
Transthyretin stability as a key factor in amyloidogenesis: X-ray analysis at atomic resolution.
Amyloidosis
Transthyretin stabilization activity of the catechol-O-methyltransferase inhibitor tolcapone (SOM0226) in hereditary ATTR amyloidosis patients and asymptomatic carriers: proof-of-concept study
Amyloidosis
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid Cardiomyopathy.
Amyloidosis
Transthyretin Stabilization: An Emerging Strategy for the Treatment of Alzheimer's Disease?
Amyloidosis
Transthyretin Stabilizer Is Associated With Expanding Apical Sparing Area and Improving Global Cardiac Function in a Patient With Wild-Type Cardiac Amyloidosis.
Amyloidosis
Transthyretin suppresses the toxicity of oligomers formed by misfolded proteins in vitro.
Amyloidosis
Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome.
Amyloidosis
Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
Amyloidosis
Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
Amyloidosis
Transthyretin VAL107, a new variant associated with familial cardiac and neuropathic amyloidosis.
Amyloidosis
Transthyretin Val122Ile amyloidosis associated with isolated gastrointestinal disease and bowel rupture in a Caucasian woman.
Amyloidosis
Transthyretin Val122Ile, accumulated Abeta, and inclusion-body myositis aspects in cultured muscle.
Amyloidosis
Transthyretin Val30Met mutation in an African American with cardiac amyloidosis.
Amyloidosis
Transthyretin valine-94-alanine, a novel variant associated with late-onset systemic amyloidosis with cardiac involvement.
Amyloidosis
Transthyretin-derived amyloidosis: Probably a common cause of lumbar spinal stenosis.
Amyloidosis
Transthyretin-derived senile systemic amyloidosis: clinicopathologic and structural considerations.
Amyloidosis
Transthyretin-related amyloid in a saphenous vein. Histological diagnosis in a patient undergoing coronary artery bypass surgery.
Amyloidosis
Transthyretin-stabilising mutation T119M is not associated with protection against vascular disease or death in the UK Biobank.
Amyloidosis
Trapping of palindromic ligands within native transthyretin prevents amyloid formation.
Amyloidosis
Treatment of hereditary and acquired forms of transthyretin amyloidosis in the era of personalized medicine: the role of randomized controlled trials.
Amyloidosis
True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis.
Amyloidosis
TTR gene silencing therapy in post liver transplant hereditary ATTR amyloidosis patients.
Amyloidosis
TTRMDB: A database for structural and functional analysis on the impact of SNPs over transthyretin (TTR) using bioinformatic tools.
Amyloidosis
Tuning transthyretin amyloidosis inhibition properties of iododiflunisal by combinatorial engineering of the nonsalicylic ring substitutions.
Amyloidosis
Two transthyretin mutations (glu42gly, his90asn) in an Italian family with amyloidosis.
Amyloidosis
Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations.
Amyloidosis
Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation.
Amyloidosis
Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights.
Amyloidosis
Uncovering the Neuroprotective Mechanisms of Curcumin on Transthyretin Amyloidosis.
Amyloidosis
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia.
Amyloidosis
Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for Integrative Data Analytic Approaches.
Amyloidosis
Unexplained cardiac failure leading to the identification of a Belgian family affected by hereditary amyloidosis.
Amyloidosis
Unfolding and aggregation of transthyretin by the truncation of 50 N-terminal amino acids.
Amyloidosis
United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis.
Amyloidosis
Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
Amyloidosis
Untangling the physiology of transthyretin cardiac amyloidosis by leveraging echocardiographically derived pressure-volume indices.
Amyloidosis
Unusual high 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid (99mTc-DPD) tracer deposition on a heart scintigraphy in a patient with AL amyloidosis: A case report.
Amyloidosis
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
Amyloidosis
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Amyloidosis
Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.
Amyloidosis
Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas.
Amyloidosis
Uptake of aggregating transthyretin by fat body in a Drosophila model for TTR-associated amyloidosis.
Amyloidosis
Use of a microchip device coupled with mass spectrometry for ligand screening of a multi-protein target.
Amyloidosis
Use of fluorine-18 sodium fluoride for the diagnosis of transthyretin cardiac amyloidosis: The birth of a new technique.
Amyloidosis
Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.
Amyloidosis
Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.
Amyloidosis
Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
Amyloidosis
Usefulness of Combining Electrocardiographic and Echocardiographic Findings and Brain Natriuretic Peptide in Early Detection of Cardiac Amyloidosis in Subjects With Transthyretin Gene Mutation.
Amyloidosis
Usefulness of electron microscopy in the diagnosis of wild-type transthyretin cardiac amyloidosis.
Amyloidosis
Usefulness of plasma B-type natriuretic peptide as a prognostic marker of cardiac function in senile systemic amyloidosis and in familial amyloidotic polyneuropathy.
Amyloidosis
Utility of 99 mTc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice.
Amyloidosis
Utility of Kumamoto Criteria in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice.
Amyloidosis
Utility of Kumamoto Criteria in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice?- Reply.
Amyloidosis
Utility of Neuropathy Screening for Wild-Type Transthyretin Amyloidosis Patients.
Amyloidosis
Val50Met hereditary transthyretin amyloidosis: not just a medical problem, but a psychosocial burden.
Amyloidosis
Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi.
Amyloidosis
Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
Amyloidosis
Value of natriuretic peptides and tissue Doppler imaging in the estimation of left ventricular filling pressure in patients with cardiac amyloidosis.
Amyloidosis
Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients.
Amyloidosis
Variant transthyretin (TTR) amyloidosis in Argentina. Detection of the trait by electrospray ionization mass spectrometry of lyophilized TTR immunoprecipitate.
Amyloidosis
Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features.
Amyloidosis
Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.
Amyloidosis
Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis.
Amyloidosis
Vascular endothelial growth factor helps differentiate neuropathies in rare plasma cell dyscrasias.
Amyloidosis
Visualization of multiple organ amyloid involvement in systemic amyloidosis using (11)C-PiB PET imaging.
Amyloidosis
Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin.
Amyloidosis
Vitreous amyloidosis associated with homozygosity for the transthyretin methionine-30 gene.
Amyloidosis
Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation.
Amyloidosis
Vitreous amyloidosis in two large mainland Chinese kindreds resulting from transthyretin variant Lys35Thr and Leu55Arg.
Amyloidosis
Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
Amyloidosis
Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report.
Amyloidosis
When to suspect transthyretin amyloidosis in cases of isolated vitreous opacities?
Amyloidosis
Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome.
Amyloidosis
White matter disorders with autosomal dominant heredity: a review with personal clinical case studies and their MRI findings.
Amyloidosis
Why are some amyloidoses systemic? Does hepatic "chaperoning at a distance" prevent cardiac deposition in a transgenic model of human senile systemic (transthyretin) amyloidosis?
Amyloidosis
Widespread Cardiac and Vasomotor Autonomic Dysfunction in Non-Val30Met Hereditary Transthyretin Amyloidosis.
Amyloidosis
Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly.
Amyloidosis
Wild type transthyretin cardiac amyloidosis in a young individual: A case report.
Amyloidosis
Wild-type transthyretin amyloid cardiomyopathy complicated by spinal canal stenosis, carpal tunnel syndrome, and rotator cuff tears: a case report.
Amyloidosis
Wild-type Transthyretin Amyloid Myopathy With an Inclusion Body Myositis Phenotype.
Amyloidosis
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
Amyloidosis
Wild-Type Transthyretin Amyloidosis in Female Patients?- Consideration of Sex Differences.
Amyloidosis
Wild-Type Transthyretin Amyloidosis Occurring in the Ligamentum Flavum of the Cervicothoracic Spine.
Amyloidosis
Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.
Amyloidosis
Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging.
Amyloidosis
Wild-type transthyretin cardiac amyloidosis: When is a rare disease no longer a rare disease?
Amyloidosis
Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
Amyloidosis
Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis.
Amyloidosis
[18F]-Florbetaben PET/CT for Differential Diagnosis Among Cardiac Immunoglobulin Light Chain, Transthyretin Amyloidosis, and Mimicking Conditions.
Amyloidosis
[Amyloid from insulin treatment: a pitfall for the pathologist and the diabetologist].
Amyloidosis
[Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
Amyloidosis
[Cardiac manifestations of amyloidosis by deposits of transthyretin and apolipoprotein A1. Report of 3 families]
Amyloidosis
[Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis].
Amyloidosis
[Clinical characteristics of Hungarian-type familial meningo-cerebrovascular amyloidosis]
Amyloidosis
[Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy].
Amyloidosis
[Current approaches for treatment of hereditary transthyretin amyloidosis (ATTR)].
Amyloidosis
[Familial transthyretin amyloidosis with Gly47Arg mutation and cardiac involvement: a case report].
Amyloidosis
[Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know]
Amyloidosis
[Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)]
Amyloidosis
[Hereditary amyloid cardiomyopathy related to a mutation at transthyretin protein number 111. A clinical, genetic and echocardiographic study of an affected Danish family]
Amyloidosis
[Hereditary cardiac amyloidosis with transthyretin mutations : A cause of sudden death.]
Amyloidosis
[Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis].
Amyloidosis
[Indications for simultaneous origin of a German and American family with type II hereditary amyloid neuropathy]
Amyloidosis
[Non-invasive diagnosis of cardiac amyloidosis due to transthyretin. Case report].
Amyloidosis
[Optimization of the immunohistochemical diagnosis of AL amyloidosis using novel antibodies].
Amyloidosis
[Perioperative management for liver transplant in a patient with familial amyloid polyneuropathy with heart involvement.]
Amyloidosis
[Problems of diagnostics and treatment of transtiretinum amyloidosis with destruction of the heart in the elderly: Clinical experience.]
Amyloidosis
[The informative value of oral mucosal biopsy for the diagnosis of systemic amyloidosis].
Amyloidosis
[Transthyretin amyloidosis in a cohort of old and very old patients with chronic heart failure].
Amyloidosis
[Transthyretin-related amyloidotic cardiomyopathy: looking for the etiological treatment].
Amyloidosis
[Treatment strategies of patients with transthyretin amyloidosis cardiomyopathy].
Amyloidosis, Familial
99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.
Amyloidosis, Familial
A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.
Amyloidosis, Familial
A case of renal and splenic LECT 2 amyloidosis: A recently recognized cause of renal and systemic amyloidosis.
Amyloidosis, Familial
A new genetic variant of hereditary apolipoprotein A-I amyloidosis: a case-report followed by discussion of diagnostic challenges and therapeutic options.
Amyloidosis, Familial
A new mutation (TTR Ala-47) in the transthyretin gene associated with hereditary amyloidosis.
Amyloidosis, Familial
A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient.
Amyloidosis, Familial
A Patient With Hereditary ATTR and a Novel AGel p.Ala578Pro Amyloidosis.
Amyloidosis, Familial
A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.
Amyloidosis, Familial
A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population.
Amyloidosis, Familial
Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation.
Amyloidosis, Familial
Ageing and amyloid fibrillogenesis: lessons from apolipoprotein AI, transthyretin and islet amyloid polypeptide.
Amyloidosis, Familial
Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin.
Amyloidosis, Familial
An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis.
Amyloidosis, Familial
Anesthetic management of a combined heart and liver transplantation in an amyloidotic patient: a case report.
Amyloidosis, Familial
Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity.
Amyloidosis, Familial
Capture of a dimeric intermediate during transthyretin amyloid formation.
Amyloidosis, Familial
Cardiac amyloidosis with gastrointestinal involvement: a case report.
Amyloidosis, Familial
Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
Amyloidosis, Familial
Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis.
Amyloidosis, Familial
Clinical characteristics in patients with hereditary amyloidosis with Glu54Gln transthyretin identified in the Romanian population.
Amyloidosis, Familial
Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin.
Amyloidosis, Familial
Clinical manifestations in hereditary amyloidosis with the variant Glu54Gln transthyretin: a comment.
Amyloidosis, Familial
Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathy.
Amyloidosis, Familial
Early diagnostic tools in hereditary amyloidosis related to transthyretin (hATTR) V30M autonomic neuropathy.
Amyloidosis, Familial
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy.
Amyloidosis, Familial
Electrochemical skin conductance in hereditary amyloidosis related to transthyretin V30M - a promising tool to assess treatment efficacy?
Amyloidosis, Familial
Electromyographic findings in transthyretin (TTR)-related familial amyloid polyneuropathy (FAP).
Amyloidosis, Familial
Erythropoietin production by distal nephron in normal and familial amyloidotic adult human kidneys.
Amyloidosis, Familial
Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
Amyloidosis, Familial
Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
Amyloidosis, Familial
Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells.
Amyloidosis, Familial
Hereditary amyloidosis related to transthyretin V30M: disease progression in treated and untreated patients.
Amyloidosis, Familial
Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D.
Amyloidosis, Familial
Homozygosity and heterozygosity for the transthyretin Leu64 mutation: clinical, biochemical and molecular findings.
Amyloidosis, Familial
Identification of transthyretin variants by sequential proteomic and genomic analysis.
Amyloidosis, Familial
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.
Amyloidosis, Familial
Inhibition of transthyretin-met30 expression using Inosine(15.1)-Hammerhead ribozymes in cell culture.
Amyloidosis, Familial
Inosine(15.1) hammerhead ribozymes for targeting the transthyretin-30 mutation.
Amyloidosis, Familial
Investigation of AGE, their receptor and NF-kappaB activation and apoptosis in patients with ATTR and Gelsolin amyloidosis.
Amyloidosis, Familial
Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (ATTR) V30M hereditary amyloidosis with polyneuropathy (FAP).
Amyloidosis, Familial
Low Prevalence of Clinically Apparent Cardiac Amyloidosis Among Carriers of Transthyretin V122I Variant in a Large Electronic Medical Record.
Amyloidosis, Familial
Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations.
Amyloidosis, Familial
Mutation and transcription analysis of transthyretin gene in Italian families with hereditary amyloidosis: a putative novel hot spot' in codon 47.
Amyloidosis, Familial
Normal transthyretin and synthetic transthyretin fragments form amyloid-like fibrils in vitro.
Amyloidosis, Familial
Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis.
Amyloidosis, Familial
Novel transthyretin missense mutation (Thr34) in an Italian family with hereditary amyloidosis.
Amyloidosis, Familial
Orthotopic liver transplantation for hereditary fibrinogen amyloidosis.
Amyloidosis, Familial
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy.
Amyloidosis, Familial
Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.
Amyloidosis, Familial
Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala.
Amyloidosis, Familial
Quantitative analysis of post-translational modifications in human serum transthyretin associated with familial amyloidotic polyneuropathy by targeted LC-MS and intact protein MS.
Amyloidosis, Familial
Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
Amyloidosis, Familial
Regional difference and similarity of familial amyloidosis with polyneuropathy in France.
Amyloidosis, Familial
Screening and biochemical characterization of transthyretin variants in the Portuguese population.
Amyloidosis, Familial
Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation.
Amyloidosis, Familial
STT3B-dependent posttranslational N-glycosylation as a surveillance system for secretory protein.
Amyloidosis, Familial
Targeting transthyretin - Mechanism-based treatment approaches and future perspectives in hereditary amyloidosis.
Amyloidosis, Familial
The premortem recognition of systemic senile amyloidosis with cardiac involvement.
Amyloidosis, Familial
The Transthyretin Amyloidosis Outcomes Survey (THAOS) registry: design and methodology.
Amyloidosis, Familial
The transthyretin cDNA sequence is normal in transthyretin-derived senile systemic amyloidosis.
Amyloidosis, Familial
The use of intravitreal ranibizumab to treat neovascular glaucoma because of retinal amyloid angiopathy in familial amyloidosis transthyretin v30m related.
Amyloidosis, Familial
Transthyretin amyloidosis: a little history of hereditary amyloidosis.
Amyloidosis, Familial
Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells.
Amyloidosis, Familial
Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome.
Amyloidosis, Familial
TRANSTHYRETIN V30M FAMILIAL AMYLOIDOSIS PRESENTING AS ISOLATED RETINAL ANGIOPATHY.
Amyloidosis, Familial
Transthyretin-associated neuropathic amyloidosis. Pathogenesis and treatment.
Amyloidosis, Familial
Transthyretin-Related Hereditary Amyloidosis in a Chinese Family with TTR Y114C Mutation.
Amyloidosis, Familial
TTR familial amyloid polyneuropathy: does a mitochondrial polymorphism entirely explain the parent-of-origin difference in penetrance?
Amyloidosis, Familial
Two transthyretin variants (TTR Ala-49 and TTR Gln-89) in two Sicilian kindreds with hereditary amyloidosis.
Amyloidosis, Familial
Tyr78Phe Transthyretin Mutation with Predominant Motor Neuropathy as the Initial Presentation.
Amyloidosis, Familial
[Clinical characteristics of Hungarian-type familial meningo-cerebrovascular amyloidosis]
Anemia
Low erythropoietin production in familial amyloidosis TTR V30M is not related with renal congophilic amyloid deposition. A clinicopathologic study of twelve cases.
Anemia
Proteomic analysis of plasma proteins of high-flux haemodialysis and on-line haemodiafiltration patients reveals differences in transthyretin levels related with anaemia.
Anemia
Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.
Aneurysm, Dissecting
Acute aortic dissection associated with wild-type transthyretin amyloid.
Angina, Unstable
[Difference expressed protein study on unstable angina blood-stasis syndrome by fluorescence labelling method]
Aortic Valve Stenosis
Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?
Aortic Valve Stenosis
Aortic stenosis, transcatheter aortic valve replacement and transthyretin cardiac amyloidosis: are we progressively unraveling the tangle?
Aortic Valve Stenosis
Association between aortic stenosis and hereditary transthyretin amyloidosis.
Aortic Valve Stenosis
Dangerous relationships: aortic stenosis and transthyretin cardiac amyloidosis.
Aortic Valve Stenosis
Early Progression of Aortic Stenosis Associated With Iatrogenic Variant Transthyretin Amyloidosis After Domino Liver Transplantation.
Aortic Valve Stenosis
Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis.
Aortic Valve Stenosis
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.
Aortic Valve Stenosis
In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
Aortic Valve Stenosis
Light-chain and transthyretin cardiac amyloidosis in severe aortic stenosis: prevalence, screening possibilities, and outcome.
Aortic Valve Stenosis
Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
Aortic Valve Stenosis
Prognostic assessment of relative apical sparing pattern of longitudinal strain for severe aortic valve stenosis.
Aortic Valve Stenosis
Prognostic Significance of Occult Transthyretin Cardiac Amyloidosis in Patients With Severe Aortic Stenosis Undergoing Surgical Aortic Valve Replacement: An Unrecognized Disease Modifier.
Aortic Valve Stenosis
Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis.
Aortic Valve Stenosis
Subthreshold Aortic Valve Calcium Scores in Severe Aortic Stenosis and Transthyretin Cardiac Amyloidosis.
Aortic Valve Stenosis
Transthyretin cardiac amyloid and aortic stenosis in the elderly, the role of nuclear imaging.
Aortic Valve Stenosis
Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications.
Aortic Valve Stenosis
Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
Aortic Valve Stenosis
Transthyretin cardiac amyloidosis in patients with severe aortic stenosis.
Aortic Valve Stenosis
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.
Aortic Valve Stenosis
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.
Aortic Valve Stenosis
Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
Arrhythmias, Cardiac
Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant).
Arrhythmias, Cardiac
Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis.
Arteriosclerosis
Significance of the amyloidogenic transthyretin Val 122 Ile allele in African Americans in the Arteriosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
Arthritis, Experimental
Proteins of rat serum V: adjuvant arthritis and its modulation by nonsteroidal anti-inflammatory drugs.
Arthritis, Rheumatoid
A case of wild-type transthyretin cardiac amyloidosis with rheumatoid arthritis.
Arthritis, Rheumatoid
Identification of Autoantibodies against Transthyretin for the Screening and Diagnosis of Rheumatoid Arthritis.
Arthritis, Rheumatoid
Retraction: Identification of Autoantibodies against Transthyretin for the Screening and Diagnosis of Rheumatoid Arthritis.
Arthritis, Rheumatoid
Transthyretin as a potential serological marker for the diagnosis of patients with early rheumatoid arthritis.
Ataxia
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia.
Atherosclerosis
Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.
Atrial Fibrillation
Anticoagulation with warfarin compared to novel oral anticoagulants for atrial fibrillation in adults with transthyretin cardiac amyloidosis: comparison of thromboembolic events and major bleeding.
Atrial Fibrillation
Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis.
Atrial Fibrillation
Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients.
Atrial Fibrillation
Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans.
Atrial Fibrillation
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: Predictors, Prevalence, and Efficacy of Rhythm Control Strategies.
Atrial Fibrillation
Atrial Fibrillation in Transthyretin Cardiac Amyloidosis: The Growing Need to Look Forward.
Atrial Fibrillation
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
Atrial Fibrillation
Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.
Atrial Fibrillation
Management Strategies for Atrial Fibrillation and Flutter in Patients with Transthyretin Cardiac Amyloidosis.
Atrial Fibrillation
Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review.
Atrial Fibrillation
Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.
Atrial Fibrillation
Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
Bile Duct Neoplasms
Plasma retinol transport system and taste acuity in patients with obstructive jaundice.
Blindness
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
Brain Ischemia
Cerebrospinal fluid transthyretin neuroprotection in a mouse model of brain ischemia.
Brain Ischemia
Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia.
Brain Ischemia
Evidence for synergistic action of transthyretin and IGF-I over the IGF-I receptor.
Brain Ischemia
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
Brain Ischemia
Transthyretin provides trophic support via megalin by promoting neurite outgrowth and neuroprotection in cerebral ischemia.
Brain Neoplasms
Faecal proteome in clinically healthy dogs and cats: Findings in pooled faeces from 10 cats and 10 dogs.
Brain Neoplasms
ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.
Brain Neoplasms
Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation.
Brain Neoplasms
Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases.
Brain Neoplasms
[Immunohistochemical study on distribution of transthyretin in normal human brain tissue and tumors]
Breast Neoplasms
Amyloidosis of the Breast: Three Different and Unusual Presentations of a Rare Entity.
Breast Neoplasms
Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.
Breast Neoplasms
PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.
Breast Neoplasms
Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions.
Bronchiectasis
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation.
Bronchitis
[Bronchoalveolar lavage. The humoral parameter spectrum in bronchial carcinoma and chronic bronchitis]
Bronchitis, Chronic
[Bronchoalveolar lavage. The humoral parameter spectrum in bronchial carcinoma and chronic bronchitis]
Bulbo-Spinal Atrophy, X-Linked
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
Bundle-Branch Block
Left Bundle Branch Pacing in Transthyretin Cardiac Amyloidosis and Alternating Bundle Branch Block.
Carcinogenesis
HCC Specific Protein Network Involving Interactions of EGFR with A-Raf and Transthyretin: Experimental Analysis and Computational Biology Correlates.
Carcinoma
Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach.
Carcinoma
The choroid plexus carcinomas of childhood: histopathology, immunocytochemistry and clinicopathological correlations.
Carcinoma
The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas.
Carcinoma
Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas.
Carcinoma
Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets.
Carcinoma
Transthyretin--an explanation of "anomalous" serum thyroid hormone values in severe illness?
Carcinoma
[Prognostic markers in the histopathological diagnosis of tumors of the choroid plexus]
Carcinoma, Bronchogenic
[Bronchoalveolar lavage. The humoral parameter spectrum in bronchial carcinoma and chronic bronchitis]
Carcinoma, Embryonal
Induction of the expression of retinol-binding protein and transthyretin in F9 embryonal carcinoma cells differentiated to embryoid bodies.
Carcinoma, Hepatocellular
Adenovirus-mediated hepatocyte nuclear factor-4alpha overexpression maintains liver phenotype in cultured rat hepatocytes.
Carcinoma, Hepatocellular
Clinical significance of serum transthyretin level in patients with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription.
Carcinoma, Hepatocellular
Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice.
Carcinoma, Hepatocellular
Differential regulation of hepatocyte-enriched transcription factors explains changes in albumin and transthyretin gene expression among hepatoma cells.
Carcinoma, Hepatocellular
Functional activity of hepatocyte nuclear factor-1 is specifically decreased in amino acid-limited hepatoma cells.
Carcinoma, Hepatocellular
Novel mutations in transthyretin gene associated with hepatocellular carcinoma.
Carcinoma, Hepatocellular
Studies on the synthesis and secretion of transthyretin by the human hepatoma cell line Hep G2.
Carcinoma, Non-Small-Cell Lung
Effect and Mechanism of Transthyretin over-Expression on Proliferation and Cell Cycle of Lung Cancer A549 Cells.
Carcinoma, Non-Small-Cell Lung
Prognostic impact of serum transthyretin in patients with non-small cell lung cancer.
Carcinoma, Ovarian Epithelial
Postoperative recurrence of epithelial ovarian cancer patients and chemoresistance related protein analyses.
Carcinoma, Ovarian Epithelial
Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer.
Carcinoma, Renal Cell
Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas.
Cardiac Conduction System Disease
Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
Cardiomegaly
Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.
Cardiomyopathies
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR).
Cardiomyopathies
99mTechnetium pyrophosphate scintigraphy with cadmium zinc telluride cameras is a highly sensitive and specific imaging modality to diagnose transthyretin cardiac amyloidosis.
Cardiomyopathies
A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.
Cardiomyopathies
A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G?>?T, p.Ala140Ser).
Cardiomyopathies
A case of unilateral shoulder joint hydrarthrosis with wild-type amyloidogenic transthyretin amyloidosis.
Cardiomyopathies
A case report of an infiltrative cardiomyopathy in everyday practice: a specific cause that cannot be missed in the elderly.
Cardiomyopathies
A clinical, echocardiographic and genetic characterization of a Danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathy.
Cardiomyopathies
A Danish kindred with familial amyloid cardiomyopathy revisited: identification of a mutant transthyretin-methionine111 variant in serum from patients and carriers.
Cardiomyopathies
A Heart too Stiff to Beat: A Case of Familial Transthyretin Amyloidosis Cardiomyopathy.
Cardiomyopathies
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells.
Cardiomyopathies
A look into amyloid formation by transthyretin: aggregation pathway and a novel kinetic model.
Cardiomyopathies
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
Cardiomyopathies
A new amyloidogenic transthyretin variant (Val122Ala) found in a compound heterozygous patient.
Cardiomyopathies
A new transthyretin variant (Ser23Asn) associated with familial amyloidosis in a Portuguese patient.
Cardiomyopathies
A novel ATTR L32V mutation causes familial amyloid polyneuropathy in a Bolivian family.
Cardiomyopathies
A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy.
Cardiomyopathies
A serine protease secreted from Bacillus subtilis cleaves human plasma transthyretin to generate an amyloidogenic fragment.
Cardiomyopathies
A transthyretin variant, Asp18Asn, associated with amyloid cardiomyopathy: a new African-American variant?
Cardiomyopathies
Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis.
Cardiomyopathies
Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.
Cardiomyopathies
Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition.
Cardiomyopathies
Amyloid cardiomyopathy: a hidden heart failure cause that is often misdiagnosed.
Cardiomyopathies
Amyloid Fibril Composition as a Predictor of Development of Cardiomyopathy After Liver Transplantation for Hereditary Transthyretin Amyloidosis.
Cardiomyopathies
Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants.
Cardiomyopathies
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy.
Cardiomyopathies
Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
Cardiomyopathies
Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
Cardiomyopathies
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy.
Cardiomyopathies
Best Practices in Specialized Amyloidosis Centers in the United States: A Survey of Cardiologists, Nurses, Patients, and Patient Advocates.
Cardiomyopathies
Biopsy Evidence of Sequential Transthyretin and Immunoglobulin Light-Chain Cardiac Amyloidosis in the Same Patient.
Cardiomyopathies
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.
Cardiomyopathies
Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
Cardiomyopathies
Cardiomyopathy in a Japanese family with the Glu61Lys transthyretin variant: a new phenotype.
Cardiomyopathies
Cardiomyopathy in Swedish patients with the Gly53Glu and His88Arg transthyretin variants.
Cardiomyopathies
Causes of Cardiovascular Hospitalization and Death in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial [ATTR-ACT]).
Cardiomyopathies
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Characterizing the High Disease Burden of Transthyretin Amyloidosis for Patients and Caregivers.
Cardiomyopathies
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis.
Cardiomyopathies
Clinical characteristics and natural history of wild-type transthyretin amyloid cardiomyopathy in Japan.
Cardiomyopathies
Clinical characteristics and prognosis of Chinese patients with hereditary transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review.
Cardiomyopathies
Clinical features and survival in senile systemic amyloidosis: comparison to familial transthyretin cardiomyopathy.
Cardiomyopathies
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis.
Cardiomyopathies
Coexistent transthyretin amyloid cardiomyopathy and monoclonal gammopathy: Diagnostic challenges and prognostic implications.
Cardiomyopathies
Combined heart and liver transplantation for familial amyloidotic neuropathy: considerations from the hepatic point of view.
Cardiomyopathies
Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
Cardiomyopathies
Compassionate drug use for patients with transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Contributions of Animal Models to the Mechanisms and Therapies of Transthyretin Amyloidosis.
Cardiomyopathies
Coronary ectasia in amyloid cardiomyopathy and neuropathy due to the transthyretin mutation c.323A>G.
Cardiomyopathies
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy.
Cardiomyopathies
Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Cardiomyopathies
Development of cardiomyopathy after liver transplantation in Swedish hereditary transthyretin amyloidosis (ATTR) patients.
Cardiomyopathies
Development of late amyloid cardiomyopathy following liver transplantation for hereditary Val30Met transthyretin amyloidosis.
Cardiomyopathies
Diagnosis of wild-type transthyretin amyloid cardiomyopathy in Japan: red-flag symptom clusters and diagnostic algorithm.
Cardiomyopathies
Diagnostic and lifetime hospital costs of patients suffering from wild-type transthyretin amyloid cardiomyopathy in Denmark.
Cardiomyopathies
Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition.
Cardiomyopathies
Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience.
Cardiomyopathies
Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis.
Cardiomyopathies
Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis.
Cardiomyopathies
Do troponin and B-natriuretic peptide detect cardiomyopathy in transthyretin amyloidosis?
Cardiomyopathies
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
Cardiomyopathies
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study.
Cardiomyopathies
Efficacy of Tafamidis in Patients With Hereditary and Wild-Type Transthyretin Amyloid Cardiomyopathy: Further Analyses From ATTR-ACT.
Cardiomyopathies
Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.
Cardiomyopathies
Establishment of an induced pluripotent stem cell line PUMCHi004-A from a hereditary transthyretin amyloid cardiomyopathy patient with transthyretin (TTR) p.Asp38Asn mutation.
Cardiomyopathies
Estimating the Gender Distribution of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: A Systematic Review and Meta-Analysis.
Cardiomyopathies
Estimating the health benefits of timely diagnosis and treatment of transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Estimating the Prevalence of Transthyretin Amyloid Cardiomyopathy in a Large In-Hospital Database in Japan.
Cardiomyopathies
Etiology of Amyloidosis Determines Myocardial 99mTc-DPD Uptake in Amyloidotic Cardiomyopathy.
Cardiomyopathies
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy.
Cardiomyopathies
Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis.
Cardiomyopathies
Extrapolation of Survival Benefits in Patients with Transthyretin Amyloid Cardiomyopathy Receiving Tafamidis: Analysis of the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial.
Cardiomyopathies
False-positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy.
Cardiomyopathies
Fluorotryptophan incorporation modulates the structure and stability of transthyretin in a site-specific manner.
Cardiomyopathies
From Clinical Clues to Final Diagnosis: The Return of Detective Work to Clinical Medicine in Cardiac Amyloidosis.
Cardiomyopathies
Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis.
Cardiomyopathies
Glycosaminoglycans in extracts of cardiac amyloid fibrils from familial amyloid cardiomyopathy of Danish origin related to variant transthyretin Met 111.
Cardiomyopathies
Green tea extract as a treatment for patients with wild-type transthyretin amyloidosis: an observational study.
Cardiomyopathies
Green tea halts progression of cardiac transthyretin amyloidosis: an observational report.
Cardiomyopathies
Health Impact of Tafamidis in Transthyretin Amyloid Cardiomyopathy patients: An Analysis from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and the Open-Label Long-term Extension Studies.
Cardiomyopathies
Hereditary amyloidosis with cardiomyopathy caused by the novel variant transthyretin A36D.
Cardiomyopathies
Hereditary ATTR Amyloidosis with Cardiomyopathy Caused by the Novel Variant Transthyretin Y114S (p.Y134S).
Cardiomyopathies
Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation.
Cardiomyopathies
Hereditary Transthyretin Amyloidosis: Clinical Presentation and Management Updates.
Cardiomyopathies
Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese.
Cardiomyopathies
Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?
Cardiomyopathies
Impact of Delayed Diagnosis and Misdiagnosis for Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM): A Targeted Literature Review.
Cardiomyopathies
Impact of Tafamidis on Health-Related Quality of Life in Patients With Transthyretin Amyloid Cardiomyopathy (from the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial).
Cardiomyopathies
In brief: Tafamidis (Vyndaqel; Vyndamax) for transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.
Cardiomyopathies
Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy.
Cardiomyopathies
Interatrial septal 99mTc-pyrophosphate uptake and reduced strain in wild-type transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Involvement of human monogenic cardiomyopathy genes in experimental polygenic cardiac hypertrophy.
Cardiomyopathies
Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
Cardiomyopathies
Kinetic analysis of the multistep aggregation pathway of human transthyretin.
Cardiomyopathies
Late-onset and fast progressive neuropathy and cardiomyopathy in Val32Ala transthyretin gene mutation.
Cardiomyopathies
Letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'.
Cardiomyopathies
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data.
Cardiomyopathies
Long-term outcome in patients treated with combined heart and liver transplantation for familial amyloidotic cardiomyopathy.
Cardiomyopathies
Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype.
Cardiomyopathies
Matrix metalloproteinases and their tissue inhibitors in cardiac amyloidosis: relationship to structural, functional myocardial changes and to light chain amyloid deposition.
Cardiomyopathies
Metabolomics analysis for diagnosis and biomarker discovery of transthyretin amyloidosis.
Cardiomyopathies
Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands.
Cardiomyopathies
Modeling of Survival and Frequency of Cardiovascular-Related Hospitalization in Patients with Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis.
Cardiomyopathies
Molecular diagnosis of the transthyretin (TTR) Met111 mutation in familial amyloid cardiomyopathy of Danish origin.
Cardiomyopathies
Molecular dynamics simulation study of AG10 and tafamidis binding to the Val122Ile transthyretin variant.
Cardiomyopathies
Monitoring treatment response to tafamidis by serial native T1 and extracellular volume in transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.
Cardiomyopathies
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Cardiomyopathies
Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Cardiomyopathies
New pathological insights into cardiac amyloidosis: implications for non-invasive diagnosis.
Cardiomyopathies
Noninvasive diagnosis of hereditary transthyretin-related cardiac amyloidosis: A case report.
Cardiomyopathies
Novel insights into rare cardiomyopathies: arrhythmogenic cardiomyopathy, non-compaction, and transthyretin amyloidosis.
Cardiomyopathies
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.
Cardiomyopathies
Orthotopic liver transplantation for familial amyloidotic polyneuropathy: a pathological study.
Cardiomyopathies
Outcome in patients treated with isolated liver transplantation for familial transthyretin amyloidosis to prevent cardiomyopathy.
Cardiomyopathies
Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
Cardiomyopathies
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis.
Cardiomyopathies
Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy).
Cardiomyopathies
Pharmacotherapy review: Emerging treatment modalities in transthyretin cardiac amyloidosis.
Cardiomyopathies
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Cardiomyopathies
Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients.
Cardiomyopathies
Potent kinetic stabilizers that prevent transthyretin-mediated cardiomyocyte proteotoxicity.
Cardiomyopathies
Preparative Scale Production of Recombinant Human Transthyretin for Biophysical Studies of Protein-Ligand and Protein-Protein Interactions.
Cardiomyopathies
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.
Cardiomyopathies
Prevalence and Outcomes of p.Val142Ile TTR Amyloidosis Cardiomyopathy: A Systematic Review.
Cardiomyopathies
Prevalence and Prognostic Significance of Frailty Among Patients With Transthyretin Amyloidosis Cardiomyopathy.
Cardiomyopathies
Prevalence of Atrial Fibrillation and Thromboembolic Risk in Wild-Type Transthyretin Amyloid Cardiomyopathy.
Cardiomyopathies
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
Cardiomyopathies
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study.
Cardiomyopathies
Prevalence of TTR variants detected by whole-exome sequencing in hypertrophic cardiomyopathy.
Cardiomyopathies
Prevalence, Incidence, and Impact on Mortality of Conduction System Disease in Transthyretin Cardiac Amyloidosis.
Cardiomyopathies
Prognostic assessment of relative apical sparing pattern of longitudinal strain for severe aortic valve stenosis.
Cardiomyopathies
Prognostic Role of Cardiopulmonary Exercise Testing in Wild-Type Transthyretin Amyloid Cardiomyopathy Patients Treated With Tafamidis.
Cardiomyopathies
Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type.
Cardiomyopathies
Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
Cardiomyopathies
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: The Transthyretin Amyloidosis Cardiac Study (TRACS).
Cardiomyopathies
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy.
Cardiomyopathies
Purification and characterization of amyloid-related transthyretin associated with familial amyloidotic cardiomyopathy.
Cardiomyopathies
Real-world versus trial patients with transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Recipe for Success in Transthyretin Cardiomyopathy: Monoclonal Protein Rule Out, SPECT Imaging, and Genetic Testing.
Cardiomyopathies
Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy.
Cardiomyopathies
Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression.
Cardiomyopathies
Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'.
Cardiomyopathies
Restrictive cardiac phenotype as primary cause of impaired aerobic capacity in Afro-Caribbean patients with val122ile variant transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Retinal microangiopathy as an initial manifestation of familial amyloid cardiomyopathy associated with transthyretin e89k mutation.
Cardiomyopathies
Retrospective molecular detection of Transthyretin Met 111 mutation in a Danish kindred with familial amyloid cardiomyopathy, using DNA from formalin-fixed and paraffin-embedded tissues.
Cardiomyopathies
S-Homocysteinylation effects on transthyretin: worsening of cardiomyopathy onset.
Cardiomyopathies
Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy.
Cardiomyopathies
Sex-Related Risk of Cardiac Involvement in Hereditary Transthyretin Amyloidosis: Insights From THAOS.
Cardiomyopathies
Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses.
Cardiomyopathies
Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series.
Cardiomyopathies
Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Cardiomyopathies
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.
Cardiomyopathies
Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
Cardiomyopathies
Structure of the Val122Ile variant transthyretin - a cardiomyopathic mutant.
Cardiomyopathies
Structure-based analysis of A19D, a variant of transthyretin involved in familial amyloid cardiomyopathy.
Cardiomyopathies
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.
Cardiomyopathies
Synthesis and characterization of potent bivalent amyloidosis inhibitors that bind prior to transthyretin tetramerization.
Cardiomyopathies
Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR).
Cardiomyopathies
Tafamidis for the Treatment of Hereditary Transthyretin Amyloid Cardiomyopathy: A Case Report.
Cardiomyopathies
Tafamidis for transthyretin amyloid cardiomyopathy: the solution or just the beginning of the end?
Cardiomyopathies
Tafamidis in transthyretin amyloid cardiomyopathy: effects on transthyretin stabilization and clinical outcomes.
Cardiomyopathies
Tafamidis Should Be Accessible for All Patients With Transthyretin Amyloid Cardiomyopathy.
Cardiomyopathies
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
Cardiomyopathies
Tafamidis, a potent and selective transthyretin kinetic stabilizer that inhibits the amyloid cascade.
Cardiomyopathies
Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy.
Cardiomyopathies
Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
Cardiomyopathies
Tc-HDP quantitative SPECT/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population.
Cardiomyopathies
The "Wagshurst study": p.Val40Ile transthyretin gene variant causes late-onset cardiomyopathy.
Cardiomyopathies
The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
Cardiomyopathies
The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic response.
Cardiomyopathies
The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies.
Cardiomyopathies
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis.
Cardiomyopathies
Three siblings of familial amyloid cardiomyopathy with isoleucine-50 transthyretin mutation.
Cardiomyopathies
Transthyretin Amyloid Cardiomyopathy Diagnosed on Incidental Myocardial Uptake During Bone Scintigraphy.
Cardiomyopathies
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges.
Cardiomyopathies
Transthyretin Amyloid Cardiomyopathy Mimicking Hypertrophic Cardiomyopathy in an Older Patient.
Cardiomyopathies
Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery.
Cardiomyopathies
Transthyretin amyloid cardiomyopathy: The emerging role of cardiac amyloid imaging.
Cardiomyopathies
Transthyretin amyloidosis with cardiomyopathy after domino liver transplantation: Results of a cross-sectional study.
Cardiomyopathies
Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
Cardiomyopathies
Transthyretin Cardiac Amyloidosis and Novel Therapies to Treat This Not-so-rare Cause of Cardiomyopathy.
Cardiomyopathies
Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
Cardiomyopathies
Transthyretin Glu54Leu - an unknown mutation within the Swedish population associated with amyloid cardiomyopathy and a unique fibril type.
Cardiomyopathies
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point.
Cardiomyopathies
Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome.
Cardiomyopathies
Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
Cardiomyopathies
Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
Cardiomyopathies
Treatment of hereditary and acquired forms of transthyretin amyloidosis in the era of personalized medicine: the role of randomized controlled trials.
Cardiomyopathies
Treatment of transthyretin cardiomyopathy with a TTR-specific antisense oligonucleotide (IONIS-TTRRx).
Cardiomyopathies
Treatment With Tafamidis Slows Disease Progression in Early-Stage Transthyretin Cardiomyopathy.
Cardiomyopathies
Two Siblings Diagnosed to Have Transthyretin-related Familial Amyloid Cardiomyopathy Around the Same Time at Different Hospitals.
Cardiomyopathies
Unmasking Early Wild-Type Transthyretin Amyloidosis Cardiomyopathy in a Patient With Refractory Atrial Fibrillation and Unremarkable Cardiac Imaging.
Cardiomyopathies
Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.
Cardiomyopathies
Usefulness of relative apical longitudinal strain index to predict positive 99m Tc-labeled pyrophosphate scintigraphy findings in advanced-age patients with suspected transthyretin amyloid cardiomyopathy.
Cardiomyopathies
V122I Transthyretin Cardiomyopathy: An Opportunity to Build Trust and Resolve Disparities.
Cardiomyopathies
Verification of the transthyretin Met 111 mutation in familial amyloid cardiomyopathy of Danish origin by DNA sequencing.
Cardiomyopathies
Wild type transthyretin cardiac amyloidosis in a young individual: A case report.
Cardiomyopathies
Wild-type transthyretin amyloid cardiomyopathy complicated by spinal canal stenosis, carpal tunnel syndrome, and rotator cuff tears: a case report.
Cardiomyopathies
Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications.
Cardiomyopathies
Wild-type Transthyretin Amyloid Myopathy With an Inclusion Body Myositis Phenotype.
Cardiomyopathies
Yield of Noncardiac Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis.
Cardiomyopathies
[Hereditary amyloid cardiomyopathy related to a mutation at transthyretin protein number 111. A clinical, genetic and echocardiographic study of an affected Danish family]
Cardiomyopathies
[Transthyretin gene V30M, H90N, and del9 mutations in cardiomyopathy patients from St. Petersburg].
Cardiomyopathy, Hypertrophic
Can echocardiography and ECG discriminate hereditary transthyretin V30M amyloidosis from hypertrophic cardiomyopathy?
Cardiomyopathy, Hypertrophic
False-positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy.
Cardiomyopathy, Hypertrophic
From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
Cardiomyopathy, Hypertrophic
Hereditary transthyretin amyloidosis caused by the rare Phe33Leu mutation.
Cardiomyopathy, Hypertrophic
Left Atrial Morphology, Size and Function in Patients With Transthyretin Cardiac Amyloidosis and Primary Hypertrophic Cardiomyopathy?- Comparative Strain Imaging Study.
Cardiomyopathy, Hypertrophic
Transthyretin Amyloid Cardiomyopathy Mimicking Hypertrophic Cardiomyopathy in an Older Patient.
Cardiomyopathy, Hypertrophic
Transthyretin amyloidosis in a septuagenarian masquerading as hypertrophic cardiomyopathy: the importance of multimodality imaging.
Cardiomyopathy, Hypertrophic
Transthyretin Amyloidosis Mimicking Obstructive Hypertrophic Cardiomyopathy: A Great Imitator.
Cardiomyopathy, Hypertrophic
Transthyretin amyloidosis: a phenocopy of hypertrophic cardiomyopathy.
Cardiomyopathy, Hypertrophic
[Liver transplantation in familial amyloid polyneuropathy. Case report and review of the literature]
Cardiomyopathy, Restrictive
A clinical, echocardiographic and genetic characterization of a Danish kindred with familial amyloid transthyretin methionine 111 linked cardiomyopathy.
Cardiomyopathy, Restrictive
Cardiac amyloidosis associated with a novel transthyretin aspartic acid-18 glutamic acid de novo mutation.
Cardiomyopathy, Restrictive
Cardiac amyloidosis associated with the transthyretin Ile122 mutation in a Caucasian family.
Cardiomyopathy, Restrictive
Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association.
Cardiomyopathy, Restrictive
Demyelinating Neuropathy in a Patient Treated With Revusiran for Transthyretin (Thr60Ala) Amyloidosis.
Cardiomyopathy, Restrictive
Disease-Specific Biomarkers in Transthyretin Cardiac Amyloidosis.
Cardiomyopathy, Restrictive
Emerging Therapeutics for the Treatment of Light Chain and Transthyretin Amyloidosis.
Cardiomyopathy, Restrictive
Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?
Cardiomyopathy, Restrictive
Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis.
Cardiomyopathy, Restrictive
Senile cardiac amyloidosis associated with homozygosity for a transthyretin variant (ILE-122).
Cardiomyopathy, Restrictive
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides.
Cardiomyopathy, Restrictive
Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.
Cardiomyopathy, Restrictive
Transthyretin Ile 122 and cardiac amyloidosis in African-Americans. 2 case reports.
Cardiomyopathy, Restrictive
Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
Cardiomyopathy, Restrictive
[Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
Cardiomyopathy, Restrictive
[Hereditary amyloid cardiomyopathy related to a mutation at transthyretin protein number 111. A clinical, genetic and echocardiographic study of an affected Danish family]
Cardiovascular Diseases
Acute Phase Reactants as Novel Predictors of Cardiovascular Disease.
Cardiovascular Diseases
Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases.
Carpal Tunnel Syndrome
A case of unilateral shoulder joint hydrarthrosis with wild-type amyloidogenic transthyretin amyloidosis.
Carpal Tunnel Syndrome
A case study of likely wild-type cardiac transthyretin amyloidosis causing rapid deterioration.
Carpal Tunnel Syndrome
A new transthyretin variant (Glu61Gly) associated with cardiomyopathy.
Carpal Tunnel Syndrome
A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndrome.
Carpal Tunnel Syndrome
A transthyretin mutation (Tyr78Phe) associated with peripheral neuropathy, carpal tunnel syndrome and skin amyloidosis.
Carpal Tunnel Syndrome
Cardiomyopathy in a Japanese family with the Glu61Lys transthyretin variant: a new phenotype.
Carpal Tunnel Syndrome
Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?
Carpal Tunnel Syndrome
Carpal Tunnel Syndrome Due to Iatrogenic Amyloidosis After Domino Liver Transplantation From Hereditary Transthyretin Amyloidosis: A Case Report.
Carpal Tunnel Syndrome
Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies.
Carpal Tunnel Syndrome
Carpal Tunnel Syndrome in Transthyretin Cardiac Amyloidosis: Implications and Protocol for Diagnosis and Treatment.
Carpal Tunnel Syndrome
Effect of synovial transthyretin amyloid deposition on preoperative symptoms and postoperative recovery of median nerve function among patients with idiopathic carpal tunnel syndrome.
Carpal Tunnel Syndrome
Establishing and validating the fluorescent amyloid ligand h-FTAA (heptamer formyl thiophene acetic acid) to identify transthyretin amyloid deposits in carpal tunnel syndrome.
Carpal Tunnel Syndrome
Familial amyloid polyneuropathy in a Spanish family with a transthyretin deletion (deltaVal 122) presenting with carpal tunnel syndrome.
Carpal Tunnel Syndrome
Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation, asparagine 70.
Carpal Tunnel Syndrome
Familial carpal tunnel syndrome due to amyloidogenic transthyretin His 114 variant.
Carpal Tunnel Syndrome
High prevalence of wild-type transthyretin deposition in patients with idiopathic carpal tunnel syndrome: a common cause of carpal tunnel syndrome in the elderly.
Carpal Tunnel Syndrome
New mutant gene (transthyretin Arg 58) in cases with hereditary polyneuropathy detected by non-isotope method of single-strand conformation polymorphism analysis.
Carpal Tunnel Syndrome
Nodular cutaneous amyloidosis and carpal tunnel syndrome due to the amyloidogenic transthyretin His 114 variant.
Carpal Tunnel Syndrome
Non-senile wild-type transthyretin systemic amyloidosis presenting as bilateral carpal tunnel syndrome.
Carpal Tunnel Syndrome
Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness.
Carpal Tunnel Syndrome
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study.
Carpal Tunnel Syndrome
Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses.
Carpal Tunnel Syndrome
The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy.
Carpal Tunnel Syndrome
The Tenosynovitis of Fingers Associated with Transthyretin Amyloidosis.
Carpal Tunnel Syndrome
Transthyretin Tyr69-to-Ile mutation (double-nucleotide substitution in codon 69) in a Japanese familial amyloidosis patient with cardiomyopathy and carpal tunnel syndrome.
Carpal Tunnel Syndrome
Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Carpal Tunnel Syndrome
Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome.
Carpal Tunnel Syndrome
Wild-type transthyretin amyloid cardiomyopathy complicated by spinal canal stenosis, carpal tunnel syndrome, and rotator cuff tears: a case report.
Carpal Tunnel Syndrome
Wild-type Transthyretin Amyloid Myopathy With an Inclusion Body Myositis Phenotype.
Cerebral Amyloid Angiopathy
Characterization of a transthyretin-related amyloid fibril protein from cerebral amyloid angiopathy in type I familial amyloid polyneuropathy.
Cerebral Amyloid Angiopathy
Coexistence of transthyretin- and A?-type cerebral amyloid angiopathy in a patient with hereditary transthyretin V30M amyloidosis.
Cerebral Amyloid Angiopathy
Comparison of clinical features in transient focal neurological episodes between hereditary transthyretin type and A? type cerebral amyloid angiopathy.
Cerebral Amyloid Angiopathy
Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy.
Cerebral Amyloid Angiopathy
Recurrent subarachnoid bleeding and superficial siderosis in a patient with histopathologically proven cerebral amyloid angiopathy.
Cerebral Amyloid Angiopathy, Familial
Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy.
Cerebral Hemorrhage
Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy.
Cerebral Hemorrhage
Protein aging Extracellular amyloid formation and intracellular repair.
Cerebrospinal Fluid Rhinorrhea
Microfluidic validation of diagnostic protein markers for spontaneous cerebrospinal fluid rhinorrhea.
Cerebrovascular Disorders
Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Cerebrovascular Disorders
ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.
Charcot-Marie-Tooth Disease
Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
Charcot-Marie-Tooth Disease
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
Cholangiocarcinoma
Serum levels of variants of transthyretin down-regulation in cholangiocarcinoma.
Cholangitis
EUS-guided Biliary Drainage for Malignant Perihilar Biliary Strictures after Further Transpapillary Intervention Has Been Judged to Be Impossible or Ineffective.
Cholangitis, Sclerosing
Systemic but asymptomatic transthyretin amyloidosis 8 years after domino liver transplantation.
Cholestasis
Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer.
Cholestasis
Impaired synthesis of retinol-binding protein and transthyretin in rat liver with bile duct obstruction.
Choriocarcinoma
CARRIER MEDIATED THYROID HORMONE TRANSPORT INTO PLACENTA BY PLACENTAL TRANSTHYRETIN.
Choriocarcinoma
Oxygen concentration regulates expression and uptake of transthyretin, a thyroxine binding protein, in JEG-3 choriocarcinoma cells.
Choroid Plexus Neoplasms
Choroid plexus papilloma with stromal deposition of amyloid and elastic material.
Choroid Plexus Neoplasms
Choroid plexus tumors in childhood. Histopathologic study and clinico-pathological correlation.
Choroid Plexus Neoplasms
Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases.
Choroid Plexus Neoplasms
Transthyretin expression in medulloblastomas and medulloblastoma cell lines.
Choroid Plexus Neoplasms
Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases.
Choroidal Neovascularization
Choroidal Neovascularization in Familial Transthyretin Amyloidosis.
Colorectal Neoplasms
Biomarkers for the early detection of relapses in metastatic colorectal cancers.
Colorectal Neoplasms
Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels.
Colorectal Neoplasms
Immunohistochemical Assessment of Transthyretin Association with Colorectal Adenocarcinoma.
Coma
Impact of a High-protein Nutritional Intake on the Clinical Outcome of the Neurocritical Patients.
Confusion
Systemic AL amyloidosis with unusual cutaneous presentation unmasked by carotenoderma.
Confusion
Transthyretin for the routine assessment of malnutrition: A clinical dilemma highlighted by an international survey of experts in the field.
Congenital Abnormalities
Naso-maxillary deformity due to frontonasal expression of human transthyretin gene in transgenic mice.
Coronary Artery Disease
Changes in the proteomic profile of blood serum in coronary atherosclerosis.
Cough
Familial amyloid polyneuropathy with chronic paroxysmal dry cough in Mainland China: A Chinese family with a proven heterozygous missense mutation c.349G>T in the transthyretin gene.
COVID-19
ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtable.
Cranial Nerve Diseases
Amyloid fibril protein in familial amyloidosis with cranial neuropathy and corneal lattice dystrophy (FAP type IV) is related to transthyretin.
CREST Syndrome
Amyloidosis of the Breast: Three Different and Unusual Presentations of a Rare Entity.
Creutzfeldt-Jakob Syndrome
Transthyretin amyloidoses of familial amyloidotic polyneuropathy as a paradigm for the genetic control of De Novo generation of Creutzfeldt-Jakob disease infectious amyloid by a spontaneous change in configuration of the host precursor protein.
Cystic Fibrosis
Involvement of hepatocyte nuclear factor 3 in endoderm differentiation of embryonic stem cells.
Deglutition Disorders
Cognitive Dysfunction and Malnutrition Are Independent Predictor of Dysphagia in Patients with Acute Exacerbation of Congestive Heart Failure.
Dementia
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia.
Dementia
Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy.
Dementia
Effects of Chronic Stress on Prefrontal Cortex Transcriptome in Mice Displaying Different Genetic Backgrounds.
Dementia
Inflammation and disability as risk factors for mortality in elderly acute care patients.
Dementia
Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia.
Dementia
Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.
Dementia
Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu).
Dementia
Serum and cerebrospinal fluid levels of transthyretin in Lewy body disorders with and without dementia.
Dementia
Serum transthyretin and risk of cognitive decline and dementia: 22-year longitudinal study.
Dementia
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors.
Dementia
[An immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid]
Demyelinating Diseases
Transthyretin amyloidosis presenting with multifocal demyelinating mononeuropathies.
Dengue
Two-dimensional difference gel electrophoresis (DiGE) analysis of plasmas from dengue fever patients.
Diabetes Complications
Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Diabetes Mellitus
ALTERED CIRCULATING LEVELS OF RETINOL BINDING PROTEIN 4 AND TRANSTHYRETIN IN RELATION TO INSULIN RESISTANCE, OBESITY, AND GLUCOSE INTOLERANCE IN ASIAN INDIANS.
Diabetes Mellitus
Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
Diabetes Mellitus
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
Diabetes Mellitus
Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
Diabetes Mellitus
Cysteinylated transthyretin as a discriminator of cardiovascular risk in patients with diabetes mellitus.
Diabetes Mellitus
Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Diabetes Mellitus
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Diabetes Mellitus
Streptozotocin-induced diabetes lowers retinol-binding protein and transthyretin concentrations in rats.
Diabetes Mellitus, Type 1
Contrasting effects of type 2 and type 1 diabetes on plasma RBP4 levels: the significance of transthyretin.
Diabetes Mellitus, Type 1
Effect of metabolic control on serum protein concentrations in diabetes.
Diabetes Mellitus, Type 1
High-normal C-reactive protein levels do not affect the vitamin A transport complex in serum of children and adolescents with type 1 diabetes.
Diabetes Mellitus, Type 1
Sardinian Type 1 diabetes patients, Transthyretin and Mycobacterium avium subspecies paratuberculosis infection.
Diabetes Mellitus, Type 2
ALTERED CIRCULATING LEVELS OF RETINOL BINDING PROTEIN 4 AND TRANSTHYRETIN IN RELATION TO INSULIN RESISTANCE, OBESITY, AND GLUCOSE INTOLERANCE IN ASIAN INDIANS.
Diabetes Mellitus, Type 2
Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
Diabetes Mellitus, Type 2
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
Diabetes Mellitus, Type 2
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis.
Diabetes Mellitus, Type 2
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
Diabetes Mellitus, Type 2
High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus.
Diabetes Mellitus, Type 2
Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Diabetes Mellitus, Type 2
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Diabetes Mellitus, Type 2
Transthyretin Predicts Cardiovascular Outcome in Hemodialysis Patients With Type 2 Diabetes.
Diabetes Mellitus, Type 2
[Biochemical studies of amyloidogenesis in two different types of amyloidoses--amyloid transthyretin variant in familial amyloidotic polyneuropathy and islet amyloid polypeptide in non-insulin-dependent diabetes mellitus]
Diabetes, Gestational
Association between transthyretin concentrations and gestational diabetes mellitus in Chinese women.
Diabetes, Gestational
Maternal Circulating Transthyretin Level Is Longitudinally Associated With Increased Risk of Gestational Diabetes Mellitus: It Is Not Just an Indicator of Nutritional Status.
Diabetes, Gestational
Serum concentrations of retinol-binding protein 4 in women with and without gestational diabetes.
Diabetic Nephropathies
[Effective usage of nutrition assessment proteins in patients with diabetic nephropathy]
Diabetic Neuropathies
Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
Diabetic Retinopathy
Negative effects of transthyretin in high myopic vitreous on diabetic retinopathy.
Diabetic Retinopathy
Repression of retinal microvascular endothelial cells by transthyretin under simulated diabetic retinopathy conditions.
Diabetic Retinopathy
Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
Diabetic Retinopathy
Transthyretin affects the proliferation and migration of human retinal microvascular endothelial cells in hyperglycemia via hnRNPA2B1.
Diabetic Retinopathy
Transthyretin Exerts Pro-Apoptotic Effects in Human Retinal Microvascular Endothelial Cells Through a GRP78-Dependent Pathway in Diabetic Retinopathy.
Diabetic Retinopathy
Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy.
Down Syndrome
Are Serum Protein Biomarkers Derived from Proteomic Analysis Useful in Screening for Trisomy 21 at 11-13 Weeks?
Down Syndrome
[Transthyretin levels in serum and cerebrospinal fluid sustain the nutrio-viral hypothesis of the Cuban epidemic neuropathy]
Erectile Dysfunction
Effect of sildenafil citrate (Viagra) on erectile dysfunction in a patient with familial amyloidotic polyneuropathy ATTR Val30Met.
Exanthema
Vitamin a supplementation of vitamin a deficient measles patients lowers the risk of measles-related pneumonia in zambian children.
Fabry Disease
A prospective, observational study of patients with uncommon distal symmetric painful small-fiber neuropathy.
Fabry Disease
Diagnosis of small fiber neuropathy: A comparative study of five neurophysiological tests.
Fabry Disease
Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review.
Fasciculation
Tongue atrophy and fasciculations in transthyretin familial amyloid neuropathy: An ALS mimicker.
Fatty Liver
Transthyretin Regulated by linc00657/miR-205-5p Promoted Cholesterol Metabolism by Inducing SREBP2-HMGCR and Inhibiting LXR?-CYP7A1.
Fetal Growth Retardation
Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.
Frontotemporal Dementia
Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.
Ganglion Cysts
[An immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid]
Gastrointestinal Diseases
Transthyretin Val122Ile amyloidosis associated with isolated gastrointestinal disease and bowel rupture in a Caucasian woman.
Gastrointestinal Neoplasms
Prognostic Value of Pretreatment Serum Transthyretin Level in Patients with Gastrointestinal Cancers.
Gastroparesis
Gastric peroral endoscopic myotomy for transthyretin amyloidosis gastroparesis.
Genetic Diseases, Inborn
Activated microglia mediate synapse loss and short-term memory deficits in a mouse model of transthyretin-related oculoleptomeningeal amyloidosis.
Genetic Diseases, Inborn
Bilateral optic neuropathy in a patient with familial amyloidotic polyneuropathy.
Genetic Diseases, Inborn
Characterization of population genetic structure of hereditary transthyretin amyloidosis in Bulgaria.
Genetic Diseases, Inborn
Clinical development of an antisense therapy for the treatment of transthyretin-associated polyneuropathy.
Genetic Diseases, Inborn
Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.
Genetic Diseases, Inborn
Erythropoietin production by distal nephron in normal and familial amyloidotic adult human kidneys.
Genetic Diseases, Inborn
Founder effect of the Glu89Gln TTR mutation in the Bulgarian population.
Genetic Diseases, Inborn
Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.
Genetic Diseases, Inborn
Genetic analysis of familial amyloidotic polyneuropathy, an autosomal dominant disease.
Genetic Diseases, Inborn
Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy.
Genetic Diseases, Inborn
Inflammatory profiling of patients with familial amyloid polyneuropathy.
Genetic Diseases, Inborn
Population diversity of the genetically determined TTR expression in human tissues and its implications in TTR amyloidosis.
Genetic Diseases, Inborn
Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial.
Genetic Diseases, Inborn
Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy.
Genetic Diseases, Inborn
Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides.
Genetic Diseases, Inborn
The crystal structure of the green tea polyphenol (-)-epigallocatechin gallate-transthyretin complex reveals a novel binding site distinct from the thyroxine binding site.
Genetic Diseases, Inborn
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.
Genetic Diseases, Inborn
Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy.
Genetic Diseases, Inborn
[Experience with tafamidis in a patient with transthyretin amyloidosis].
Giant Cell Arteritis
Transthyretin amyloidosis and herpes zoster infection: a mimic of temporal arteritis.
Glaucoma
Ahmed valve for secondary glaucoma in patients with hereditary transthyretin amyloidosis.
Glaucoma
Baerveldt glaucoma drainage implant surgery for secondary glaucoma in patients with transthyretin-related familial amyloid polyneuropathy.
Glaucoma
Excisional goniotomy with Kahook Dual Blade in a patient with glaucoma secondary to Transthyretin Amyloidosis.
Glaucoma
Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Glaucoma
Small gauge vitrectomy for vitreous amyloidosis and subsequent management of secondary glaucoma in patients with hereditary transthyretin amyloidosis.
Glaucoma
Systemic Alterations of Immune Response-Related Proteins during Glaucoma Development in the Murine Model DBA/2J.
Glaucoma
Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma.
Glaucoma, Neovascular
The use of intravitreal ranibizumab to treat neovascular glaucoma because of retinal amyloid angiopathy in familial amyloidosis transthyretin v30m related.
Glaucoma, Open-Angle
Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma.
Glioma
Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples.
Glucose Intolerance
ALTERED CIRCULATING LEVELS OF RETINOL BINDING PROTEIN 4 AND TRANSTHYRETIN IN RELATION TO INSULIN RESISTANCE, OBESITY, AND GLUCOSE INTOLERANCE IN ASIAN INDIANS.
Glucose Intolerance
High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus.
Glucose Intolerance
Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice.
Glycogen Storage Disease Type II
Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide.
Guillain-Barre Syndrome
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Hearing Loss
Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy.
Hearing Loss, Sensorineural
How your ears can tell what is hidden in your heart: wild-type transthyretin amyloidosis as potential cause of sensorineural hearing loss inelderly-AmyloDEAFNESS pilot study.
Heart Block
[Liver transplantation in familial amyloid polyneuropathy. Case report and review of the literature]
Heart Diseases
Cardiac amyloid imaging with 18F-florbetaben positron emission tomography: a pilot study.
Heart Diseases
Exploring the influence of mutation on transthyretin aggregation in heart disease.
Heart Diseases
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis.
Heart Diseases
Transthyretin V122I (pV142I)* cardiac amyloidosis: an age-dependent autosomal dominant cardiomyopathy too common to be overlooked as a cause of significant heart disease in elderly African Americans.
Heart Diseases
Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.
Heart Diseases
[Transthyretin familial amyloid polyneuropathy - three Hungarian cases with rare mutations (His88Arg and Phe33Leu)].
Heart Failure
2021 Advocacy Statements for the Role of 99mTc-Pyrophosphate Scintigraphy in the Diagnosis of Transthyretin Cardiac Amyloidosis: A Report of the Taiwan Society of Cardiology and the Society of Nuclear Medicine of the Republic of China.
Heart Failure
A case study of likely wild-type cardiac transthyretin amyloidosis causing rapid deterioration.
Heart Failure
A Heart too Stiff to Beat: A Case of Familial Transthyretin Amyloidosis Cardiomyopathy.
Heart Failure
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells.
Heart Failure
A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy.
Heart Failure
A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK.
Heart Failure
A transthyretin variant, Asp18Asn, associated with amyloid cardiomyopathy: a new African-American variant?
Heart Failure
AG10 inhibits amyloidogenesis and cellular toxicity of the familial amyloid cardiomyopathy-associated V122I transthyretin.
Heart Failure
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy.
Heart Failure
Assessment of Transthyretin Combined With Mini Nutritional Assessment on Admission Provides Useful Prognostic Information in Patients With Acute Decompensated Heart Failure.
Heart Failure
Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes.
Heart Failure
Association of Low Plasma Transthyretin Concentration With Risk of Heart Failure in the General Population.
Heart Failure
Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
Heart Failure
Association of the V122I Transthyretin Amyloidosis Genetic Variant With Cardiac Structure and Function in Middle-aged Black Adults: Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Heart Failure
Beneficial Effect of Pimobendan for Severe Heart Failure Due to Transthyretin Cardiac Amyloidosis.
Heart Failure
Best Practices for Prognostic Evaluation of a Patient With Transthyretin Amyloid Cardiomyopathy.
Heart Failure
Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Heart Failure
Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure.
Heart Failure
Cost-Effectiveness of Tafamidis Therapy for Transthyretin Amyloid Cardiomyopathy.
Heart Failure
Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy.
Heart Failure
Diagnosis and treatment of heart failure in hereditary transthyretin amyloidosis.
Heart Failure
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis.
Heart Failure
Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis.
Heart Failure
Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis.
Heart Failure
Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience.
Heart Failure
Genetic variation of the transthyretin gene in wild-type transthyretin amyloidosis (ATTRwt).
Heart Failure
Genomic Screening Identifies Individuals at High Risk for Hereditary Transthyretin Amyloidosis.
Heart Failure
Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
Heart Failure
Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser.
Heart Failure
Heart Failure Complicated by Alveolar Hemorrhage due to Vascular Collapse and Amyloid Deposits in Wild-Type Transthyretin Amyloidosis.
Heart Failure
Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study.
Heart Failure
High prevalence of heart failure with reduced ejection fraction in patients with transthyretin cardiac amyloidosis.
Heart Failure
Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model.
Heart Failure
Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.
Heart Failure
Isolated heart transplantation for familial transthyretin (TTR) V122I cardiac amyloidosis.
Heart Failure
Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African Americans.
Heart Failure
Misfolded Transthyretin as a Novel Risk Factor for Heart Failure: A Rich History With Implications for Future Diagnosis and Treatment.
Heart Failure
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.
Heart Failure
Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis.
Heart Failure
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System.
Heart Failure
Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis.
Heart Failure
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.
Heart Failure
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy.
Heart Failure
Patients with cardiac amyloidosis have a greater neurohormonal activation than those with non-amyloidotic heart failure.
Heart Failure
Patisiran for advanced heart failure with hereditary transthyretin cardiac amyloidosis.
Heart Failure
Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.
Heart Failure
Postmortem findings in two familial amyloidosis patients with transthyretin variant Asp38Ala.
Heart Failure
Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure With Preserved Ejection Fraction.
Heart Failure
Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
Heart Failure
Rapid decline in ejection fraction and persistent elevation of troponin associated with cardiac amyloidosis.
Heart Failure
Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis Due to Val122Ile Mutation: Insights from Noninvasive Pressure-Volume Analysis.
Heart Failure
Stabilization of Cardiac Function With Diflunisal in Transthyretin (ATTR) Cardiac Amyloidosis.
Heart Failure
Standard heart failure medication in cardiac transthyretin amyloidosis: useful or harmful?
Heart Failure
Tafamidis: A First-in-Class Transthyretin Stabilizer for Transthyretin Amyloid Cardiomyopathy.
Heart Failure
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.
Heart Failure
The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis.
Heart Failure
The Structural Understanding of Transthyretin Misfolding and the Inspired Drug Approaches for the Treatment of Heart Failure Associated With Transthyretin Amyloidosis.
Heart Failure
Trajectory of left ventricular geometry and diastolic dysfunction in hereditary transthyretin cardiac amyloidosis.
Heart Failure
Transthyretin amyloid cardiomyopathy in women: frequency, characteristics, and diagnostic challenges.
Heart Failure
Transthyretin amyloid fibrils alter primary fibroblast structure, function, and inflammatory gene expression.
Heart Failure
Transthyretin Cardiac Amyloidosis as Diagnosed by 99mTc-PYP Scanning in Patients with Acute Heart Failure and Preserved Ejection Fraction.
Heart Failure
Transthyretin cardiac amyloidosis in aortic stenosis: Prevalence, diagnostic challenges, and clinical implications.
Heart Failure
Transthyretin Cardiac Amyloidosis in Older Adults: Optimizing Cardiac Imaging to the Corresponding Diagnostic and Management Goal.
Heart Failure
Transthyretin Cardiac Amyloidosis in the Elderly-Tip of a Heart Failure Iceberg?
Heart Failure
Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
Heart Failure
Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure.
Heart Failure
Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
Heart Failure
Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.
Heart Failure
Use of Serum Transthyretin as a Prognostic Indicator and Predictor of Outcome in Cardiac Amyloid Disease Associated With Wild-Type Transthyretin.
Heart Failure
Use of Ventilatory Efficiency Slope as a Marker for Increased Mortality in Wild-Type Transthyretin Cardiac Amyloidosis.
Heart Failure
Usefulness of electron microscopy in the diagnosis of wild-type transthyretin cardiac amyloidosis.
Heart Failure
Utility of 99 mTc-Pyrophosphate Scintigraphy in Diagnosing Transthyretin Cardiac Amyloidosis in Real-World Practice.
Heart Failure
Utility of Neuropathy Screening for Wild-Type Transthyretin Amyloidosis Patients.
Heart Failure
Where Neurosurgery Meets Heart Failure: A Case Report of a Patient with Amyloid Transthyretin Wild Type in the Ligamentum Flavum and Cardiac Tissue with Bilateral Carpal Tunnel Syndrome.
Heart Failure
Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly.
Heart Failure
Wild-Type Transthyretin Amyloid Cardiomyopathy: A Missed Cause of Heart Failure With Preserved Ejection Fraction With Evolving Treatment Implications.
Heart Failure
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction.
Heart Failure
Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
Heart Failure
[Bone seeking tracers' scintigraphy for the diagnosis of transthyretin cardiac amyloidosis].
Heart Failure, Diastolic
The quintessential form of diastolic heart failure in older adults: Wild type transthyretin cardiac amyloidosis.
Heart Failure, Systolic
Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis.
HELLP Syndrome
Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.
Hematuria
Gross hematuria: An unusual presenting symptom of systemic wild-type transthyretinamyloidosis.
Hemoglobinopathies
Top-Down Analysis of Small Plasma Proteins Using an LTQ-Orbitrap. Potential for Mass Spectrometry-Based Clinical Assays for Transthyretin and Hemoglobin.
Hepatitis C
Multimodality Imaging of Cardiac Transthyretin Amyloidosis 16 years after a Domino Liver Transplantation.
Hepatomegaly
Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice.
Heredodegenerative Disorders, Nervous System
The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.
Hernias, Diaphragmatic, Congenital
Nitrofen interferes with trophoblastic expression of retinol-binding protein and transthyretin during lung morphogenesis in the nitrofen-induced congenital diaphragmatic hernia model.
Herpes Zoster
Transthyretin amyloidosis and herpes zoster infection: a mimic of temporal arteritis.
HIV Infections
Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.
HIV Infections
Longitudinal evaluation of markers of inflammation in HIV-positive and HIV-negative Rwandan women.
Huntington Disease
Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal.
Hydrarthrosis
A case of unilateral shoulder joint hydrarthrosis with wild-type amyloidogenic transthyretin amyloidosis.
Hydrocephalus
Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.
Hydrocephalus
The Expression of Transthyretin and Amyloid-? Protein Precursor is Altered in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
Hydrocephalus
[Case report of transthyretin Val30Met familial amyloid polyneuropathy presenting hydrocephalus].
Hydrocephalus, Normal Pressure
Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia.
Hydrocephalus, Normal Pressure
The Expression of Transthyretin and Amyloid-? Protein Precursor is Altered in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
Hypercholesterolemia
Differential proteomic distribution of TTR (pre-albumin) forms in serum and HDL of patients with high cardiovascular risk.
Hyperglycemia
A novel transthyretin/STAT4/miR-223-3p/FBXW7 signaling pathway affects neovascularization in diabetic retinopathy.
Hyperglycemia
Transthyretin affects the proliferation and migration of human retinal microvascular endothelial cells in hyperglycemia via hnRNPA2B1.
Hyperhomocysteinemia
S-homocysteinylation of transthyretin is detected in plasma and serum of humans with different types of hyperhomocysteinemia.
Hyperhomocysteinemia
Vegetarianism produces subclinical malnutrition, hyperhomocysteinemia and atherogenesis.
Hyperinsulinism
Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults.
Hyperinsulinism
Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and {beta}-Amyloid in Normal Adults.
Hyperlipoproteinemia Type II
Development and Clinical Applications of Antisense Oligonucleotide Gapmers.
Hypertension
Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
Hyperthyroidism
Transthyretin expression in the rat brain: effect of thyroid functional state and role in thyroxine transport.
Hyperthyroxinemia
A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study.
Hyperthyroxinemia
A novel variant of transthyretin (prealbumin), Thr119 to Met, associated with increased thyroxine binding.
Hyperthyroxinemia
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemia.
Hyperthyroxinemia
Production and functional analysis of normal and variant recombinant human transthyretin proteins.
Hyperthyroxinemia
Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.
Hyperthyroxinemia
X-ray crystal structure of the Ala-109-->Thr variant of human transthyretin which produces euthyroid hyperthyroxinemia.
Hyperthyroxinemia
[Thyroxine-binding proteins--familial euthyroid hyperthyroxinemia due to point mutations of transthyretin]
Hypertrophy, Left Ventricular
Plasma hepatocyte growth factor is a novel marker of AL cardiac amyloidosis.
Hypertrophy, Left Ventricular
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study.
Hypertrophy, Left Ventricular
Prevalence of transthyretin amyloidosis in patients with heart failure and no left ventricular hypertrophy.
Hypertrophy, Left Ventricular
Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy.
Hypertrophy, Left Ventricular
The electrocardiographic features associated with cardiac amyloidosis of variant transthyretin isoleucine 122 type in Afro-Caribbean patients.
Hypesthesia
Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Hypoalbuminemia
Down regulation of a harmful variant protein by replacement of its normal protein.
Hypotension, Orthostatic
A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family.
Hypotension, Orthostatic
Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS).
Hypotension, Orthostatic
Familial Transthyretin Amyloidosis with Variant Asp38Ala Presenting with Orthostatic Hypotension and Chronic Diarrhea.
Hypotension, Orthostatic
Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management.
Hypothyroidism
Hypothyroidism Induced by Polychlorinated Biphenyls and Up-Regulation of Transthyretin.
Hypothyroidism
Transthyretin is not necessary for thyroid hormone metabolism in conditions of increased hormone demand.
Hypothyroidism
[Potentializing of tricyclics and serotoninergics by thyroid hormones in resistant depressive disorders]
Immune System Diseases
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia.
Immunoglobulin Light-chain Amyloidosis
A practical approach to the diagnosis of systemic amyloidoses.
Immunoglobulin Light-chain Amyloidosis
A review of the amyloidoses that infiltrate the heart.
Immunoglobulin Light-chain Amyloidosis
A sporadic case of late-onset familial amyloid polyneuropathy with a monoclonal gammopathy.
Immunoglobulin Light-chain Amyloidosis
Amyloidosis and cardiovascular diseases: A clinical insight.
Immunoglobulin Light-chain Amyloidosis
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Cardiac amyloidosis is associated with increased aortic stiffness.
Immunoglobulin Light-chain Amyloidosis
Cardiac Amyloidosis: Diagnosis and Treatment Strategies.
Immunoglobulin Light-chain Amyloidosis
Clinical diagnosis and typing of systemic amyloidosis in subcutaneous fat aspirates by mass spectrometry-based proteomics.
Immunoglobulin Light-chain Amyloidosis
Current trends in diagnosis and management of cardiac amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Differential Myocyte Responses in Patients with Cardiac Transthyretin Amyloidosis and Light-Chain Amyloidosis: A Cardiac MR Imaging Study.
Immunoglobulin Light-chain Amyloidosis
Imaging Techniques As An Aid In The Early Detection Of Cardiac Amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings.
Immunoglobulin Light-chain Amyloidosis
Mass Spectrometric-Based Proteomic Analysis of Amyloid Neuropathy Type in Nerve Tissue.
Immunoglobulin Light-chain Amyloidosis
Mucocutaneous manifestations in systemic amyloidosis A retrospective analytical study in a tertiary care center.
Immunoglobulin Light-chain Amyloidosis
Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Musculoskeletal pathology as an early warning sign of systemic amyloidosis: a systematic review of amyloid deposition and orthopedic surgery.
Immunoglobulin Light-chain Amyloidosis
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance.
Immunoglobulin Light-chain Amyloidosis
Pupil abnormality in amyloidosis with autonomic neuropathy.
Immunoglobulin Light-chain Amyloidosis
Renal Infarction and Its Consequences for Renal Function in Patients With Cardiac Amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review.
Immunoglobulin Light-chain Amyloidosis
Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Two types of amyloidosis presenting in a single patient: a case series.
Immunoglobulin Light-chain Amyloidosis
Use of biomarkers to diagnose and manage cardiac amyloidosis.
Immunoglobulin Light-chain Amyloidosis
Wild-type transthyretin cardiac amyloidosis (ATTRwt-CA), previously known as senile cardiac amyloidosis: clinical presentation, diagnosis, management and emerging therapies.
Immunoglobulin Light-chain Amyloidosis
[An immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid]
Immunoglobulin Light-chain Amyloidosis
[Cardiac scintigraphy-centered diagnostic process in transthyretin cardiac amyloidosis].
Immunoglobulin Light-chain Amyloidosis
[Senile systemic amyloidosis: definition, diagnosis, why thinking about?].
Infections
C-reactive protein to transthyretin ratio for the early diagnosis and follow-up of postoperative infection.
Infections
Cloning and expression of the gene for soybean hydroxyisourate hydrolase. Localization and implications for function and mechanism.
Infections
Diagnostic value of C-reactive protein and transthyretin in bone infections of the lower limb.
Infections
Distinct neural stem cell tropism, early immune activation, and choroid plexus pathology following coxsackievirus infection in the neonatal central nervous system.
Infections
Effect of corticotherapy on proteomics of endometrial fluid from mares susceptible to persistent postbreeding endometritis.
Infections
Effects of acute inflammation on plasma retinol, retinol-binding protein, and its mRNA in the liver and kidneys of vitamin A-sufficient rats.
Infections
Haemonchus contortus transthyretin domain - containing protein (HcTTR): A promising vaccine candidate against Haemonchus contortus infection.
Infections
Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia.
Infections
Repletion of the plasma pool of nutrient transport proteins occurs at different rates during the nutritional rehabilitation of severely malnourished children.
Infections
Sardinian Type 1 diabetes patients, Transthyretin and Mycobacterium avium subspecies paratuberculosis infection.
Infections
Serum transthyretin is a predictor of clinical outcomes in critically ill trauma patients.
Infections
The association between plasma levels of acute phase proteins, haptoglobin, alpha-1 acid glycoprotein (AGP), Pig-MAP, transthyretin and serum amyloid A (SAA) in Large White and Meishan pigs.
Infections
The molar ratio of serum retinol-binding protein (RBP) to transthyretin (TTR) is not useful to assess vitamin A status during infection in hospitalised children.
Infections
The negative acute phase response of serum transthyretin following Streptococcus suis infection in the pig.
Infections
Transthyretin amyloidosis and herpes zoster infection: a mimic of temporal arteritis.
Infections
Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.
Infections
[C-reactive protein and transthyretin in early diagnosis of infection after open fractures of the lower limbs (a preliminary study)]
Inflammatory Bowel Diseases
Retinol Binding Protein 4 in children with Inflammatory Bowel Disease: a negative correlation with the disease activity.
Influenza, Human
Rapidly progressive amyloid polyneuropathy associated with a novel variant transthyretin serine 25.
Insulin Resistance
ALTERED CIRCULATING LEVELS OF RETINOL BINDING PROTEIN 4 AND TRANSTHYRETIN IN RELATION TO INSULIN RESISTANCE, OBESITY, AND GLUCOSE INTOLERANCE IN ASIAN INDIANS.
Insulin Resistance
Association between transthyretin concentrations and gestational diabetes mellitus in Chinese women.
Insulin Resistance
Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
Insulin Resistance
Elevated serum adiponectin and tumor necrosis factor-? and decreased transthyretin in Japanese elderly women with low grip strength and preserved muscle mass and insulin sensitivity.
Insulin Resistance
Identification of cysteinylated transthyretin, a predictive biomarker of treatment response to partially hydrolyzed guar gum in type 2 diabetes rats, by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Insulin Resistance
Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.
Insulin Resistance
Transthyretin contributes to insulin resistance and diminishes exercise-induced insulin sensitivity in obese mice by inhibiting AMPK activity in skeletal muscle.
Intellectual Disability
An association study between the transthyretin (TTR) gene and mental retardation.
Interatrial Block
The Prevalence of Advanced Interatrial Block and Its Relationship to Left Atrial Function in Patients with Transthyretin Cardiac Amyloidosis.
Iron Deficiencies
Serum transferrin receptor concentrations in women with mild malnutrition.
Iron Overload
Spectrum of Restrictive and Infiltrative Cardiomyopathies: Part 1 of a 2-Part Series.
Ischemic Stroke
Atrial Fibrillation and Ischemic Stroke With the Amyloidogenic V122I Transthyretin Variant Among Black Americans.
Ischemic Stroke
Cerebrospinal fluid transthyretin neuroprotection in a mouse model of brain ischemia.
Ischemic Stroke
Predictive value of serum transthyretin for outcome in acute ischemic stroke.
Kidney Diseases
Liver transplantation in transthyretin amyloidosis: Characteristics and management related to kidney disease.
Kidney Failure, Chronic
Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M).
Kidney Failure, Chronic
End-stage renal disease and dialysis in hereditary amyloidosis TTR V30M: presentation, survival and prognostic factors.
Kidney Failure, Chronic
End-stage renal failure due to transthyretin amyloidosis after liver transplantation: outcomes in 19 registry cases.
Kidney Failure, Chronic
Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients.
Kidney Failure, Chronic
Observations with regard to the National Kidney Foundation K/DOQI clinical practice guidelines concerning serum transthyretin in chronic renal failure.
Kidney Failure, Chronic
Proteomic analysis of plasma proteins of high-flux haemodialysis and on-line haemodiafiltration patients reveals differences in transthyretin levels related with anaemia.
Kidney Failure, Chronic
Serum Retinol, Retinol-Binding Protein, and Transthyretin in Children Receiving Dialysis.
Leptospirosis
Potential serum biomarkers associated with mild and severe leptospirosis infection: A cohort study in the Malaysian population.
Leukemia
Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.
Leukemia
[Transthyretin and albumin in cerebrospinal fluid in patients with acute leukemias or lymphomas of high grade malignancy]
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
CD5 molecule-like and transthyretin as putative biomarkers of chronic myeloid leukemia - an insight from the proteomic analysis of human plasma.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Small-Molecule Screening for Genetic Diseases.
Leukoencephalopathies
White matter disorders with autosomal dominant heredity: a review with personal clinical case studies and their MRI findings.
Liver Cirrhosis
Oral supplementation with branched-chain amino acids improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis.
Liver Cirrhosis, Biliary
Impaired release of vitamin A from liver in primary biliary cirrhosis.
Liver Diseases
Amyloid Polyneuropathy and Myocardial Amyloidosis 10 Years after Domino Liver Transplantation from a Patient with a Transthyretin Ser50Arg Mutation.
Liver Diseases
Effect of tacrolimus and partial hepatectomy on transthyretin metabolism in rats.
Liver Diseases
Expression and function of thyroid hormone receptor variants in normal and chronically diseased human liver.
Liver Diseases
Relationship of insulin resistance to protein-energy malnutrition in patients with alcoholic liver cirrhosis: effect of short-term nutritional support.
Liver Diseases
Self-reported gastrointestinal symptoms are more common in liver transplanted transthyretin amyloidosis patients than in healthy controls and in patients transplanted for end-stage liver disease.
Liver Diseases
Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Liver Failure
Plasma levels of transthyretin and retinol-binding protein in Child-A cirrhotic patients in relation to protein-calorie status and plasma amino acids, zinc, vitamin A and plasma thyroid hormones.
Lung Neoplasms
Diagnostic Value of Combining Tumor and Inflammatory Markers in Lung Cancer.
Lung Neoplasms
Effect and Mechanism of Transthyretin over-Expression on Proliferation and Cell Cycle of Lung Cancer A549 Cells.
Lung Neoplasms
Prognostic impact of serum transthyretin in patients with non-small cell lung cancer.
Lung Neoplasms
Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.
Lung Neoplasms
Transthyretin Stimulates Tumor Growth through Regulation of Tumor, Immune, and Endothelial Cells.
Lymphocytic Choriomeningitis
Expression of Viral Antigen by the Liver Leads to Chronic Infection Through the Generation of Regulatory T Cells.
Lymphoma
[Transthyretin and albumin in cerebrospinal fluid in patients with acute leukemias or lymphomas of high grade malignancy]
Lymphoma, B-Cell
[Clinical Value of Serum Amyloid A and Misfolded Transthyretin for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients].
Lymphoma, Large B-Cell, Diffuse
[Clinical Value of Serum Amyloid A and Misfolded Transthyretin for Relapsed/Refractory Diffuse Large B-Cell Lymphoma Patients].
Lymphoma, T-Cell, Cutaneous
Confirmation of the biological significance of transthyretin as a biomarker for cutaneous T-cell lymphoma by its protein interaction partners.
Machado-Joseph Disease
Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal.
Macroglossia
High prevalence of recurrent nocturnal desaturations in systemic AL amyloidosis: a cross-sectional pilot study.
Macroglossia
Pompe Disease Could Mimic Exam Findings of Amyloidosis: Two Rare Diagnoses Bona Fide.
Macular Degeneration
Identification of Transthyretin Tetramer Kinetic Stabilizers That Are Capable of Inhibiting the Retinol-Dependent Retinol Binding Protein 4-Transthyretin Interaction: Potential Novel Therapeutics for Macular Degeneration, Transthyretin Amyloidosis, and Their Common Age-Related Comorbidities.
Malnutrition
Alteration of transthyretin microheterogeneity in serum of multiple trauma patients.
Malnutrition
Assessment of nutritional status in organ transplant: is transthyretin a reliable indicator?
Malnutrition
Assessment of the nutritional status of adult patients with acute myeloid leukemia during induction chemotherapy.
Malnutrition
Assessment of Transthyretin Combined With Mini Nutritional Assessment on Admission Provides Useful Prognostic Information in Patients With Acute Decompensated Heart Failure.
Malnutrition
Assessment of transthyretin cut-off values for a better screening of malnutrition: Retrospective determination and prospective validation.
Malnutrition
Associations of decreased serum transthyretin with elevated high-sensitivity CRP, serum copper and decreased hemoglobin in ambulatory elderly women.
Malnutrition
Bioelectrical impedance analysis (BIA)-derived phase angle (PA) is a practical aid to nutritional assessment in hospital in-patients.
Malnutrition
Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases.
Malnutrition
Clinical indications for plasma protein assays: transthyretin (prealbumin) in inflammation and malnutrition.
Malnutrition
Exploring the Physiological Role of Transthyretin in Glucose Metabolism in the Liver.
Malnutrition
Inflammation and disability as risk factors for mortality in elderly acute care patients.
Malnutrition
Intestinal dysbiosis is common in systemic sclerosis and associated with gastrointestinal and extraintestinal features of disease.
Malnutrition
Levels of plasma insulin-like growth factor I (IGF I), IGF II, IGF binding proteins, type 1 IGF receptor and growth hormone binding protein in community-dwelling elderly subjects with no malnutrition and no inflammation.
Malnutrition
Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype.
Malnutrition
Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients.
Malnutrition
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation.
Malnutrition
Nutritional regulation of visceral markers in rat liver and cultured hepatoma cells.
Malnutrition
Nutritional status and muscle strength in patients with emphysema and severe alpha(1)-antitrypsin deficiency.
Malnutrition
Quick and effective improvement of leucine enriched dietary supplement on malnutrition in acute stroke patients receiving enteral tube feeding.
Malnutrition
Repletion of the plasma pool of nutrient transport proteins occurs at different rates during the nutritional rehabilitation of severely malnourished children.
Malnutrition
Serum Transthyretin Level as a Plausible Marker for Diagnosis of Child Acute Malnutrition.
Malnutrition
Short Nutritional Assessment Questionnaire as a predictor of undernutrition in cancer patients receiving outpatient chemotherapy: A retrospective study.
Malnutrition
Transthyretin for the routine assessment of malnutrition: A clinical dilemma highlighted by an international survey of experts in the field.
Malnutrition
Transthyretin: its response to malnutrition and stress injury. clinical usefulness and economic implications.
Malnutrition
[Assessment of nutritional status and body composition in patients with COPD: comparison of several methods]
Malnutrition
[Transthyretin levels in serum and cerebrospinal fluid sustain the nutrio-viral hypothesis of the Cuban epidemic neuropathy]
Marfan Syndrome
Exome analysis of connective tissue dysplasia: Death and rebirth of clinical genetics?
Measles
A low molar ratio of retinol binding protein to transthyretin indicates vitamin A deficiency during inflammation: studies in rats and a posterior analysis of vitamin A-supplemented children with measles.
Measles
Vitamin a supplementation of vitamin a deficient measles patients lowers the risk of measles-related pneumonia in zambian children.
Medulloblastoma
Transthyretin expression in medulloblastomas and medulloblastoma cell lines.
Melanoma
Serum proteomic profile of cutaneous malignant melanoma and relation to cancer progression: Association to tumor derived alpha-N-acetylgalactosaminidase activity.
Memory Disorders
Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-?1-42 oligomers are revealed in vivo by using a novel animal model.
Memory Disorders
The common environmental pollutant dioxin-induced memory deficits by altering estrogen pathways and a major route of retinol transport involving transthyretin.
Memory Disorders
Transthyretin knockout mice display decreased susceptibility to AMPA-induced neurodegeneration.
Memory Disorders
Transthyretin: a key gene involved in the maintenance of memory capacities during aging.
Meningitis, Bacterial
Cerebrospinal fluid transthyretin in the neonate and blood-cerebrospinal fluid barrier permeability.
Meningitis, Viral
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Metabolic Syndrome
Analysis of the factors contributing to serum retinol binding protein and transthyretin levels in Japanese adults.
Metabolic Syndrome
Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
Metabolic Syndrome
Transthyretin contributes to insulin resistance and diminishes exercise-induced insulin sensitivity in obese mice by inhibiting AMPK activity in skeletal muscle.
Migraine Disorders
Exome analysis of connective tissue dysplasia: Death and rebirth of clinical genetics?
Migraine with Aura
Exome analysis of connective tissue dysplasia: Death and rebirth of clinical genetics?
Miller Fisher Syndrome
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Mitral Valve Insufficiency
Cardiac devices in patients with transthyretin amyloidosis: Impact on functional class, left ventricular function, mitral regurgitation, and mortality.
Mitral Valve Insufficiency
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.
Monoclonal Gammopathy of Undetermined Significance
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
Monoclonal Gammopathy of Undetermined Significance
Paraproteinemias and Peripheral Nerve Disease.
Monoclonal Gammopathy of Undetermined Significance
[Amyloid from insulin treatment: a pitfall for the pathologist and the diabetologist].
Mononeuropathies
Transthyretin amyloidosis presenting with multifocal demyelinating mononeuropathies.
Moyamoya Disease
Detection of a gamma-carboxy-glutamate as novel post-translational modification of human transthyretin.
Multiple Myeloma
Amyloidosis of the Breast: Three Different and Unusual Presentations of a Rare Entity.
Multiple Myeloma
Functional Amyloid Signaling via the Inflammasome, Necrosome, and Signalosome: New Therapeutic Targets in Heart Failure.
Multiple Myeloma
Gastrointestinal Tract Amyloidosis Presenting With Pneumatosis Intestinalis.
Multiple Sclerosis
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Multiple Sclerosis
Oxidative modifications of cerebral transthyretin are associated with multiple sclerosis.
Muscle Weakness
A case of familial amyloid polyneuropathy (FAP ATTR Ile107Val) with proximal muscle weakness in the lower extremities.
Muscle Weakness
A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features.
Muscle Weakness
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Muscular Atrophy
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Muscular Atrophy
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
Muscular Atrophy, Spinal
Comparison of the United Kingdom and United States approaches to approval of new neuromuscular therapies.
Muscular Atrophy, Spinal
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
Muscular Diseases
A case of transthyretin amyloidosis with myopathy, neuropathy, and cardiomyopathy resulting from an exceedingly rare mutation transthyretin Ala120Ser (c.418G?>?T, p.Ala140Ser).
Muscular Diseases
A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features.
Muscular Diseases
Muscular amyloid angiopathy with amyloidgenic transthyretin Ser50Ile and Tyr114Cys.
Muscular Diseases
Transthyretin V122I amyloidosis with clinical and histological evidence of amyloid neuropathy and myopathy.
Muscular Diseases
Wild-type Transthyretin Amyloid Myopathy With an Inclusion Body Myositis Phenotype.
Muscular Dystrophy, Duchenne
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
Mycosis Fungoides
Confirmation of the biological significance of transthyretin as a biomarker for cutaneous T-cell lymphoma by its protein interaction partners.
Mycosis Fungoides
Posttranslational modifications of transthyretin are serum markers in patients with mycosis fungoides.
Myocardial Infarction
Reversible myocardial oedema due to acute myocardial infarction as differential diagnosis of cardiac transthyretin amyloidosis.
Myocarditis
Inflammatory and Molecular Pathways in Heart Failure-Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis.
Myocarditis
Transradial left ventricular endomyocardial biopsy feasibility, safety and clinical usefulness: Initial experience of a tertiary university center.
Myopia
Correlation of misfolded transthyretin in abnormal vitreous and high myopia related ocular pathologies.
Myopia
Functional analysis of misfolded transthyretin extracted from abnormal vitreous with high myopia related ocular pathologies.
Myopia
Vitreous and serum levels of transthyretin (TTR) in high myopia patients are correlated with ocular pathologies.
Myositis
Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele.
Myositis
Transthyretin Val122Ile, accumulated Abeta, and inclusion-body myositis aspects in cultured muscle.
Myositis
Wild-type Transthyretin Amyloid Myopathy With an Inclusion Body Myositis Phenotype.
Myositis, Inclusion Body
Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele.
Myositis, Inclusion Body
Wild-type Transthyretin Amyloid Myopathy With an Inclusion Body Myositis Phenotype.
Neoplasm Metastasis
CM156, a sigma receptor ligand, reverses cocaine-induced place conditioning and transcriptional responses in the brain.
Neoplasm Metastasis
Comparative analysis of the prognostic utility of preoperative nutritional parameters in patients with resectable esophageal carcinoma.
Neoplasm Metastasis
Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients.
Neoplasms
2D-PAGE of ovarian cancer: analysis of soluble and insoluble fractions using medium-range immobilized pH gradients.
Neoplasms
A 2-DE MALDI-TOF study to identify disease regulated serum proteins in lung cancer of c-myc transgenic mice.
Neoplasms
A case of choroid plexus papilloma with stromal sclerosis and indistinct papillary structures.
Neoplasms
A pediatric intramedullary spinal cord tumor with unusual solid-cystic and papillary features: a case report.
Neoplasms
Amyloidosis of the Breast: Three Different and Unusual Presentations of a Rare Entity.
Neoplasms
An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions.
Neoplasms
Biomarkers of phenethyl isothiocyanate-mediated mammary cancer chemoprevention in a clinically relevant mouse model.
Neoplasms
Cellular gene expression in papillomas of the choroid plexus from transgenic mice that express the simian virus 40 large T antigen.
Neoplasms
Changes of transthyretin and clusterin after androgen ablation therapy and correlation with prostate cancer malignancy.
Neoplasms
Choroid plexus papilloma with stromal deposition of amyloid and elastic material.
Neoplasms
Choroid plexus tumors in childhood. Histopathologic study and clinico-pathological correlation.
Neoplasms
Clinicopathologic correlations in epithelial choroid plexus neoplasms: a study of 52 cases.
Neoplasms
Clinicopathological features from long-term observation of a papillary tumor of the pineal region (PTPR): a case report.
Neoplasms
Comparative analysis of the prognostic utility of preoperative nutritional parameters in patients with resectable esophageal carcinoma.
Neoplasms
Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer.
Neoplasms
Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
Neoplasms
Deficiency of 5-hydroxyisourate hydrolase causes hepatomegaly and hepatocellular carcinoma in mice.
Neoplasms
Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels.
Neoplasms
Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus.
Neoplasms
Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients.
Neoplasms
Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients.
Neoplasms
Elevated risks for amyotrophic lateral sclerosis and blood disorders in Ashkenazi schizophrenic pedigrees suggest new candidate genes in schizophrenia.
Neoplasms
Elevated serum adiponectin and tumor necrosis factor-? and decreased transthyretin in Japanese elderly women with low grip strength and preserved muscle mass and insulin sensitivity.
Neoplasms
Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis.
Neoplasms
Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfalls.
Neoplasms
Four-year clinical and neuroradiological follow-up of a papillary tumor of the pineal region.
Neoplasms
Hepatic gene expression changes in pigs experimentally infected with the lung pathogen Actinobacillus pleuropneumoniae as analysed with an innate immunity focused microarray.
Neoplasms
Hydrophilic Small Molecules That Harness Transthyretin To Enhance the Safety and Efficacy of Targeted Chemotherapeutic Agents.
Neoplasms
Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults.
Neoplasms
Hyperinsulinemia Provokes Synchronous Increases in Central Inflammation and {beta}-Amyloid in Normal Adults.
Neoplasms
Immunohistochemical study of ependymal neoplasms: histological subtypes and glial and epithelial characteristics.
Neoplasms
Low Transthyretin Levels Predict Poor Prognosis in Cancer Patients in Palliative Care Settings.
Neoplasms
Plasma retinol transport system and taste acuity in patients with obstructive jaundice.
Neoplasms
Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer.
Neoplasms
Pressure-temperature folding landscape in proteins involved in neurodegenerative diseases and cancer.
Neoplasms
Prognosis and histopathologic features in papillary tumors of the pineal region: a retrospective multicenter study of 31 cases.
Neoplasms
Prognostic Value of Pretreatment Serum Transthyretin Level in Patients with Gastrointestinal Cancers.
Neoplasms
Proteomics based drug repositioning applied to improve in vitro fertilization implantation: an artificial intelligence model.
Neoplasms
Rapid T cell-based identification of human tumor tissue antigens by automated two-dimensional protein fractionation.
Neoplasms
Serum glutamine and hospital-acquired infections after aneurysmal subarachnoid hemorrhage.
Neoplasms
Serum proteomics of lung adenocarcinomas induced by targeted overexpression of c-raf in alveolar epithelium identifies candidate biomarkers.
Neoplasms
Serum transthyretin level is associated with prognosis of patients with gastric cancer.
Neoplasms
Tc-99m pyrophosphate imaging for transthyretin cardiac amyloidosis: Importance of estimation of cancer risk with the modality.
Neoplasms
The expression of viral and cellular genes in papillomas of the choroid plexus induced in transgenic mice.
Neoplasms
Transthyretin and cystatin C are catabolized in proximal tubular epithelial cells and the proteins are not useful as markers for renal cell carcinomas.
Neoplasms
Transthyretin messenger ribonucleic acid expression in the pancreas and in endocrine tumors of the pancreas and gut.
Neoplasms
Transthyretin Stimulates Tumor Growth through Regulation of Tumor, Immune, and Endothelial Cells.
Neoplasms
Transthyretin--an explanation of "anomalous" serum thyroid hormone values in severe illness?
Neoplasms
Transthyretin-driven oncolytic adenovirus suppresses tumor growth in orthotopic and ascites models of hepatocellular carcinoma.
Neoplasms
[Immunohistochemical study on distribution of transthyretin in normal human brain tissue and tumors]
Neoplasms
[Mechanisms of electroacupuncture for improving Alzheimer's disease from reducing ? amyloid protein level].
Neoplasms
[Prognostic markers in the histopathological diagnosis of tumors of the choroid plexus]
Neoplasms
[Transthyretin and albumin in cerebrospinal fluid in patients with acute leukemias or lymphomas of high grade malignancy]
Neoplastic Cells, Circulating
Biomarkers for the early detection of relapses in metastatic colorectal cancers.
Nephrotic Syndrome
The Accumulation of Heparan Sulfate S-Domains in Kidney Transthyretin Deposits Accelerates Fibril Formation and Promotes Cytotoxicity.
Nervous System Diseases
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Nervous System Diseases
Capture of a dimeric intermediate during transthyretin amyloid formation.
Nervous System Diseases
TTR-FAP Progression Evaluation Based on Gait Analysis Using a Single RGB-D Camera.
Neuralgia
Biomarkers mapping of neuropathic pain in a nerve chronic constriction injury mice model.
Neuralgia
Multimodality Imaging of Cardiac Transthyretin Amyloidosis 16 years after a Domino Liver Transplantation.
Neuralgia
Spinal cord stimulation markedly ameliorated refractory neuropathic pain in transthyretin Val30Met familial amyloid polyneuropathy.
Neuroblastoma
The heat shock response in FAP: the role of the extracellular chaperone clusterin.
Neuroblastoma
The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.
Neuroblastoma
The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.
Neurodegenerative Diseases
Activation of ERK1/2 MAP kinases in Familial Amyloidotic Polyneuropathy.
Neurodegenerative Diseases
Activation of the heat shock response in familial amyloidotic polyneuropathy.
Neurodegenerative Diseases
alphaB-crystallin (HspB5) in familial amyloidotic polyneuropathy.
Neurodegenerative Diseases
An overview of drugs currently under investigation for the treatment of transthyretin-related hereditary amyloidosis.
Neurodegenerative Diseases
Animal models of human amyloidoses: are transgenic mice worth the time and trouble?
Neurodegenerative Diseases
Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model.
Neurodegenerative Diseases
Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
Neurodegenerative Diseases
Curcumin could reduce the monomer of TTR with Tyr114Cys mutation via autophagy in cell model of familial amyloid polyneuropathy.
Neurodegenerative Diseases
Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
Neurodegenerative Diseases
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Neurodegenerative Diseases
Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.
Neurodegenerative Diseases
Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model.
Neurodegenerative Diseases
Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging.
Neurodegenerative Diseases
Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy.
Neurodegenerative Diseases
In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE).
Neurodegenerative Diseases
Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-associated amyloidosis.
Neurodegenerative Diseases
MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.
Neurodegenerative Diseases
Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.
Neurodegenerative Diseases
Oligomeric TTR V30M aggregates compromise cell viability, erythropoietin gene expression and promoter activity in the human hepatoma cell line Hep3B.
Neurodegenerative Diseases
Structural stabilization of transthyretin by a new compound, 6-benzoyl-2-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione.
Neurodegenerative Diseases
Synthesis and structural analysis of halogen substituted fibril formation inhibitors of Human Transthyretin (TTR).
Neurodegenerative Diseases
The Expression of Chemokines Is Downregulated in a Pre-Clinical Model of TTR V30M Amyloidosis.
Neurodegenerative Diseases
The putative role of some conserved water molecules in the structure and function of human transthyretin.
Neurodegenerative Diseases
The sour side of neurodegenerative disorders: the effects of protein glycation.
Neurodegenerative Diseases
Transthyretin interacts with actin regulators in a Drosophila model of familial amyloid polyneuropathy.
Neurodegenerative Diseases
Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity.
Neurodegenerative Diseases
Uptake of aggregating transthyretin by fat body in a Drosophila model for TTR-associated amyloidosis.
Neurodegenerative Diseases
Variants in RBP4 and AR genes modulate age at onset in familial amyloid polyneuropathy (FAP ATTRV30M).
Neuroinflammatory Diseases
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive Rats.
Neuromuscular Diseases
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation.
Non-alcoholic Fatty Liver Disease
Serum proteomic analysis of diet-induced steatohepatitis and metabolic syndrome in the Ossabaw miniature swine.
Obesity
ALTERED CIRCULATING LEVELS OF RETINOL BINDING PROTEIN 4 AND TRANSTHYRETIN IN RELATION TO INSULIN RESISTANCE, OBESITY, AND GLUCOSE INTOLERANCE IN ASIAN INDIANS.
Obesity
Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
Osteoarthritis
A case report of osteoarthritis associated with hereditary transthyretin amyloidosis ATTRV30M.
Osteoarthritis
Expression of proteins in serum, synovial fluid, synovial membrane, and articular cartilage samples obtained from dogs with stifle joint osteoarthritis secondary to cranial cruciate ligament disease and dogs without stifle joint arthritis.
Osteoarthritis
The delaying effect of alpha-glycerophosphocholine on senescence, transthyretin deposition, and osteoarthritis in senescence-accelerated mouse prone 8 mice.
Osteoarthritis
Transthyretin deposition in articular cartilage: a novel mechanism in the pathogenesis of osteoarthritis.
Osteoarthritis, Knee
Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid.
Osteoporosis
Decreased retinol transport proteins in Thai post-menopausal women with osteoporosis.
Ovarian Diseases
Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers.
Ovarian Neoplasms
A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer.
Ovarian Neoplasms
An ovarian cancer malignancy risk index composed of HE4, CA125, ultrasonographic score, and menopausal status: use in differentiation of ovarian cancers and benign lesions.
Ovarian Neoplasms
Classification of cancer types by measuring variants of host response proteins using SELDI serum assays.
Ovarian Neoplasms
Development of multiplexed bead-based immunoassays for the detection of early stage ovarian cancer using a combination of serum biomarkers.
Ovarian Neoplasms
Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population.
Ovarian Neoplasms
Evaluation of HE4 and TTR for diagnosis of ovarian cancer: Comparison with CA-125.
Ovarian Neoplasms
Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients.
Ovarian Neoplasms
Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer model.
Ovarian Neoplasms
Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients.
Ovarian Neoplasms
Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.
Ovarian Neoplasms
Two-dimensional electrophoretic proteome study of serum thermostable fraction from patients with various tumor conditions.
Ovarian Neoplasms
Validation of serum biomarkers for detection of early-stage ovarian cancer.
Pancreatic Neoplasms
Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer.
Pancreatitis
Protein status in pancreatitis--transthyretin is a sensitive biomarker of malnutrition in acute and chronic pancreatitis.
Pancreatitis, Chronic
Confounding effect of obstructive jaundice in the interpretation of proteomic plasma profiling data for pancreatic cancer.
Papilledema
Macular and optic disc edema and retinal vascular leakage in familial amyloid polyneuropathy with a transthyretin Val30Met mutation: a case report.
Papilloma
Choroid plexus papilloma with stromal deposition of amyloid and elastic material.
Papilloma
Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus.
Papilloma
Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach.
Papilloma, Choroid Plexus
Choroid plexus papilloma with stromal deposition of amyloid and elastic material.
Papilloma, Choroid Plexus
Differential expression of transthyretin in papillary tumors of the endolymphatic sac and choroid plexus.
Papilloma, Choroid Plexus
Identification of novel diagnostic markers for choroid plexus tumors: a microarray-based approach.
Papilloma, Choroid Plexus
Primary choroid plexus papilloma located in the suprasellar region: case report.
Papilloma, Choroid Plexus
[Immunohistochemical study for choroid plexus papillomas and ependymomas]
Paralysis
Coexistence of transthyretin familial amyloid polyneuropathy and hereditary neuropathy with liability to pressure palsy.
Paraproteinemias
Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis.
Paraproteinemias
Coexistent transthyretin amyloid cardiomyopathy and monoclonal gammopathy: Diagnostic challenges and prognostic implications.
Paraproteinemias
Diagnosis of small fiber neuropathy: A comparative study of five neurophysiological tests.
Paraproteinemias
Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
Paraproteinemias
Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients.
Paraproteinemias
Isolated atrial amyloidosis and the importance of molecular classification.
Paraproteinemias
Monoclonal Gammopathy of Uncertain Significance and Transthyretin Cardiac Amyloidosis.
Paraproteinemias
Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR).
Paraproteinemias
Prevalence of Monoclonal Gammopathy in Wild-Type Transthyretin Amyloidosis.
Paraproteinemias
Senile transthyretin cardiac amyloidosis in patients with plasma cell dyscrasias: importance of cardiac biopsy for making the correct diagnosis.
Paraproteinemias
Strong transthyretin immunostaining: potential pitfall in cardiac amyloid typing.
Paraproteinemias
Transthyretin amyloidosis with pulmonary involvement in a patient with monoclonal gammapathy.
Paraproteinemias
Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
Paraproteinemias
[Amyloid from insulin treatment: a pitfall for the pathologist and the diabetologist].
Paratuberculosis
Sardinian Type 1 diabetes patients, Transthyretin and Mycobacterium avium subspecies paratuberculosis infection.
Paresthesia
Familial amyloid polyneuropathy involving a homozygous Val30Met mutation in the amyloidogenic transthyretin gene presenting with superficial siderosis: a case report.
Parkinson Disease
Alanine-to-threonine substitutions and amyloid diseases: Butyrylcholinesterase as a case study.
Parkinson Disease
Chromolaena odorata (Siam weed): A natural reservoir of bioactive compounds with potent anti-fibrillogenic, antioxidative, and cytocompatible properties.
Parkinson Disease
Fluorescence as a method to reveal structures and membrane-interactions of amyloidogenic proteins.
Parkinson Disease
Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging.
Parkinson Disease
Nucleobindin 1 binds to multiple types of pre-fibrillar amyloid and inhibits fibrillization.
Parkinson Disease
Use of haptoglobin and transthyretin as potential biomarkers for the preclinical diagnosis of Parkinson's disease.
Peripheral Nervous System Diseases
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR).
Peripheral Nervous System Diseases
A new transthyretin mutation associated with amyloid cardiomyopathy.
Peripheral Nervous System Diseases
A new transthyretin variant (Glu61Gly) associated with cardiomyopathy.
Peripheral Nervous System Diseases
A novel amyloidogenic transthyretin variant, Gly53Ala, associated with intermittent headaches and ataxia.
Peripheral Nervous System Diseases
A novel ATTR L32V mutation causes familial amyloid polyneuropathy in a Bolivian family.
Peripheral Nervous System Diseases
A Patient With Hereditary ATTR and a Novel AGel p.Ala578Pro Amyloidosis.
Peripheral Nervous System Diseases
A transthyretin mutation (Tyr78Phe) associated with peripheral neuropathy, carpal tunnel syndrome and skin amyloidosis.
Peripheral Nervous System Diseases
Binding of amyloidogenic transthyretin to the plasma membrane alters membrane fluidity and induces neurotoxicity.
Peripheral Nervous System Diseases
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy.
Peripheral Nervous System Diseases
Burden of hereditary transthyretin amyloidosis on quality of life.
Peripheral Nervous System Diseases
Cardiomyopathy in a Japanese family with the Glu61Lys transthyretin variant: a new phenotype.
Peripheral Nervous System Diseases
Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
Peripheral Nervous System Diseases
Demyelinating Neuropathy in a Patient Treated With Revusiran for Transthyretin (Thr60Ala) Amyloidosis.
Peripheral Nervous System Diseases
Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy.
Peripheral Nervous System Diseases
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France.
Peripheral Nervous System Diseases
Electrophysiological parameters that contribute to the pathogenesis of familial amyloid polyneuropathy caused by transthyretin mutations.
Peripheral Nervous System Diseases
Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences.
Peripheral Nervous System Diseases
Identification of a novel TTR Gly67Glu mutant and the first case series of familial transthyretin amyloidosis in Hong Kong Chinese.
Peripheral Nervous System Diseases
Isolated atrial amyloidosis suspected by electrophysiological voltage mapping and diagnosed by 99m Tc-DPD scintigraphy.
Peripheral Nervous System Diseases
Late-onset peripheral neuropathy in patients with wild type transthyretin amyloidosis (wtATTR).
Peripheral Nervous System Diseases
Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD 18G)
Peripheral Nervous System Diseases
Ostertag revisited: the inherited systemic amyloidoses without neuropathy.
Peripheral Nervous System Diseases
Peripheral neuropathy symptoms in wild type transthyretin amyloidosis.
Peripheral Nervous System Diseases
Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.
Peripheral Nervous System Diseases
Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
Peripheral Nervous System Diseases
Technetium pyrophosphate myocardial uptake and peripheral neuropathy in a rare variant of familial transthyretin (TTR) amyloidosis (Ser23Asn): a case report and literature review.
Peripheral Nervous System Diseases
Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?
Peripheral Nervous System Diseases
Transthyretin amyloidosis (serine 44) with headache, hearing loss, and peripheral neuropathy.
Peripheral Nervous System Diseases
Transthyretin amyloidosis: a new mutation associated with dementia.
Peripheral Nervous System Diseases
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point.
Peripheral Nervous System Diseases
[An immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid]
Phenylketonurias
Tissue-specific activation of mitogen-activated protein kinases for expression of transthyretin by phenylalanine and its metabolite, phenylpyruvic acid.
Pneumonia
A case of wild-type transthyretin amyloidosis associated with organizing pneumonia.
Pneumonia
Protein expression profiles distinguish between experimental invasive pulmonary aspergillosis and Pseudomonas pneumonia.
Polymyositis
A deceptive case of amyloid myopathy: clinical and magnetic resonance imaging features.
Polyneuropathies
1H-NMR structural studies of a cystine-linked peptide containing residues 71-93 of transthyretin and effects of a Ser84 substitution implicated in familial amyloidotic polyneuropathy.
Polyneuropathies
4'-iodo-4'-deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species: screening for TTR fibril disrupters.
Polyneuropathies
99mTc-DPD scintigraphy in transthyretin-related familial amyloidotic polyneuropathy.
Polyneuropathies
A basic transthyretin variant (Glu61-->Lys) causes familial amyloidotic polyneuropathy: protein and DNA sequencing and PCR-induced mutation restriction analysis.
Polyneuropathies
A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation.
Polyneuropathies
A case of familial amyloid polyneuropathy homozygous for the transthyretin Val30Met gene with motor-dominant sensorimotor polyneuropathy and unusual sural nerve pathological findings.
Polyneuropathies
A case of hereditary amyloidosis transthyretin variant Met 30 with amyloid cardiomyopathy, less polyneuropathy, and the presence of giant cells.
Polyneuropathies
A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy.
Polyneuropathies
A chemometric approach for characterization of serum transthyretin in familial amyloidotic polyneuropathy type I (FAP-I) by electrospray ionization-ion mobility mass spectrometry.
Polyneuropathies
A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Polyneuropathies
A double-variant transthyretin allele (Ser 6, Ile 33) in the Israeli patient "SKO" with familial amyloidotic polyneuropathy.
Polyneuropathies
A low amyloidogenic E61K transthyretin mutation may cause familial amyloid polyneuropathy.
Polyneuropathies
A new diagnostic procedure to detect unknown transthyretin (TTR) mutations in familial amyloidotic polyneuropathy (FAP).
Polyneuropathies
A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation.
Polyneuropathies
A new nonamyloid transthyretin variant, G101S, detected by electrospray ionization/mass spectrometry. Mutations in brief no. 201. Online.
Polyneuropathies
A new transthyretin variant from a patient with familial amyloidotic polyneuropathy has asparagine substituted for histidine at position 90.
Polyneuropathies
A non-invasive method based on saliva to characterize transthyretin in familial amyloidotic polyneuropathy patients using FT-ICR high-resolution MS.
Polyneuropathies
A novel tool for detecting amyloid deposits in systemic amyloidosis in vitro and in vivo.
Polyneuropathies
A novel transthyretin mutation associated with familial amyloidotic polyneuropathy.
Polyneuropathies
A novel transthyretin mutation at position 30 (Leu for Val) associated with familial amyloidotic polyneuropathy.
Polyneuropathies
A novel transthyretin mutation V32A in a Chinese man with late-onset amyloid polyneuropathy.
Polyneuropathies
A Novel Variant Mutation of Transthyretin Ile73Val-Related Amyloidotic Polyneuropathy in Taiwanese.
Polyneuropathies
A novel variant of transthyretin (Glu89Lys) associated with familial amyloidotic polyneuropathy.
Polyneuropathies
A novel variant of transthyretin (Tyr114 to Cys) deduced from the nucleotide sequences of gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases.
Polyneuropathies
A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis.
Polyneuropathies
A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers.
Polyneuropathies
A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis.
Polyneuropathies
A second transthyretin mutation at position 33 (Leu/Phe) associated with familial amyloidotic polyneuropathy.
Polyneuropathies
A severe form of amyloidotic polyneuropathy in a Costa Rican family with a rare transthyretin mutation (Glu54Lys).
Polyneuropathies
A transgenic rat with the human ATTR V30M: a novel tool for analyses of ATTR metabolisms.
Polyneuropathies
A transthyretin variant (alanine 49) associated with familial amyloidotic polyneuropathy in a French family.
Polyneuropathies
A transthyretin variant (alanine 71) associated with familial amyloidotic polyneuropathy in a French family.
Polyneuropathies
A trinucleotide deletion in the transthyretin gene (delta V 122) in a kindred with familial amyloidotic polyneuropathy.
Polyneuropathies
Abnormal transthyretin in asymptomatic relatives in familial amyloidotic polyneuropathy.
Polyneuropathies
Accelerating restrictive cardiomyopathy after liver transplantation in a patient with familial amyloidotic polyneuropathy: a case report.
Polyneuropathies
Activation of the heat shock response in familial amyloidotic polyneuropathy.
Polyneuropathies
Advanced glycation end products (AGE) and the receptor for AGE are present in gastrointestinal tract of familial amyloidotic polyneuropathy patients but do not induce NF-kappaB activation.
Polyneuropathies
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects.
Polyneuropathies
Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis.
Polyneuropathies
Ala97Ser transthyretin amyloidosis-associated polyneuropathy, clinical and neurophysiological profiles in a Thai cohort.
Polyneuropathies
Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin.
Polyneuropathies
Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis.
Polyneuropathies
Amyloid deposition in a mouse model humanized at the transthyretin and retinol-binding protein 4 loci.
Polyneuropathies
Amyloid deposits in transthyretin-derived amyloidosis: cleaved transthyretin is associated with distinct amyloid morphology.
Polyneuropathies
Amyloid deposits inside myocardial fibers in transthyretin-Met30 familial amyloidotic polyneuropathy. A histological and biochemical study.
Polyneuropathies
Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis.
Polyneuropathies
Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).
Polyneuropathies
Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants.
Polyneuropathies
Amyloidosis of the Breast: Three Different and Unusual Presentations of a Rare Entity.
Polyneuropathies
An aggressive familial amyloidotic polyneuropathy caused by a new variant transthyretin Lys 54.
Polyneuropathies
An Italian family with Ala-47 transthyretin mutation associated with cardiomyopathy and polyneuropathy.
Polyneuropathies
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy.
Polyneuropathies
Analysis of amyloid deposition in a transgenic mouse model of homozygous familial amyloidotic polyneuropathy.
Polyneuropathies
Analysis of Mitochondrial Haplogroups Associated With TTR Val30Ala Familial Amyloidotic Polyneuropathy in Chinese Patients.
Polyneuropathies
Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met).
Polyneuropathies
Analysis of transthyretin in human serum by capillary zone electrophoresis electrospray ionization time-of-flight mass spectrometry. Application to familial amyloidotic polyneuropathy type I.
Polyneuropathies
Analysis of x-ray diffraction patterns from amyloid of biopsied vitreous humor and kidney of transthyretin (TTR) Met30 familial amyloidotic polyneuropathy (FAP) patients: axially arrayed TTR monomers constitute the protofilament.
Polyneuropathies
Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of Familial Amyloidotic Polyneuropathy.
Polyneuropathies
Antibody recognition of amyloidogenic transthyretin variants in serum of patients with familial amyloidotic polyneuropathy.
Polyneuropathies
Applying an artificial neural network model for developing a severity score for patients with hereditary amyloid polyneuropathy.
Polyneuropathies
Association of C3 and C4A complement types with familial amyloidotic polyneuropathy.
Polyneuropathies
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study.
Polyneuropathies
Association of the transthyretin variant V122I with polyneuropathy among individuals of African ancestry.
Polyneuropathies
Beyond genetic factors in familial amyloidotic polyneuropathy: protein glycation and the loss of fibrinogen's chaperone activity.
Polyneuropathies
Bilateral optic neuropathy in a patient with familial amyloidotic polyneuropathy.
Polyneuropathies
Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy.
Polyneuropathies
Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant.
Polyneuropathies
Biomarkers in the assessment of therapies for familial amyloidotic polyneuropathy.
Polyneuropathies
Biophysical analyses of the transthyretin variants, Tyr114His and Tyr116Ser, associated with familial amyloidotic polyneuropathy.
Polyneuropathies
Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy.
Polyneuropathies
Canadian Guidelines for Hereditary Transthyretin Amyloidosis Polyneuropathy Management.
Polyneuropathies
Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant.
Polyneuropathies
Carvedilol treatment reduces transthyretin deposition in a familial amyloidotic polyneuropathy mouse model.
Polyneuropathies
Cerebrospinal fluid and vitreous body exposure to orally administered tafamidis in hereditary ATTRV30M (p.TTRV50M) amyloidosis patients.
Polyneuropathies
Chain reaction of amyloid fibril formation with induction of basement membrane in familial amyloidotic polyneuropathy.
Polyneuropathies
Chance or challenge, spoilt for choice? New recommendations on diagnostic and therapeutic considerations in hereditary transthyretin amyloidosis with polyneuropathy: the German/Austrian position and review of the literature.
Polyneuropathies
Change in variant transthyretin levels in patients with familial amyloidotic polyneuropathy type I following liver transplantation.
Polyneuropathies
Characterisation of serum transthyretin by electrospray ionisation-ion mobility mass spectrometry: Application to familial amyloidotic polyneuropathy type I (FAP-I).
Polyneuropathies
Characteristics of Patients with Hereditary Transthyretin Amyloidosis and an Evaluation of the Safety of Tafamidis Meglumine in Japan: An Interim Analysis of an All-case Postmarketing Surveillance.
Polyneuropathies
Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss).
Polyneuropathies
Characterization of cysteine and homocysteine bound to human serum transthyretin.
Polyneuropathies
Characterization of end-stage renal disease after liver transplantation in transthyretin amyloidosis (ATTR V30M).
Polyneuropathies
Cholesterol and anionic phospholipids increase the binding of amyloidogenic transthyretin to lipid membranes.
Polyneuropathies
Chromium(III) ion and thyroxine cooperate to stabilize the transthyretin tetramer and suppress in vitro amyloid fibril formation.
Polyneuropathies
Clinical 3-D Gait Assessment of Patients With Polyneuropathy Associated With Hereditary Transthyretin Amyloidosis.
Polyneuropathies
Clinical and histopathological features of familial amyloidotic polyneuropathy with transthyretin Val30Ala in a Chinese family.
Polyneuropathies
Clinical and pathological findings in familial amyloid polyneuropathy caused by a transthyretin E61K mutation.
Polyneuropathies
Clinicopathological features of senile systemic amyloidosis: an ante- and post-mortem study.
Polyneuropathies
Clusterin overexpression and its possible protective role in transthyretin deposition in familial amyloidotic polyneuropathy.
Polyneuropathies
CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
Polyneuropathies
Combined heart and liver transplantation for familial amyloidotic neuropathy.
Polyneuropathies
Common origin of the Val30Met mutation responsible for the amyloidogenic transthyretin type of familial amyloidotic polyneuropathy.
Polyneuropathies
Comparative calorimetric study of non-amyloidogenic and amyloidogenic variants of the homotetrameric protein transthyretin.
Polyneuropathies
Comparative studies of two transthyretin variants with protective effects on familial amyloidotic polyneuropathy: TTR R104H and TTR T119M.
Polyneuropathies
Comparison of quantitative sensory testing and heart rate variability in Swedish Val30Met ATTR.
Polyneuropathies
Complement C1Q polymorphisms modulate onset in familial amyloidotic polyneuropathy TTR Val30Met.
Polyneuropathies
Continuous development of arrhythmia is observed in Swedish transplant patients with familial amyloidotic polyneuropathy (amyloidogenic transthyretin Val30Met variant).
Polyneuropathies
Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis.
Polyneuropathies
Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.
Polyneuropathies
Cutaneous nerve biomarkers in transthyretin familial amyloid polyneuropathy.
Polyneuropathies
Cys114-linked dimers of transthyretin are compatible with amyloid formation.
Polyneuropathies
Cysteine 10 is a key residue in amyloidogenesis of human transthyretin Val30Met.
Polyneuropathies
Decreased thermodynamic stability as a crucial factor for familial amyloidotic polyneuropathy.
Polyneuropathies
Denervation of eccrine glands in patients with familial amyloidotic polyneuropathy type I.
Polyneuropathies
Deposition of transthyretin amyloid is not accelerated by the same amyloid in vivo.
Polyneuropathies
Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates.
Polyneuropathies
Description of transthyretin S50A, S52P and G47A mutations in familial amyloidosis polyneuropathy.
Polyneuropathies
Detection and characterization of aggregates, prefibrillar amyloidogenic oligomers, and protofibrils using fluorescence spectroscopy.
Polyneuropathies
Detection of different forms of variant transthyretin (Met30) in cerebrospinal fluid.
Polyneuropathies
Detection of three transthyretin gene mutations in familial amyloidotic polyneuropathy by analysis of DNA extracted from formalin-fixed and paraffin-embedded tissues.
Polyneuropathies
Development and validation of a liquid chromatography-tandem mass spectrometry method for the assay of tafamidis in rat plasma: Application to a pharmacokinetic study in rats.
Polyneuropathies
Diagnosis and Treatment of Hereditary Transthyretin Amyloidosis (hATTR) Polyneuropathy: Current Perspectives on Improving Patient Care.
Polyneuropathies
Diagnosis of familial amyloidotic polyneuropathy in Sweden by RFLP analysis.
Polyneuropathies
Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy.
Polyneuropathies
Diagnostic radioimmunoassay and DNA-analysis in Swedish and Japanese patients with familial amyloidotic polyneuropathy. Homozygosity for the TTR met30 gene.
Polyneuropathies
Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience.
Polyneuropathies
Discordant penetrance of the trait for familial amyloidotic polyneuropathy in two pairs of monozygotic twins.
Polyneuropathies
Discordant phenotype in monozygotic female twins with Lys35Thr TTR familial amyloidotic polyneuropathy.
Polyneuropathies
DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis.
Polyneuropathies
Disulfide-bond formation in the transthyretin mutant Y114C prevents amyloid fibril formation in vivo and in vitro.
Polyneuropathies
DJ-1 degrades transthyretin and an inactive form of DJ-1 is secreted in familial amyloidotic polyneuropathy.
Polyneuropathies
Dominant cardiac type of familial amyloidotic polyneuropathy associated with a novel transthyretin variant Thr59Arg.
Polyneuropathies
Down regulation of a harmful variant protein by replacement of its normal protein.
Polyneuropathies
Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model.
Polyneuropathies
Early changes of nerve integrity in preclinical carriers of hereditary transthyretin Ala117Ser amyloidosis with polyneuropathy.
Polyneuropathies
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.
Polyneuropathies
Early Data on Long-term Impact of Inotersen on Quality-of-Life in Patients with Hereditary Transthyretin Amyloidosis Polyneuropathy: Open-Label Extension of NEURO-TTR.
Polyneuropathies
Early onset vitreous amyloidosis in familial amyloidotic polyneuropathy with a transthyretin Glu54Gly mutation is associated with elevated vitreous VEGF.
Polyneuropathies
Effect of age and sex differences on wild-type transthyretin amyloid formation in familial amyloidotic polyneuropathy: a proteomic approach.
Polyneuropathies
Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Polyneuropathies
Effect of liver trasplantation on familial amyloidotic polyneuropathy (FAP) and its limt.
Polyneuropathies
Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis.
Polyneuropathies
Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy.
Polyneuropathies
Effect of serum amyloid P component level on transthyretin-derived amyloid deposition in a transgenic mouse model of familial amyloidotic polyneuropathy.
Polyneuropathies
Effect of sildenafil citrate (Viagra) on erectile dysfunction in a patient with familial amyloidotic polyneuropathy ATTR Val30Met.
Polyneuropathies
Effect of tacrolimus and partial hepatectomy on transthyretin metabolism in rats.
Polyneuropathies
Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy.
Polyneuropathies
Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients.
Polyneuropathies
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France.
Polyneuropathies
Elevated interleukin-6 levels are associated with impaired outcome in cardiac transthyretin amyloidosis.
Polyneuropathies
Endoplasmic reticulum stress associated with extracellular aggregates. Evidence from transthyretin deposition in familial amyloid polyneuropathy.
Polyneuropathies
Endothelium-dependent vasodilatation in patients with familial amyloidotic polyneuropathy.
Polyneuropathies
Enzyme-linked immunosorbent assay of transthyretin devised for semimicro plasma diagnosis of familial amyloidotic polyneuropathy.
Polyneuropathies
Epigallocatechin-3-gallate as a potential therapeutic drug for TTR-related amyloidosis: "in vivo" evidence from FAP mice models.
Polyneuropathies
Evaluation of Mortality During Long-Term Treatment with Tafamidis for Transthyretin Amyloidosis with Polyneuropathy: Clinical Trial Results up to 8.5 Years.
Polyneuropathies
Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy.
Polyneuropathies
Evidence for early cytotoxic aggregates in transgenic mice for human transthyretin Leu55Pro.
Polyneuropathies
Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs.
Polyneuropathies
Exertional chest pain is sometimes more than just coronary atherosclerosis.
Polyneuropathies
Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
Polyneuropathies
Extracellular matrix markers for disease progression and follow-up of therapies in familial amyloid polyneuropathy V30M TTR-related.
Polyneuropathies
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
Polyneuropathies
Familial amyloidosis in a large Spanish kindred resulting from a D38V mutation in the transthyretin gene.
Polyneuropathies
Familial amyloidosis with polyneuropathy associated with TTR Ser50Arg mutation.
Polyneuropathies
Familial amyloidosis with polyneuropathy type 1 caused by transthyretin mutation Val50Met (Val30Met): 4 cases in a non-endemic area.
Polyneuropathies
Familial amyloidotic polyneuropathy (ATTR Ser50Ile): the first autopsy case report.
Polyneuropathies
Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders. 2nd International Symposium. Skelleftea, Sweden, June 1-3, 1992. Abstracts.
Polyneuropathies
Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence.
Polyneuropathies
Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation, asparagine 70.
Polyneuropathies
Familial amyloidotic polyneuropathy type 1 in Brazil is associated with the transthyretin Val30Met variant.
Polyneuropathies
Familial amyloidotic polyneuropathy type I with extracellular superoxide dismutase mutation: a case report.
Polyneuropathies
Familial amyloidotic polyneuropathy with late-onset and well-preserved autonomic function: a Japanese kindred with novel mutant transthyretin (Ala97 to Gly).
Polyneuropathies
Familial amyloidotic polyneuropathy with severe renal involvement in association with transthyretin Gly47Glu in Dutch, British and American-Finnish families.
Polyneuropathies
Familial amyloidotic polyneuropathy without familial occurrence: carrier detection by the radioimmunoassay of variant transthyretin.
Polyneuropathies
Familial amyloidotic polyneuropathy: a new transthyretin position 30 mutation (alanine for valine) in a family of German descent.
Polyneuropathies
Familial amyloidotic polyneuropathy: report of patients heterozygous for the transthyretin Gly42 gene.
Polyneuropathies
Familial amyloidotic polyneuropathy: transthyretin (prealbumin) variants in kindreds of Italian origin.
Polyneuropathies
Family studies of the genetic abnormality in transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy.
Polyneuropathies
Fibril in senile systemic amyloidosis is derived from normal transthyretin.
Polyneuropathies
Formation of cytotoxic transthyretin is not dependent on inter-molecular disulphide bridges commonly found within the amyloid form.
Polyneuropathies
Gastrointestinal amyloidosis associated with transthyretin Phe64Ser mutation.
Polyneuropathies
Gene therapy approach to FAP: in vivo influence of T119M in TTR deposition in a transgenic V30M mouse model.
Polyneuropathies
Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells.
Polyneuropathies
Generation of transgenic mice producing a human transthyretin variant: a possible mouse model for familial amyloidotic polyneuropathy.
Polyneuropathies
Genetic analysis of familial amyloidotic polyneuropathy, an autosomal dominant disease.
Polyneuropathies
Genetic anticipation in Portuguese kindreds with familial amyloidotic polyneuropathy is unlikely to be caused by triplet repeat expansions.
Polyneuropathies
Genetic expression of a transthyretin mutation in a case of amyloidotic polyneuropathy occurring in an African.
Polyneuropathies
Genetic expression of a transthyretin mutation in typical and late-onset Portuguese families with familial amyloidotic polyneuropathy.
Polyneuropathies
Genetics of familial amyloidotic polyneuropathy in a Hong Kong Chinese kindred.
Polyneuropathies
Health-related quality of life in hereditary transthyretin amyloidosis polyneuropathy: a prospective, observational study.
Polyneuropathies
Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
Polyneuropathies
Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease.
Polyneuropathies
Homozygosity for the met30 transthyretin gene in a Turkish kindred with familial amyloidotic polyneuropathy.
Polyneuropathies
Homozygosity for the transthyretin-Met30 gene in three Japanese siblings with type I familial amyloidotic polyneuropathy.
Polyneuropathies
Homozygosity for the transthyretin-Met30-gene in seven individuals with familial amyloidosis with polyneuropathy detected by restriction enzyme analysis of amplified genomic DNA sequences.
Polyneuropathies
Human transthyretin (prealbumin) gene and molecular genetics of familial amyloidotic polyneuropathy.
Polyneuropathies
Hydration and packing are crucial to amyloidogenesis as revealed by pressure studies on transthyretin variants that either protect or worsen amyloid disease.
Polyneuropathies
Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation.
Polyneuropathies
Identification of a new transthyretin variant (Ile49) in familial amyloidotic polyneuropathy using electrospray ionization mass spectrometry and nonisotopic RNase cleavage assay.
Polyneuropathies
Identification of a novel transthyretin variant (Val30----Leu) associated with familial amyloidotic polyneuropathy.
Polyneuropathies
Immunization in familial amyloidotic polyneuropathy: counteracting deposition by immunization with a Y78F TTR mutant.
Polyneuropathies
Immunogenicity Assessment of Inotersen, a 2'-O-(2-Methoxyethyl) Antisense Oligonucleotide in Animals and Humans: Effect on Pharmacokinetics, Pharmacodynamics, and Safety.
Polyneuropathies
Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine.
Polyneuropathies
Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy.
Polyneuropathies
Impact of serotonin transporter and catechol-O-methyl transferase genes polymorphism on gastrointestinal dysfunction in Swedish and Japanese familial amyloidotic polyneuropathy patients.
Polyneuropathies
Impaired in vitro growth response of plasma-treated cardiomyocytes predicts poor outcome in patients with transthyretin amyloidosis.
Polyneuropathies
Impairment of the ubiquitin-proteasome system associated with extracellular transthyretin aggregates in familial amyloidotic polyneuropathy.
Polyneuropathies
Improvement of transthyretin familial amyloidotic polyneuropathy after liver transplantation in Argentinian patients.
Polyneuropathies
In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE).
Polyneuropathies
In vitro modelling of familial amyloidotic polyneuropathy allows quantitative detection of transthyretin amyloid fibril-like structures in hepatic derivatives of patient-specific induced pluripotent stem cells.
Polyneuropathies
In vivo detection of nerve injury in familial amyloid polyneuropathy by magnetic resonance neurography.
Polyneuropathies
Incidence of nonamyloidogenic mutations in the transthyretin gene in patients with autonomic and small fiber neuropathy.
Polyneuropathies
Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.
Polyneuropathies
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis.
Polyneuropathies
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis.
Polyneuropathies
Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation.
Polyneuropathies
Investigation into thiol conjugation of transthyretin in hereditary transthyretin amyloidosis.
Polyneuropathies
Japanese monozygotic twins with familial amyloidotic polyneuropathy (FAP) (ATTR Val30Met).
Polyneuropathies
Kind and distribution of cutaneous sensation loss in hereditary transthyretin amyloidosis with polyneuropathy.
Polyneuropathies
Kinetic analysis of the multistep aggregation pathway of human transthyretin.
Polyneuropathies
Kinetic assay for high-throughput screening of in vitro transthyretin amyloid fibrillogenesis inhibitors.
Polyneuropathies
Late-onset Familial Amyloidotic Polyneuropathy with Bence Jones Proteinuria and Cardiomyopathy.
Polyneuropathies
Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data.
Polyneuropathies
Lipid droplets are present in amyloid deposits in familial amyloidotic polyneuropathy and dialysis related amyloidosis.
Polyneuropathies
Liver transplantation and new therapeutic approaches for familial amyloidotic polyneuropathy (FAP).
Polyneuropathies
Liver transplantation for familial amyloidotic polyneuropathy in Australia.
Polyneuropathies
Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients.
Polyneuropathies
Liver transplantation in transthyretin familial amyloid polyneuropathy: first report from Argentina.
Polyneuropathies
Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (ATTR) V30M hereditary amyloidosis with polyneuropathy (FAP).
Polyneuropathies
Long-term outcome of patients with hereditary transthyretin V30M amyloidosis with polyneuropathy after liver transplantation.
Polyneuropathies
Long-term outcomes and complications of trabeculectomy for secondary glaucoma in patients with familial amyloidotic polyneuropathy.
Polyneuropathies
Loss of functional albumin triggers acceleration of transthyretin amyloid fibril formation in familial amyloidotic polyneuropathy.
Polyneuropathies
Magnetization transfer ratio quantifies polyneuropathy in hereditary transthyretin amyloidosis.
Polyneuropathies
Marked cardiomegaly in a patient with familial amyloidotic polyneuropathy after orthotopic liver transplantation: a case study.
Polyneuropathies
Metabolomics analysis for diagnosis and biomarker discovery of transthyretin amyloidosis.
Polyneuropathies
Methods to evaluate the inhibition of TTR fibrillogenesis induced by small ligands.
Polyneuropathies
Misfolded transthyretin causes behavioral changes in a Drosophila model for transthyretin-associated amyloidosis.
Polyneuropathies
Mitochondrial haplogroup is associated with the phenotype of familial amyloidosis with polyneuropathy in Swedish and French patients.
Polyneuropathies
MMP-14 overexpression correlates with the neurodegenerative process in familial amyloidotic polyneuropathy.
Polyneuropathies
mNIS+7 and lower limb function in inotersen treatment of hereditary transthyretin-mediated amyloidosis.
Polyneuropathies
Modifications of transthyretin in amyloid fibrils: analysis of amyloid from homozygous and heterozygous individuals with the Met30 mutation.
Polyneuropathies
Molecular diagnosis of transthyretin Met30 mutation in an Italian family with familial amyloidotic polyneuropathy.
Polyneuropathies
Nerve ultrasonography features in hereditary transthyretin amyloidosis with V30M mutation and polyneuropathy.
Polyneuropathies
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy.
Polyneuropathies
Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy.
Polyneuropathies
Neurofilament light chain, a biomarker for polyneuropathy in systemic amyloidosis.
Polyneuropathies
Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis.
Polyneuropathies
New mutant gene (transthyretin Arg 58) in cases with hereditary polyneuropathy detected by non-isotope method of single-strand conformation polymorphism analysis.
Polyneuropathies
New structural information and update on liver transplantation in transthyretin-associated amyloidosis. Report from the 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, Umeå Sweden, June 1999.
Polyneuropathies
New transthyretin variants SER 91 and SER 116 associated with familial amyloidotic polyneuropathy. Mutations in brief no. 151. Online.
Polyneuropathies
Novel methods for detecting amyloidogenic proteins in transthyretin related amyloidosis.
Polyneuropathies
Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C.
Polyneuropathies
Orthotopic liver transplantation for familial amyloidotic polyneuropathy: a pathological study.
Polyneuropathies
Outcome of exercise electrocardiography in familial amyloidotic polyneuropathy patients, Portuguese type, under evaluation for liver transplantation.
Polyneuropathies
Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients.
Polyneuropathies
Outcomes of domino liver transplantation: a single institution's experience.
Polyneuropathies
Overexpression of Protocadherin-10 in Transthyretin-Related Familial Amyloidotic Polyneuropathy.
Polyneuropathies
Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient.
Polyneuropathies
Pathology of familial amyloidotic polyneuropathy with TTR met 30 in Kumamoto, Japan.
Polyneuropathies
Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.
Polyneuropathies
Polyacrylamide gel electrophoresis followed by sodium dodecyl sulfate gradient polyacrylamide gel electrophoresis for the study of the dimer to monomer transition of human transthyretin.
Polyneuropathies
Polymeric monolithic microcartridges with gold nanoparticles for the analysis of protein biomarkers by on-line solid-phase extraction capillary electrophoresis-mass spectrometry.
Polyneuropathies
Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin Amyloidosis.
Polyneuropathies
Potential use of glucuronylglucosyl-?-cyclodextrin as a novel therapeutic tool for familial amyloidotic polyneuropathy.
Polyneuropathies
Potential use of glucuronylglucosyl-?-cyclodextrin/dendrimer conjugate (G2) as a siRNA carrier for the treatment of familial amyloidotic polyneuropathy.
Polyneuropathies
Potential use of lactosylated dendrimer (G3)/?-cyclodextrin conjugates as hepatocyte-specific siRNA carriers for the treatment of familial amyloidotic polyneuropathy.
Polyneuropathies
Preimplantation genetic diagnosis for familial amyloidotic polyneuropathy (FAP).
Polyneuropathies
Prenatal diagnosis of familial amyloidotic polyneuropathy: evidence for an early expression of the associated transthyretin methionine 30.
Polyneuropathies
Preparative Scale Production of Recombinant Human Transthyretin for Biophysical Studies of Protein-Ligand and Protein-Protein Interactions.
Polyneuropathies
Presence of a plasma transthyretin (prealbumin) variant in familial amyloidotic polyneuropathy in a kindred of Greek origin.
Polyneuropathies
Presence of an abnormal transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy.
Polyneuropathies
Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: an escape from ERAD.
Polyneuropathies
Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation.
Polyneuropathies
Prevalence of hereditary transthyretin amyloid polyneuropathy in idiopathic progressive neuropathy in conurban areas.
Polyneuropathies
Production and functional analysis of normal and variant recombinant human transthyretin proteins.
Polyneuropathies
Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP).
Polyneuropathies
Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant.
Polyneuropathies
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis.
Polyneuropathies
Proline at position 36: a new transthyretin mutation associated with familial amyloidotic polyneuropathy.
Polyneuropathies
Protective role of anakinra against transthyretin-mediated axonal loss and cell death in a mouse model of familial amyloidotic polyneuropathy.
Polyneuropathies
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy.
Polyneuropathies
Quantified sensory abnormalities in early genetically verified transthyretin amyloid polyneuropathy.
Polyneuropathies
Quantitative analysis of amyloid fibril protein in systemic organs of patients with familial amyloidotic polyneuropathy.
Polyneuropathies
Quantitative analysis of post-translational modifications in human serum transthyretin associated with familial amyloidotic polyneuropathy by targeted LC-MS and intact protein MS.
Polyneuropathies
Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.
Polyneuropathies
Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
Polyneuropathies
Rapid method to characterize mutations in transthyretin in cerebrospinal fluid from familial amyloidotic polyneuropathy patients by use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Polyneuropathies
Rate of neuropathic progression in hereditary transthyretin amyloidosis with polyneuropathy and other peripheral neuropathies: a systematic review and meta-analysis.
Polyneuropathies
RE-INTERVENTION IN DE NOVO VITREOUS OPACITIES AFTER PARS PLANA VITRECTOMY IN FAMILIAL AMYLOIDOTIC POLYNEUROPATHY TTR VAL30METPORTUGUESE PATIENTS.
Polyneuropathies
Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience.
Polyneuropathies
Recent Advances in Oligonucleotide-Based Therapy for Transthyretin Amyloidosis: Clinical Impact and Future Prospects.
Polyneuropathies
Recurrent syncope as persistently isolated feature of transthyretin amyloidotic polyneuropathy.
Polyneuropathies
Red flags in patients with hereditary transthyretin amyloidosis at diagnosis in a non-endemic area of Spain.
Polyneuropathies
Regional difference and similarity of familial amyloidosis with polyneuropathy in France.
Polyneuropathies
Relationship between amyloid deposition and intracellular structural changes in familial amyloidotic polyneuropathy.
Polyneuropathies
Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR).
Polyneuropathies
Responder analysis for neuropathic impairment and quality-of-life assessment in patients with hereditary transthyretin amyloidosis with polyneuropathy in the NEURO-TTR study.
Polyneuropathies
Restriction fragment analysis confirms the position 33 mutation in transthyretin from an Israeli patient (SKO) with familial amyloidotic polyneuropathy.
Polyneuropathies
Role of VLDL/chylomicron in amyloid formation in familial amyloidotic polyneuropathy.
Polyneuropathies
Safety and efficacy of long-term diflunisal administration in hereditary transthyretin (ATTR) amyloidosis.
Polyneuropathies
Scavenger treatment of free radical injury in familial amyloidotic polyneuropathy: a study on Swedish transplanted and non-transplanted patients.
Polyneuropathies
Schwann cells contribute to neurodegeneration in transthyretin amyloidosis.
Polyneuropathies
SELDI-TOF Mass Spectrometry Evaluation of Variant Transthyretins for Diagnosis and Pathogenesis of Familial Amyloidotic Polyneuropathy.
Polyneuropathies
Selective binding to transthyretin and tetramer stabilization in serum from patients with familial amyloidotic polyneuropathy by an iodinated diflunisal derivative.
Polyneuropathies
Selective silencing of a mutant transthyretin allele by small interfering RNAs.
Polyneuropathies
Serum transthyretin levels in senile systemic amyloidosis: effects of age, gender and ethnicity.
Polyneuropathies
Severe congestive heart failure with cardiac liver cirrhosis 10 years after orthotopic liver transplantation for familial amyloidotic polyneuropathy.
Polyneuropathies
Simple detection of abnormal serum transthyretin from patients with familial amyloidotic polyneuropathy by high-performance liquid chromatography/electrospray ionization mass spectrometry using material precipitated with specific antiserum.
Polyneuropathies
Simplified method for screening populations at risk for transthyretin Met30-associated familial amyloidotic polyneuropathy.
Polyneuropathies
Small transthyretin (TTR) ligands as possible therapeutic agents in TTR amyloidoses.
Polyneuropathies
Societal costs and burden of hereditary transthyretin amyloidosis polyneuropathy.
Polyneuropathies
Somatic mosaicism with reversion to normality of a mutated transthyretin allele related to a familial amyloidotic polyneuropathy.
Polyneuropathies
Specific Disruption of Transthyretin(105-115) Fibrilization Using "Stabilizing" Inhibitors of Transthyretin Amyloidogenesis.
Polyneuropathies
Specific removal of transthyretin from plasma of patients with familial amyloidotic polyneuropathy: optimization of an immunoadsorption procedure.
Polyneuropathies
Structural distribution of mutations associated with familial amyloidotic polyneuropathy in human transthyretin.
Polyneuropathies
Structural insight to mutated Y116S transthyretin by molecular dynamics simulation.
Polyneuropathies
Structural insights into a zinc-dependent pathway leading to Leu55Pro transthyretin amyloid fibrils.
Polyneuropathies
Structurally abnormal transthyretin causing familial amyloidotic polyneuropathy in Sweden.
Polyneuropathies
Structure of Met30 variant of transthyretin and its amyloidogenic implications.
Polyneuropathies
Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type.
Polyneuropathies
Study of an anti-human transthyretin immunoadsorbent. Influence of coupling chemistry on binding capacity and ligand leakage.
Polyneuropathies
Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin.
Polyneuropathies
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.
Polyneuropathies
Suppression of transthyretin expression by ribozymes: a possible therapy for familial amyloidotic polyneuropathy.
Polyneuropathies
Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix.
Polyneuropathies
Synergy of combined doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models.
Polyneuropathies
Synthesis of an analog of the thyroid hormone-binding protein transthyretin via regioselective chemical ligation.
Polyneuropathies
Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met 30) gene. Pathological and immunohistochemical similarity to human familial amyloidotic polyneuropathy, type I.
Polyneuropathies
Systemic amyloidosis in transgenic mice carrying the human mutant transthyretin (Met30) gene. Pathologic similarity to human familial amyloidotic polyneuropathy, type I.
Polyneuropathies
Systemic delivery of transthyretin siRNA mediated by lactosylated dendrimer/?-cyclodextrin conjugates into hepatocyte for familial amyloidotic polyneuropathy therapy.
Polyneuropathies
Tafamidis, a Noninvasive Therapy for Delaying Transthyretin Familial Amyloid Polyneuropathy: Systematic Review and Meta-Analysis.
Polyneuropathies
Targeting a rare amyloidotic disease through rationally designed polymer conjugates.
Polyneuropathies
Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: new model for amyloid fibril formation.
Polyneuropathies
Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer.
Polyneuropathies
Tetraparesis and sensorimotor axonal polyneuropathy due to co-occurrence of Pompe disease and hereditary ATTR amyloidosis.
Polyneuropathies
The amyloidogenic potential of transthyretin variants correlates with their tendency to aggregate in solution.
Polyneuropathies
The binding of 2,4-dinitrophenol to wild-type and amyloidogenic transthyretin.
Polyneuropathies
The crystal structure of amyloidogenic Leu55 --> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils.
Polyneuropathies
The Extracellular Protein, Transthyretin Is an Oxidative Stress Biomarker.
Polyneuropathies
The flavonoid luteolin, but not luteolin-7-O-glucoside, prevents a transthyretin mediated toxic response.
Polyneuropathies
The high frequency of TTR M30 in familial amyloidotic polyneuropathy is not due to a founder effect.
Polyneuropathies
The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy.
Polyneuropathies
The impact of V30A mutation on transthyretin protein structural stability and cytotoxicity against neuroblastoma cells.
Polyneuropathies
The Italian neuromuscular registry: a coordinated platform where patient organizations and clinicians collaborate for data collection and multiple usage.
Polyneuropathies
The transmissible amyloidoses: genetical control of spontaneous generation of infectious amyloid proteins by nucleation of configurational change in host precursors: kuru-CJD-GSS-scrapie-BSE.
Polyneuropathies
Tissue remodeling after interference RNA mediated knockdown of transthyretin in a familial amyloidotic polyneuropathy mouse model.
Polyneuropathies
Transthyretin (prealbumin) in familial amyloidotic polyneuropathy: genetic and functional aspects.
Polyneuropathies
Transthyretin ALA 71: a new transthyretin variant in a Spanish family with familial amyloidotic polyneuropathy.
Polyneuropathies
Transthyretin Ala97Ser is associated with familial amyloidotic polyneuropathy in a Chinese-Taiwanese family.
Polyneuropathies
Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
Polyneuropathies
Transthyretin amyloidoses of familial amyloidotic polyneuropathy as a paradigm for the genetic control of De Novo generation of Creutzfeldt-Jakob disease infectious amyloid by a spontaneous change in configuration of the host precursor protein.
Polyneuropathies
Transthyretin amyloidoses of familial amyloidotic polyneuropathy as a paradigm for the genetic control of spontaneous generation of infectious amyloids by patterned configurational change in host precursors in Creutzfeldt-Jacob disease.
Polyneuropathies
Transthyretin amyloidosis: an under-recognized neuropathy and cardiomyopathy.
Polyneuropathies
Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration.
Polyneuropathies
Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.
Polyneuropathies
Transthyretin familial amyloid polyneuropathy due to lle107Val mutation mimicking atypical chronic inflammatory demyelinating polyneuropathy: case report.
Polyneuropathies
Transthyretin familial amyloidotic polyneuropathy: histopathological study of the explanted livers.
Polyneuropathies
Transthyretin fibrillogenesis entails the assembly of monomers: a molecular model for in vitro assembled transthyretin amyloid-like fibrils.
Polyneuropathies
Transthyretin forms amyloid fibrils at physiological pH with ultrasonication.
Polyneuropathies
Transthyretin Ile73Val is associated with familial amyloidotic polyneuropathy in a Bangladeshi family. Mutations in brief no. 158. Online.
Polyneuropathies
Transthyretin oligomers induce calcium influx via voltage-gated calcium channels.
Polyneuropathies
Transthyretin Pro 36 associated with familial amyloidotic polyneuropathy in an Ashkenazic Jewish kindred.
Polyneuropathies
Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cells.
Polyneuropathies
Transthyretin RNA profiling in livers from transplanted patients affected by familial amyloidotic polyneuropathy, and identification of a dual transcription start point.
Polyneuropathies
Transthyretin Thr60Ala Appalachian-type mutation in a Japanese family with familial amyloidotic polyneuropathy.
Polyneuropathies
TRANSTHYRETIN V30M FAMILIAL AMYLOIDOSIS PRESENTING AS ISOLATED RETINAL ANGIOPATHY.
Polyneuropathies
Transthyretin Val71Ala mutation in a Dutch family with familial amyloidotic polyneuropathy.
Polyneuropathies
Transthyretin valine-94-alanine, a novel variant associated with late-onset systemic amyloidosis with cardiac involvement.
Polyneuropathies
Transthyretin-related familial amyloidotic polyneuropathy-Progress in Kumamoto, Japan (1967-2010)-.
Polyneuropathies
TTR-related amyloid neuropathy: clinical, electrophysiological and pathological findings in 15 unrelated patients.
Polyneuropathies
Two novel variants of transthyretin identified in Japanese cases with familial amyloidotic polyneuropathy: transthyretin (Glu42 to Gly) and transthyretin (Ser50 to Arg).
Polyneuropathies
Two transthyretin mutations (glu42gly, his90asn) in an Italian family with amyloidosis.
Polyneuropathies
Two-tiered DNA-based diagnosis of transthyretin amyloidosis reveals two novel point mutations.
Polyneuropathies
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia.
Polyneuropathies
Understanding the Disease Course and Therapeutic Benefit of Tafamidis Across Real-World Studies of Hereditary Transthyretin Amyloidosis with Polyneuropathy: A Proof of Concept for Integrative Data Analytic Approaches.
Polyneuropathies
Unusual self-association properties of transthyretin Y114C related to familial amyloidotic polyneuropathy: effects on detection and quantification.
Polyneuropathies
Uptake of aggregating transthyretin by fat body in a Drosophila model for TTR-associated amyloidosis.
Polyneuropathies
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area.
Polyneuropathies
Variable Presentation of Hereditary Transthyretin-Mediated Amyloidosis at a Single Center.
Polyneuropathies
Variant transthyretin in cerebrospinal fluid in familial amyloidotic polyneuropathy.
Polyneuropathies
VIth International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Disorders and the Vth International Workshop on Liver Transplantation in Familial Amyloidotic Polyneuropathy 24-26 August 2005 La Jolla, CA, USA.
Polyneuropathies
Vitreous amyloidosis associated with homozygosity for the transthyretin methionine-30 gene.
Polyneuropathies
Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation.
Polyneuropathies
Vitreous amyloidosis in two sisters as the indication of transthyretin-related familial form of systemic amyloidosis among liver transplantation candidates.
Polyneuropathies
Vitreous opacities in a case of familial amyloidotic polyneuropathy associated with a transthyretin Lys 54.
Polyneuropathies
Wild-type transthyretin-derived amyloidosis in various ligaments and tendons.
Polyneuropathies
X-ray absorption spectroscopy reveals a substantial increase of sulfur oxidation in transthyretin (TTR) upon fibrillization.
Polyneuropathies
[A late onset familial amyloidotic polyneuropathy (FAP) with a novel variant transthyretin characterized by a basic-for-acidic amino acid substitution (Glu61-->Lys)]
Polyneuropathies
[Amyloidogenesis of variant transthyretin in familial amyloidotic polyneuropathy]
Polyneuropathies
[An immunocytochemical study of alpha 1-antichymotrypsin in the senescent cerebral amyloid]
Polyneuropathies
[Biochemical studies of amyloidogenesis in two different types of amyloidoses--amyloid transthyretin variant in familial amyloidotic polyneuropathy and islet amyloid polypeptide in non-insulin-dependent diabetes mellitus]
Polyneuropathies
[Case report; The first transthyretin Thr49Ala variant case of familial amyloidotic polyneuropathy in Japan].
Polyneuropathies
[Clinical and genetic heterogeneity in familial amyloidotic polyneuropathy associated with variant transthyretin]
Polyneuropathies
[Clinical characteristics of Hungarian-type familial meningo-cerebrovascular amyloidosis]
Polyneuropathies
[Familial amyloidotic polyneuropathy with a transthyretin variant (Val30-->Leu)]
Polyneuropathies
[Familial amyloidotic polyneuropathy without familial occurrence but with asymptomatic carriers discovered by radioimmunoassay of variant transthyretin]
Polyneuropathies
[Gene therapy in familial amyloidotic polyneuropathy by single-stranded oligonucleotides (SSOs)]
Polyneuropathies
[Liver transplantation in familial amyloid polyneuropathy. Case report and review of the literature]
Polyneuropathies
[Myocardiopathy caused by Portuguese-type familial amyloidotic polyneuropathy. Sequential morphologic and functional study of 60 patients]
Polyneuropathies
[Protein and DNA sequencing analyses of transthyretin in familial amyloidotic polyneuropathy]
Polyneuropathies
[Review of the recent literature on peripheral neuropathies: therapeutic advances].
Polyneuropathies
[The importance of TTR met 30 in the diagnosis of familial amyloidotic polyneuropathy in the absence of a positive family history]
Polyneuropathies
[The use of FD-6 monoclonal antibody in diagnosing and detecting the carriers of familial amyloidotic polyneuropathy type I]
Polyneuropathies
[Transthyretin familial amyloid polyneuropathy - three Hungarian cases with rare mutations (His88Arg and Phe33Leu)].
Polyneuropathies
[Two brother cases of late-onset familial amyloidotic polyneuropathy in Kyoto]
Polyradiculoneuropathy
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid.
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Hard to swallow: atypical transthyretin amyloid neuropathy mistaken for CIDP.
Pre-Eclampsia
Aggregated transthyretin is specifically packaged into placental nano-vesicles in preeclampsia.
Pre-Eclampsia
An altered pattern of circulating apolipoprotein E3 isoforms is implicated in preeclampsia.
Pre-Eclampsia
Human placental transthyretin in fetal growth restriction in combination with preeclampsia and the HELLP syndrome.
Pre-Eclampsia
MicroRNA regulation of transthyretin in trophoblast biofunction and preeclampsia.
Pre-Eclampsia
Multifactorial Analysis of Affinity-Mass Spectrometry Data from Serum Protein Samples: A Strategy to Distinguish Patients with Preeclampsia from Matching Control Individuals.
Pre-Eclampsia
Transthyretin Is Dysregulated in Preeclampsia, and Its Native Form Prevents the Onset of Disease in a Preclinical Mouse Model.
Pressure Ulcer
Inflammation and disability as risk factors for mortality in elderly acute care patients.
Primary Dysautonomias
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR).
Primary Dysautonomias
Cardiac Dysautonomia and Survival in Hereditary Transthyretin Amyloidosis.
Primary Dysautonomias
Cardiac Dysautonomia Predicts Long-Term Survival in Hereditary Transthyretin Amyloidosis After Liver Transplantation.
Primary Dysautonomias
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis.
Prion Diseases
Benefit of doxycycline treatment on articular disability caused by dialysis related amyloidosis.
Prostatic Hyperplasia
Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel- and lectin-based proteomics analyses.
Prostatic Neoplasms
Changes of transthyretin and clusterin after androgen ablation therapy and correlation with prostate cancer malignancy.
Prostatic Neoplasms
Tetraiodothyroacetic acid and transthyretin silencing inhibit pro-metastatic effect of L-thyroxin in anoikis-resistant prostate cancer cells through regulation of MAPK/ERK pathway.
Protein Deficiency
Expression of liver-specific genes coding for plasma proteins in protein deficiency.
Protein-Energy Malnutrition
Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases.
Protein-Energy Malnutrition
Plasma levels of transthyretin and retinol-binding protein in Child-A cirrhotic patients in relation to protein-calorie status and plasma amino acids, zinc, vitamin A and plasma thyroid hormones.
Protein-Energy Malnutrition
Repletion of the plasma pool of nutrient transport proteins occurs at different rates during the nutritional rehabilitation of severely malnourished children.
Protein-Energy Malnutrition
Structural modifications of serum transthyretin in rats during protein-energy malnutrition.
Protein-Energy Malnutrition
Value of serum transthyretin measurements in the assessment of marginal protein-energy malnutrition in rats.
Proteinuria
Albumin/creatinine (uACR) and protein/creatinine (uPCR) ratios in spot urine samples can be used to evaluate albuminuria and proteinuria in hereditary transthyretin amyloidosis patients.
Proteinuria
Clinical associations of an increased transthyretin band in routine serum and urine protein electrophoresis.
Proteinuria
Transthyretin Is Dysregulated in Preeclampsia, and Its Native Form Prevents the Onset of Disease in a Preclinical Mouse Model.
Proteostasis Deficiencies
Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.
Proteostasis Deficiencies
Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs.
Proteostasis Deficiencies
Native state kinetic stabilization as a strategy to ameliorate protein misfolding diseases: a focus on the transthyretin amyloidoses.
Proteostasis Deficiencies
Structural Stabilization of Human Transthyretin by Centella asiatica (L.) Urban Extract: Implications for TTR Amyloidosis.
Pulmonary Disease, Chronic Obstructive
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation.
Pulmonary Disease, Chronic Obstructive
Transthyretin--an explanation of "anomalous" serum thyroid hormone values in severe illness?
Renal Insufficiency
Metabolism and clinical interest of serum transthyretin (prealbumin) in dialysis patients.
Renal Insufficiency
Metabolomics analysis for diagnosis and biomarker discovery of transthyretin amyloidosis.
Renal Insufficiency
[Amyloid from insulin treatment: a pitfall for the pathologist and the diabetologist].
Renal Insufficiency, Chronic
Human TTRV30M localization within podocytes in a transgenic mouse model of transthyretin related amyloidosis: does the environment play a role?
Respiratory Insufficiency
Nutritional depletion in patients on long-term oxygen therapy and/or home mechanical ventilation.
Retinal Vein Occlusion
Intravitreal bevacizumab upregulates transthyretin in experimental branch retinal vein occlusion.
Rhabdomyolysis
Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone.
Sarcoidosis
A quantitative proteomic analysis of soluble bronchoalveolar fluid proteins from patients with sarcoidosis and chronic beryllium disease.
Sarcoma, Avian
Optimized AAV-protein phosphatase 5 helper-viruses for efficient liver transduction by single-stranded AAV vectors: Therapeutic expression of Factor IX at reduced vector doses.
Sarcopenia
A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease.
Schistosomiasis
Protein C deficiency in the compensated form of hepatosplenic schistosomiasis.
Seizures
Effects of Chronic Stress on Prefrontal Cortex Transcriptome in Mice Displaying Different Genetic Backgrounds.
Seizures
Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene.
Seizures
Peony root extract upregulates transthyretin and phosphoglycerate mutase in mouse cobalt focus seizure.
Seizures
Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu).
Sepsis
Continuous evaluation of changes in the serum proteome from early to late stages of sepsis caused by Klebsiella pneumoniae.
Sepsis
Measurement of granulocyte maturation may improve the early diagnosis of the septic state.
Shock, Cardiogenic
Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shock.
Siderosis
Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
Siderosis
Familial amyloid polyneuropathy involving a homozygous Val30Met mutation in the amyloidogenic transthyretin gene presenting with superficial siderosis: a case report.
Siderosis
Familial leptomeningeal amyloidosis with a transthyretin variant Asp18Gly representing repeated subarachnoid haemorrhages with superficial siderosis.
Sigmoid Neoplasms
Significant deposition of wild type transthyretin-derived amyloid in the gastrointestinal tract of aged individuals.
Silicosis
[Utilizing 2-DE and MALDI-TOF MS/MS to screen differentially expressed serum proteins of silicosis]
Small Fiber Neuropathy
Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France.
Small Fiber Neuropathy
Incidence of nonamyloidogenic mutations in the transthyretin gene in patients with autonomic and small fiber neuropathy.
Small Fiber Neuropathy
Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy.
Small Fiber Neuropathy
Small fiber neuropathy in Sjögren syndrome: Comparison with other small fiber neuropathies.
Smoldering Multiple Myeloma
Coexistent transthyretin amyloid cardiomyopathy and monoclonal gammopathy: Diagnostic challenges and prognostic implications.
Smoldering Multiple Myeloma
Pilot Study of F18-Florbetapir in the Early Evaluation of Cardiac Amyloidosis.
Spinal Cord Diseases
Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu).
Spinal Stenosis
Increased thickness of lumbar spine ligamentum flavum in wild-type transthyretin amyloidosis.
Spinal Stenosis
Lumbar ligamentum flavum burden: Evaluating the role of ATTRwt amyloid deposition in ligamentum flavum thickness at all lumbar levels.
Spinal Stenosis
Lumbosacral stenosis in Labrador retriever military working dogs - an exomic exploratory study.
Spinal Stenosis
Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis.
Spinocerebellar Ataxias
Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report.
Spinocerebellar Degenerations
Twenty Years of a Pre-Symptomatic Testing Protocol for Late-Onset Neurological Diseases in Portugal.
Spondylarthropathies
Early destructive spondyloarthropathy from combined beta2-microglobulin and transthyretin Met30 amyloidosis in a dialysed patient.
Squamous Cell Carcinoma of Head and Neck
Analysis of the saliva proteome from patients with head and neck squamous cell carcinoma reveals differences in abundance levels of proteins associated with tumour progression and metastasis.
ST Elevation Myocardial Infarction
Plasma Exosome Profile in ST-Elevation Myocardial Infarction Patients with and without Out-of-Hospital Cardiac Arrest.
Starvation
Pretreatment of starved rats with ornithine alpha-ketoglutarate: effects on hepatic mRNA levels and plasma concentrations of three liver-secreted proteins.
Stomach Neoplasms
Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer.
Stomach Neoplasms
Serum transthyretin level is associated with prognosis of patients with gastric cancer.
Stroke
Acute-phase proteins before cerebral ischemia in stroke-prone rats: identification by proteomics.
Stroke
Quick and effective improvement of leucine enriched dietary supplement on malnutrition in acute stroke patients receiving enteral tube feeding.
Stroke
Transthyretin Concentrations in Acute Stroke Patients Predict Convalescent Rehabilitation.
Strongyloidiasis
Shotgun proteomics of Strongyloides venezuelensis infective third stage larvae: Insights into host-parasite interaction and novel targets for diagnostics.
Subarachnoid Hemorrhage
Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu).
Syncope
Cardiac amyloidosis associated with a novel transthyretin aspartic acid-18 glutamic acid de novo mutation.
Syncope
Recurrent syncope as persistently isolated feature of transthyretin amyloidotic polyneuropathy.
Syncope
Syncope as a Phenotypic Expression of Hereditary Transthyretin Amyloidosis Val142Ile (Val122Ile).
Teratocarcinoma
Induction of the expression of retinol-binding protein and transthyretin in F9 embryonal carcinoma cells differentiated to embryoid bodies.
Thrombocytopenia
Underlying Immune Disorder May Predispose Some Transthyretin Amyloidosis Subjects to Inotersen-Mediated Thrombocytopenia.
Thrombosis
No Association Between CHADS-VASc Score and Left Atrial Appendage Thrombus in Patients With Transthyretin Amyloidosis.
Thyrotoxicosis
A new family with hyperthyroxinemia caused by transthyretin Val109 misdiagnosed as thyrotoxicosis and resistance to thyroid hormone--a clinical research center study.
Thyrotoxicosis
Isoelectric focussing of human thyroxine binding globulin (thyropexin) and human prealbumin (transthyretin).
Trisomy 18 Syndrome
Molecular analysis of the expression of transthyretin in intestine and liver from trisomy 18 fetuses.
Typhoid Fever
Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis.
Uterine Cervical Neoplasms
Identification of potential cervical cancer serum biomarkers in Thai patients.
Uveitis
Vitreous amyloidosis with autonomic neuropathy of the digestive tract associated with a novel transthyretin p.Gly87Arg variant in a Bangladeshi patient: a case report.
Vascular Diseases
Genetic stabilization of transthyretin, cerebrovascular disease, and life expectancy.
Vascular Diseases
ProApolipoprotein A1: a serum marker of brain metastases in lung cancer patients.
Vasculitis, Central Nervous System
Transthyretin amyloid-related cerebral angiitis after liver transplantation.
Virus Diseases
[Transthyretin levels in serum and cerebrospinal fluid sustain the nutrio-viral hypothesis of the Cuban epidemic neuropathy]
Vitamin A Deficiency
A low molar ratio of retinol binding protein to transthyretin indicates vitamin A deficiency during inflammation: studies in rats and a posterior analysis of vitamin A-supplemented children with measles.
Vitamin A Deficiency
Proxy markers of serum retinol concentration, used alone and in combination, to assess population vitamin A status in Kenyan children: a cross-sectional study.
Vitreoretinopathy, Proliferative
[Differential expression and significance of complement C4b and transthyretin in proliferative vitreoretinopathy].
Waldenstrom Macroglobulinemia
True, true unrelated? Coexistence of Waldenström macroglobulinemia and cardiac transthyretin amyloidosis.
Wasting Syndrome
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy.
html completed